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Abstract
Ca2+ is an important messenger which mediates several physiological functions, in-
cluding muscle contraction, fertilisation, heart regulation and gene transcription. One
major way its cytosolic level is raised is via a G-protein coupled receptor (GPCR)–
mediated release from intracellular stores. GPCR’s are the target of approximately 50%
of all drugs in clinical use. Hence, understanding the underlying mechanisms of sig-
nalling in this pathway could lead to improved therapy in disease conditions associ-
ated with abnornmal Ca2+ signalling, and to the identification of new drug targets. To
gain such insight, this thesis builds and analyses a detailed mathematical model of key
processes leading to Ca2+ mobilisation.
Ca2+ signalling is considered in the particular context of the M3 muscarinic recep-
tor system. Guided by available data, the Ca2+ mobilisation model is assembled, first
by analysing a base G-protein activation model, and subsequently extending it with
downstream details. Computationally efficient designs of a global parameter sensi-
tivity analysis method are used to identify the key controlling parameters with re-
spect to the main features of the Ca2+ data. The underlying mechanism behind the
experimentally observed, rapid, amplified Ca2+ response is shown to be a rapid rate
of inositol trisphosphate (IP3) formation from Phosphatidylinositol 4,5-bisphosphate
(PIP2) hydrolysis. Using the same results, potential drug targets (apart from the GPCR)
are identified, including the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) and
PIP2. Moreover, possible explanations for therapeutic failures were found when some
parameters exerted a biphasic effect on the relative Ca2+ increase.
The sensitivity analysis results are used to simplify the process of parameter esti-
mation by a significant reduction of the parameter space of interest. An evolutionary
algorithm is used to successfully fit the model to a significant portion of the Ca2+ data.
Subsequent sensitivity analyses of the best-fitting parameter sets suggest that mecha-
nistic modelling of kinase-mediated GPCR desensitisation, and SERCA dynamics may
be required for a comprehensive representation of the data.
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CHAPTER 1
Introduction
1.1 Cell signalling
The proper functioning of any organism depends on the ability of its individual cells
to correctly interact with their environment and each other. For example, a normal im-
mune response to harmful compounds (like insect bites) is the release of Histamine,
which then interacts with cells in the affected area to induce protective mechanisms
like swelling and muscle contraction. The processing of a variety of such signals by
various cells is what enables the proper functioning of organisms, and the underly-
ing mechanisms can collectively be referred to as cell signalling. Understanding those
mechanisms can help explain and rectify failures in physiological functioning. For in-
stance, in allergy sufferers, the protective release of Histamine occurs in response to
innocuous substances, and therapies (such as antihistamines) were developed using
knowledge of the mechanisms of Histamine’s interaction with cells.
One of the ways that cells respond to signals is via proteins called receptors, which
act as sensors. They are activated by ligands, which are molecules that induce a re-
sponse by binding to receptors and forming a complex; they often alter the conforma-
tion, and hence functionality of the receptors. Receptors which reside in the cell mem-
brane are called cell surface receptors; these possess an extracellular portion to which
ligands can bind, and a portion on the membrane interior where other molecules can
interact (see Figure 1.1). In this way the extracellular signal can be detected and relayed
into the cell. Molecules which can act as ligands, include hormones, neurotransmitters
and drugs [106]. Hormones are chemical messengers which, from organs where they
are produced, travel through the bloodstream to other organs [56], where they can in-
duce a cellular response by interacting with cell surface receptors; physiological func-
tions as varied as growth, metabolism, digestion and heart rate regulation are initiated
by hormones. Neurotransmitters are chemical messengers which transmit impulses
between nerves, or between nerves and muscles. Many existing drugs are synthetic
1
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Figure 1.1: Schematic of a G-protein coupled receptor, which is a cell surface receptor.
compounds, either designed to induce similar responses to endogenous ligands or to
inhibit their action. For instance, antihistamines work by blocking the binding of His-
tamine to its receptor.
1.1.1 G-protein coupled receptor signalling
The interest of this work is confined to cell signalling pathways initiated by G-protein
coupled receptors (GPCR’s), a family of cell surface receptors. GPCR’s are the largest
family of membrane-bound receptors, through which the majority of extracellular sig-
nals are processed [1]. They span themembrane bywinding back and forth seven times
through it, and G proteins, which are located on the inside of the cell membrane, can
bind to their intracellular portion. It is reported that more than 50% of all drugs in clin-
ical practice are targeted toward GPCR’s [18]; this is because they mediate numerous
physiological functions, including metabolism, reproduction, development, hormonal
homeostasis, and behaviour [98].
G-proteins are so called because of the role that guanine nucleotides play in regu-
lating their activity [79]. The G-protein is a heterotrimer, i.e., it is composed of three
subunits: the α, β, γ units. There is a guanine nucleotide binding site on the α subunit,
and β and γ are very closely associated, and thought to operate as one subunit [27].
In the G-protein’s inactive state, the α subunit’s binding site is occupied by the gua-
nine nucleotide, guanosine diphosphate (GDP). The receptor can be activated with or
without a bound ligand, and when (in its active state) it binds to the G-protein, GDP
dissociates and leaves room for the guanine nucleotide, guanosine triphosphate (GTP),
to bind. GTP activates the G-protein, causing a change in conformation, and causing
the G-protein to dissociate from the ligand-receptor complex, which can subsequently
bind to other inactive G-proteins (see Figure 1.2).
A widely held hypothesis is that the G-protein’s subunits dissociate on activation.
However, there are objections to this hypothesis which state that while it is certain that
2
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Figure 1.2: Schematic of the G-protein activation cycle (reproduced with permission
from [106]), based on the hypothesis that the G-protein’s subunits dissociate; an alterna-
tive hypothesis states that they do not dissociate.
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Figure 1.3: Pathways activated by different G-proteins, and interactions between them.
Ca2+ mobilisation is mediated via the Gq protein. Picture reproduced with permission
from [32].
the G-protein can dissociate under certain experimental conditions (for example, in de-
tergent solution, in the presence of high concentrations of magnesium ions), it might
not necessarily do so in cell membranes [27]. Consequently, an alternative, experimen-
tally supported hypothesis is that the active α subunit does not need to dissociate in
order to mediate downstream signalling [27, 79]. Most mathematical models are based
on the former hypothesis [37, 44, 48, 86, 106], but in this chapter both will be consid-
ered.
The α subunit is inactivated when GTP is hydrolysed back to GDP, through an
intrinsic ability of the α subunit, referred to as GTPase activity. There are other proteins,
including Regulators of G protein signalling (RGS) and the enzyme Phospholipase C
(PLC), which have the ability to bind to the α subunit and accelerate its intrinsic GTPase
activity.
There are four main G-protein classes: Gs, Gi, Gq, and G12/13, to which all the afore-
mentioned G-protein activation mechanisms apply, but each type is capable of medi-
ating different pathways. Gs-coupled receptors stimulate adenylyl cyclase, which syn-
thesises cyclic adenosine monophosphate (cAMP), which in turn mediates gene tran-
scription; Gi-coupled receptors inhibit adenylyl cyclase and so reduce cAMP formation
(see Figure 1.3). The βγ subunits from Gi and other G-proteins are also able to mediate
downstream signalling [32]. The G12/13 class of G-proteins is the most recently discov-
ered of the four [89], and mediates signalling to the cytoskeleton via the GTPases Rac
and RhoA [27]. This thesis focuses on the pathway activated by the Gq protein, which
leads to calcium release from intracellular stores.
The active Gq-protein activates the β isoform of PLC (PLCβ) by binding, after which
4
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its membrane-bound substrate phosphatidylinositoldiphosphate (PIP2) is cleaved by
PLCβ into inositol triphosphate (IP3) and diacylglycerol (DAG). Subsequently, IP3 and
DAG trigger divergent pathways. DAG remains in themembrane and activates Protein
Kinase C (PKC), which contributes to receptor desensitisation, and continues a path-
way that eventually reaches the nucleus of the cell [55]. IP3 diffuses into the cytosol
and goes on to stimulate calcium (Ca2+) release from intracellular stores into the cy-
tosol, ultimately leading to cellular responses such as smooth muscle contraction and
changes in gene expression via the activation of transcription factors. This thesis aims
to develop amathematical model that encompasses signalling events from ligand bind-
ing to Ca2+ mobilisation, but because of the complexity involved, this will be done in
stages, of which the early signalling event, G-protein activation is the first.
1.1.2 Motivation
Pharmacology has been described as “a way of thinking and designing experiments
[which] compare the activities of natural and synthetic compounds on a biological tar-
get (usually a GPCR) and use quantitative measurements to gain insight into mecha-
nisms of action” [33]. Exploring the relationship between drugs (synthetic compounds)
and the nature and extent of the cellular response they induce is an important part of
the process of drug discovery, where drugs are tested for potential use in medicine. The
work in this thesis was done in collaboration with pharmacological experimentalists
from the Institute of Cell Signalling at the University of Nottingham, who have studied
in particular the M3 muscarinic GPCR system, for which there are synthetic drugs that
successfully induce a similar Ca2+ response as the receptor’s natural ligand, Acetyl-
choline.
The model which will be assembled in this thesis will be tailored to match Ca2+
mobilisation data from the M3 muscarinic pathway [52, 54], from experiments carried
out by Dr Lauren May under the supervision of Professor Stephen Hill. Guided by
these data, the aim is to use a detailed model to provide further insight into mecha-
nisms of drug action in this pathway, and where possible, other GPCR-mediated Ca2+
pathways.
Pharmacological analysis frequently uses simplified functional forms which phe-
nomenologically describe the data, but, by lumping several processes together, might
obscure mechanistic detail. Hence, a detailed model can be used to shed light on im-
portant mechanisms in the pathway. It is hoped that this will inspire new ways of
thinking about, and designing, experiments. The M3 receptor is already a drug tar-
get in the treatment of lung-related and urological disorders [5], but understanding
the pathway mechanisms might highlight other drug targets. Also, this pathway is in-
5
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volved in controlling cell-cycle progression and cell death in activated T cells [49], so
important insights for regenerative medicine might be gained by better understanding
this pathway.
1.2 Experimental studies of GPCR signalling
For obvious reasons, testing the effects of ligands on receptor systems cannot routinely
be carried out in the human host. In previous years, the lack of access to human re-
ceptors necessitated the use of animal receptor systems, as many of the ligands medi-
ating response via these receptors were the same in animals as in humans [38]. Most
of the known therapeutic drugs were discovered using these surrogate animal tissues.
However, these experiments have largely given way to experiments carried out in en-
gineered human receptor systems known as recombinant systems [40]. These are set-ups
in which human DNA is used to make non-human cells express human receptors. This
process of introducing nucleic acid into cells to express particular proteins is what is
referred to as transfection. Another important term is overexpression, which refers to the
process by which these surrogate cells are exposed to high DNA concentrations in or-
der to yield increased expression of particular proteins [40]. Current technology allows
for both receptor and G-protein overexpression in appropriate GPCR systems [39, 85].
Recombinant systems are often used in drug discovery. Two terms often used to
describe the properties of a drug are affinity and efficacy (For a glossary of these, and
other, pharmacological terms, see appendix A). Affinity is a ligand-specific property
which refers to the ability of a drug to bind (or stay bound) to its receptor, and so is
purely ameasure of the strength of interaction, while efficacy is a measure of the drug’s
ability to induce a response. The latter would depend on a ligand’s intrinsic efficacy,
and system-specific mechanisms [40].
An agonist is a ligand which acts to positively increase cellular response, so it pos-
sesses positive efficacy; different agonists can have different efficacies. An inverse ago-
nist acts to decrease basal activity, hence it possesses negative efficacy, while an antago-
nistmerely occupies the binding site and in itself does not act to influence the response
either way. Figure 1.4 shows examples of dose-response curves which are often used in
pharmacology to quantify drug activity. The steepness of a curve depends on both the
affinity and efficacy of the agonist it represents, while its maximum value is dependent
on its efficacy alone. So in Figure 1.4(a), agonists A, B and C all produce the maximum
response, i.e. they are full agonists, but A and B are more left-shifted than C because
the agonists have varying affinites. In Figure 1.4(b), only A is a full agonist. B and C
are partial agonists, but B has the greater efficacy because the highest response it can
6
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Figure 1.4: Dose-response curves illustrating (a) the action of full agonists; some curves
are more left-shifted, but all produce the maximal response. (b) the action of a full ago-
nist (A) and partial agonists (B and C), which do not induce the maximal response.
produce is higher than C’s.
In the study of receptor systems, cellular response cannot always bemeasured at ev-
ery level of the pathway. For GPCR’s there are currently no experimental methods for
tracking αGTP or βγ over time, hence there are no data with which to directly compare
time course simulations. But there are available procedures to measure the binding
of a GTP analogue GTPγS to the α subunit [58], which cannot be hydrolysed, so that
the whole G-protein cycle is not completed; hence, the G-protein responsemeasured in
such experiments is likely higher than it would normally be. Also, the accumulation of
ligand-receptor complexes and time courses for secondmessengers like Ca2+ are easily
measured. Experimental methods for measuring Ca2+ will be discussed in Chapter 3.
1.3 Previous mathematical models of GPCR signalling
Over the years, many models have been developed to describe the behaviour of recep-
tor signalling systems, which are largely a series of biochemical reactions. The majority
of models utilise the law of mass action, which states that the rate of a reaction is pro-
portional to the product of the concentrations of its reactants. Given the following
reversible reaction
A + B
k+−−⇀
↽−−
k−
AB, (1.1)
the rate of production of the product AB, is given by
7
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d[AB]
dt
= −d[A]
dt
= −d[B]
dt
= k+[A][B]− k−[AB], (1.2)
where (and throughout this thesis), [∗] refers to the concentration of ∗. If the reaction
is irreversible, the rates are given by substituting k− = 0.
The majority of existing GPCR signalling models are equilibrium models. These are
models which describe the equilibrium states of the receptors with algebraic equations
derived from applying steady state conditions to themass action equations can be used
to describe how the addition of ligand changes the steady state distribution of receptor
states [46].
The simplest of these equilibrium models is Clark’s classical model [16], proposed
in 1933, which describes the interaction of two components only, the receptor, R and
ligand, L, and assume that they bind following the law of mass action, so that the
receptor can exist in two states: unbound (R) and ligand-bound (LR) [103]. The only
possible reactions are:
L + R
k+−−⇀
↽−−
k−
LR, (1.3)
Using the law of mass action and the assumption of equilibrium (that the forward
rate is equal to the backward rate):
Ka =
k+
k−
=
[LR]
[L][R]
, (1.4)
where Ka is called the equilibrium association constant. Its reciprocal, KD, is called the
dissociation constant, and is measured in the same unit as the ligand. Both constants
are measures of affinity. A high Ka (or equivalently, low KD) indicates a strong affinity
for the receptor.
In this model, the efficacy of a drug is taken to be the ratio of ligand-bound to total
receptor concentration, and is quantified by the following saturation function:
Response =
[L]
[L] + KD
, (1.5)
using the fact that the total number of receptors is conserved and given by RTOT =
[R] + [LR]. No provision was made in this model for different drugs with similar affini-
ties but varying efficacies. In 1954, E. J. Ariens introduced a proportionality factor κ to
address this limitation as follows [4]:
8
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Response =
κ . [L]
[L] + KD
. (1.6)
κ values exist in the range of 0 to 1, representing a spectrum of agonists that pro-
duce no response to those that produce the maximum response. Since then many more
models with differing levels of complexity [103] have been developed to account for
further experimental observations. After it came to light that receptors can bind to
other membrane proteins (the G-protein in the case of GPCR’s), the ternary complex
model (TCM) [19] was proposed, which incorporates G-protein binding into the classi-
cal model. It allows the receptor to bind to a third component, the G-protein (G). The
reactions for this model are:
L+ R ⇋ LR (1.7)
LR+ G ⇋ LRG (1.8)
In this model the receptor can only bind to the G-protein when it has itself been
bound by the ligand.
New experimental evidence revealed that unbound receptors can spontaneously
become active and in turn activate G-proteins in the absence of any ligand; such a re-
sponse is referred to as constitutive activity. Increased constitutive activity has been
observed in systems where receptors have been overexpressed; for instance, it was
observed in Sf9 insect cells that the second messenger cAMP can be generated at a
rate which is directly proportional to the level of receptor expression [27]. Constitu-
tive activity has been detected by overexpressing many other GPCR’s, including the
Ca2+-activating Gq-coupled Histamine H1 receptor [84]. Another source of constitu-
tive activity is G-protein overexpression; in [85], GTPase activity was reported to in-
crease with G-protein expression levels. The TCM could not account for constitutive
activity, so an extension was proposed: the extended ternary complex model (eTCM).
This model assumes that the receptor can exist in two states: one active (R), one inac-
tive (R∗), with the ligand able to bind to both states with different affinities. The active
receptor, whether ligand-bound or not, can bind and activate the G-protein [103], al-
though the ligand can alter its affinity for the G-protein. Consequently, there are six
receptor species: R, R∗, LR, LR∗, R∗G, LR∗G (see Figure 1.5).
The discovery of promiscuous receptors, which can bind tomore than oneG-protein
type, prompted the proposal of a three-state receptor model. This model assumes the
simplest case, in which the receptor can exist in two active conformations, R∗ and R∗∗,
each able to bind to a unique G-protein type [71]. An explanation for the ability of a
drug to be an agonist in one system and an inverse agonist in another was offered by
the model.
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R
LR
R*
LR*
RG
LR*G
Figure 1.5: The extended cubic ternary complex model (eCTM) accounts for the fact that
receptor can become spontaneously become active (R∗).
R LR
RG LRG
R∗ LR
∗
R∗G LR∗G
G binding
R activation
L binding
Figure 1.6: The cubic ternary complex (CTC) model accounts for all possible states.
All the previously mentioned models (except the three state model) are subsets of
the cubic ternary complex model (CTC), a comprehensive model which includes all
possible combinations of receptor, ligand and one G-protein type, based on the as-
sumption that the ligand and G-protein never directly encounter each other [103]. In
this model the receptor can exist in eight states, as shown in Figure 1.6, and agonist effi-
cacy is the ability of a ligand to increase the number of receptors in the active, signalling
state (R∗G and LR∗G) at equilibrium.
1.3.1 Equilibrium vs kinetic models
The assumption of equilibrium in the previously discussed models limit the ability to
characterise a drug’s properties because important time-dependent (e.g. transient) re-
sponsesmight go uncharacterised. As a result, kinetic models are nowmore commonly
used tomodel GPCR signalling. The cubic ternary complex activation model (cTCAM),
for example, integrates the kinetics of G protein activation and deactivation in the CTC
model with three additional irreversible reactions that describe the G-protein activa-
tion cycle [86]. Without the assumption of equilibrium, the model consists of a system
10
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Figure 1.7: Transient responses induced by two different drugs. If only the equilibrium
response is measured, both drugs appear to have little efficacy. However, if the peak
response is used, drug B is efficacious.
of ODEs, allowing, for instance, a transient αGTP peak to be predicted [41]. Figure 1.7 is
used to illustrate why it may be important to use transient responses as measures of a
drug’s action. If only the equilibrium response is measured, both drugs would appear
to be similar, having little efficacy. However, if the peak response is used, only drug A
has little efficacy, and such behaviour can be captured by a kinetic model.
1.3.2 A kinetic model: The cubic ternary complex activation model
The cTCAM, which will be used to analyse the dynamics of G-protein activation in this
thesis, is now described in detail.
Receptor-Ligand binding
The model assumes that the receptor switches between an active and inactive state, as
follows:
R
kact−−⇀
↽−−
kdeact
R∗, (1.9)
The ligand can bind to both receptor states with different affinites, modelled by the
thermodynamic constant ζ = ζ+ζ− , as follows:
L + R
klb+−−⇀
↽−−
klb−
LR, (1.10)
L+ R∗
ζ+klb+−−⇀
↽−−
ζ−klb−
LR∗. (1.11)
ζ = 1 indicates an antagonist, a drug which binds indiscriminately to both receptor
states; ζ > 1 indicates an agonist, which favours the receptor’s active state; ζ < 1
11
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models an inverse agonist, which favours the inactive state of the receptor. The ligand
concentration is assumed constant, since it is usually supplied in excess.
The inactive receptor-ligand complex can also spontaneously become active, as fol-
lows:
LR
ζ+kact−−⇀
↽−−
ζ−kdeact
LR∗. (1.12)
The four receptor states can also bind to the G-protein with different affinities. This
includes the possibility of precoupling, a situation in which a G protein binds to a recep-
tor before the ligand:
R + G
kg+−−⇀
↽−−
kg−
RG, (1.13)
R∗ + G
µ+kg+−−⇀
↽−−
µ−kg−
R∗G, (1.14)
LR+ G
ν+kg+−−⇀
↽−−
ν−kg−
LRG, (1.15)
LR∗ + G
θνµµ+ν+kg+−−⇀
↽−−
θνµµ−ν−kg−
LR∗G, (1.16)
where µ+ and µ− make up the equilibrium constant, µ =
µ+
µ− , which models the extent
to which the active receptor binds more or less preferably to the G-protein than the
inactive receptor. ν+ and ν− make up the equilibrium constant ν = ν+ν− , which models
the extent to which the ligand binds more preferably to the precoupled receptors (RG,
R∗G) than to the uncoupled ones. θνµ quantifies the extent to which ligand binding and
receptor activation jointly facilitate the binding of G-protein.
The inactive receptor-G-protein complexes can also spontaneously become active:
RG
µ+kact−−⇀
↽−−
µ−kdeact
R∗G, (1.17)
LRG
θζµζ+µ+kact−−⇀
↽−−
θζµζ−µ−kdeact
, LR∗G. (1.18)
where θνµ quantifies the extent to which ligand binding and G-protein coupling jointly
facilitate receptor activation.
The ligand can also bind to precoupled receptors, as follows:
L+ RG
ν+klb+−−⇀
↽−−
ν−klb−
LRG, (1.19)
12
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L + R∗G
θζνζ+ν+klb+−−⇀
↽−−
θζνζ−ν−klb−
LR∗G, (1.20)
where θζν quantifies the extent to which receptor activation and G-protein coupling
jointly facilitate ligand binding.
It is assumed that only the active receptor states, R∗G and LR∗G, can carry on the
signalling pathway, by activating the G-protein.
The G-protein activation cycle
As noted previously, there are divided views on the exact mechanisms of G-protein
activation and deactivation. The cTCAM is built on the hypothesis that GTP bind-
ing causes the α and the βγ subunits of the G-protein to dissociate into two activated
components, αGTP and βγ, which can interact with effector molecules and propagate
signalling [1], as given by the following reactions:
R∗G + GTP −→ R∗ + αGTP + GDP+ βγ
LR∗G + GTP −→ LR∗ + αGTP + GDP+ βγ.
It is assumed that GTP and GDP are present at constant levels. This means that
their concentrations can be incorporated into the rate constants, so that the activation
reactions are given by:
R∗G
kGTP+−→ R∗ + αGTP + βγ, (1.21)
LR∗G
kGTP+−→ LR∗ + αGTP + βγ. (1.22)
As previously mentioned, αGTP has the ability to deactivate itself by hydrolysing
GTP to GDP; its bound GTP loses one phosphate molecule, leaving the inactive form,
αGDP,; the inactive G-protein (G) is recovered when αGDP reunites with βγ:
αGTP
kgd+−→ kgd− αGDP, (1.23)
αGDP + βγ
kRA+−→ kRA− G. (1.24)
The law of mass action is used to convert all reactions to ODEs which can then be
integrated and used to describe time-dependent behaviour. A variant model, with a
G-protein activation and deactivation cycle built on the hypothesis that the G-protein
subunits do not dissociate will also be described in the next chapter.
There are other relevant kinetic mathematical models of G-protein signalling that
describe events beyond G-protein activation. Lemon et al. incorporated the dynamics
of IP3 formation and Ca
2+ mobilisation into the G-protein cascade [44], while Kang
13
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and Othmer incorporated the dynamics of IP3 formation, PKC feedback and Ca
2+ mo-
bilisation [37]. In another study, agonist-induced Ca2+ mobilisation was coupled to
downstream phosphorylation events [48]. Thesemodels will be discussedwhen events
downstream of G-protein activation are considered, later in Chapter 3.
1.4 Thesis Outline
The rest of the thesis is outlined below.
In Chapter 2, the cTCAM is analysed by considering the effects of varying cell-
specific parameters (total receptor and G-protein concentration) on the active G-protein
response. The effects of ligand-specific parameters are also considered, when particular
drugs are modelled. In addition, the cTCAM is compared with a variant model, in
which the G-protein subunits do not dissociate.
In Chapter 3, Ca2+ signalling is discussed in more detail. The cTCAM is then ex-
tended by adapting downstream details from an existing Ca2+ model [37]. Guided by
experimental results, the parameters of the extended model are then fine-tuned using
manual variation and numerical simulation. A more systematic parameter analysis is
then carried out in Chapter 4, by using a global sensitivity analysis method to identify
parameters which most influence key features of the Ca2+ response seen in the data.
Such parameters are then adjusted to enable the model match the data more closely,
while providing insight about pathway dynamics.
In Chapter 5, possible adjustments to the model (suggested by the results of Chap-
ter 4) are considered, resulting in variant Ca2+ mobilisation models, which are subse-
quently analysed.
In Chapter 6, a global parameter optimisation is carried out to improve the quan-
titative fit to the data, and to provide further insight about the model, while a further
sensitivity analysis points to possible model extensions.
Finally, in Chapter 7, themain results of the thesis are summarised, and suggestions
are made about future work that can build on these results.
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Modelling G-protein Activation
2.1 Introduction
The pathway from ligand binding to Ca2+ release consists of multiple processes, many
ofwhich are complex in nature. This thesis seeks to assemble amodel of these processes
which is detailed enough to provide insight into important pathwaymechanisms; how-
ever, this results in a complex model; it therefore makes sense to start by analysing a
simpler, existing model of early signalling events (such as the cubic ternary complex
activation model (cTCAM)), which can subsequently be developed into a more exten-
sive model. This allows the model to be better understood before it is used as a base
model in the extension process. In addition, insight can be gained about the earlier
signalling events.
In this chapter, the cTCAM (see section 1.3), is used to study the responses of the
mediators of downstream signalling, αGTP and βγ; in particular, the effects of changing
model parameters such as the total receptor, total G-protein, and ligand concentrations
are explored; these parameters can be experimentally manipulated, and so have direct
practical application. Also, ligand-specific parameters such as affinity and efficacy are
modelled for actual drugs which were used in Dr Lauren May’s M3 muscarinic exper-
iments [52, 54].
As noted in Chapter 1, traditionally, GPCR modelling has made use of equilibrium
models, so time courses for active G-protein have only recently been simulated; αGTP,
but not βγ, has been simulated in some relatively recent studies [41, 44, 106]. Although
Ca2+ release in the M3 muscarinic pathway is mediated through αGTP, the βγ response
will also be discussed in this chapter, for comparison, since both subunits partake in
the G-protein activation cycle.
The cTCAM model equations, derived by applying the law of mass action to reac-
tions (1.9) - (1.24) in Chapter 1, are given by:
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d[R]
dt
= −kact[R] + kdeact[R∗]− klb+[L][R] + klb−[LR]
−kg+[R][G] + kg−[RG] (2.1)
d[R∗]
dt
= kact[R]− kdeact[R∗]− ζ+klb+[L][R∗] + ζ−klb−[LR∗]
−µ+kg+[R∗][G] + µ−kg−[R∗G] + kGTP+[R∗G] (2.2)
d[LR]
dt
= klb+[L][R]− klb−[LR]− ζ+kact[LR] + ζ−kdeact[LR∗]
−ν+kg+[LR][G] + ν−kg−[LRG] (2.3)
d[LR∗]
dt
= ζ+klb+[L][R
∗]− ζ−klb−[LR∗] + ζ+kact[LR]− ζ−kdeact[LR∗]
−θνµµ+ν+kg+[LR∗][G] + θνµµ−ν−kg−[LR∗G]
+kGTP+[LR
∗G] (2.4)
d[RG]
dt
= kg+[R][G]− kg−[RG]− µ+kact[RG] + µ−kdeact[R∗G]
−ν+klb+[L][RG] + ν−klb−[LRG] (2.5)
d[R∗G]
dt
= µ+kg+[R
∗][G]− µ−kg−[R∗G] + µ+kact[RG]− µ−kdeact[R∗G]
−θζνζ+ν+klb+[L][R∗G] + θζνζ−ν−klb−[LR∗G]− kGTP+[R∗G] (2.6)
d[LRG]
dt
= ν+kg+[LR][G]− ν−kg−[LRG]− θζµζ+µ+kact[LRG]
+θζµζ−µ−kdeact[LR∗G] + ν+klb+[L][RG]− ν−klb−[LRG] (2.7)
d[LR∗G]
dt
= θνµµ+ν+kg+[LR
∗][G]− θνµµ−ν−kg−[LR∗G]
+θζµζ+µ+kact[LRG]− θζµζ−µ−kdeact[LR∗G]
+θζνζ+ν+klb+[L][R
∗G]− θζνζ−ν−klb−[LR∗G]
−kGTP+[LR∗G] (2.8)
d[G]
dt
= −ν+kg+[LR][G] + ν−kg−[LRG]
−θνµµ+ν+kg+[LR∗][G] + θνµµ−ν−kg−[LR∗G]
−µ+kg+[R∗][G] + µ−kg−[R∗G]
−kg+[R][G] + kg−[RG] + kRA+[αGDP][βγ] (2.9)
d[αGTP]
dt
= kGTP+[R
∗G]− kgd+[αGTP] + kGTP+[LR∗G] (2.10)
d[βγ]
dt
= kGTP+[R
∗G] + kGTP+[LR∗G]− kRA+[αGDP][βγ] (2.11)
d[αGDP]
dt
= kgd+[αGTP]− kRA+[αGDP][βγ] (2.12)
The variables are the concentrations of the different signalling molecules (measured
in moles per litre, M) and time, measured in seconds. Because of the number of reac-
tions involved in the signalling pathway, the model is a high order system of coupled
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Figure 2.1: The unstimulated phase of signalling. (Note the log scale of the x axes.)
Initially, only the unbound receptor (R) and G-protein states (G) exist. (a) Receptor pre-
coupling occurs when the receptor and G-protein bind; (b) spontaneous receptor activa-
tion also occurs, allowing the active pre-coupled state (R∗G) to form; (c) some G-protein
activation also occurs. The steady state levels of these species then serve as initial condi-
tions for ligand stimulation.
ODEs which cannot be solved analytically, hence computational methods are heavily
relied on for the analysis of the models in this thesis. Model simulations are carried out
in MATLAB using the ode15s solver for stiff systems, because the existence of various
time scales makes the model stiff [106]. Parameter values for this chapter are listed in
Appendix B and were taken from a previous study [106].
In order to compare the hypotheses of G-protein subunit dynamics discussed in
section 1.1.1, this chapter finally compares the cTCAM with an adapted version, in
which the G-protein does not dissociate into αGTP and βγ.
2.2 Agonist-induced G-protein activation
This section uses the cTCAM to mimic experiments in which cells are in a basal state
before stimulation by a drug (specifically, an agonist) [54]. Hence, the ligand concentra-
tion is initially set as [L] = 0. In addition, the total (unbound) G-protein concentration
and total (unbound) receptor concentration are given by GTOT = 4.15× 10−10M and
RTOT = 4.15× 10−10M respectively (following a previous study [106]), while all other
species are at zero concentration. During this unstimulated phase, formation of other
species then occurs until a steady state is reached, as illustrated in Figure 2.1; precou-
pled receptors, RG and R∗G form, (Figure 2.1(a) (b)), and from the latter, basal αGTP
and βγ form (Figure 2.1(c)). The equilibrium values of all species then serve as the
initial conditions for ligand stimulation.
Unless otherwise indicated, a stimulation of [L] = 10−5M of a strong agonist will
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Figure 2.2: (a) αGTP and βγ responses in the cTCAM to an agonist, added after 10000s
(when a steady state has been reached). Both subunits exhibit the same transient peak
response when GTOT = 4.15× 10−10M, RTOT = 4.15× 10−10M; (b) Experimental results
reveal that Ca2+ also exhibits a transient peak response over various agonist concentra-
tions [54].
be used in the simulations; the strength of the agonist is modelled by the values
klb+ = 8.4× 107M−1s−1,
klb− = 0.37s−1,
ζ =
ζ+
ζ−
= 1000.
This is an agonist that quickly binds to the receptor and strongly favours the recep-
tor’s active state, since ζ is much greater than 1 (see section 1.3.2). As mentioned, the
cellular response will be defined as the concentration of activated G-protein.
2.2.1 The transient peak response
Previous studies illustrate that in response to agonist stimulation, αGTP can exhibit a
rapid, transient peak response [41, 106], brought on by rapid agonist binding which
increases αGTP production via reaction (1.22); consequent GTPase action via reaction
1.24) then makes the peak transient [106]. With the parameter set in Table B.2.1, the
cTCAM model predicts that rapid (≈ 5 seconds), transient αGTP peak, as illustrated in
Figure 2.2(a); βγ also exhibits an early peak due to rapid agonist binding, but unlike
αGTP, βγ does not undergo GTPase action, hence its descent to steady state level (also
referred to as the plateau in this chapter) is due to its subsequent re-association with
αGDP (see reaction (1.24)).
Figure 2.2(b) shows Ca2+ time courses from the M3 muscarinic receptor pathway
[54], from which it can be seen that Ca2+ also exhibits a rapid, transient peak. Because
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αGTP mediates the production of IP3, which is the trigger for Ca
2+ mobilisation, the
lifetime of the αGTP response can be expected to have an impact on the lifetime of cy-
tosolic Ca2+. Even though the pathway has downstreammechanisms for IP3 and Ca
2+
removal [74, 94], which would contribute to the transience of the Ca2+ response, their
efficiency would depend on the strength of αGTP activation. Hence, this section ex-
plores the hypothesis that the transience of the Ca2+ peak depends on the existence of
a transient αGTP peak (referred to as the transient peak hypothesis). In that case, parame-
ters that control αGTP’s peak could also be used to manipulate Ca
2+ release in a similar
fashion.
2.2.2 The influence of receptor and G-protein expression levels
In a previous study [41], a sensitivity analysis identified the key parameters that influ-
ence the dynamics of αGTP production in the cTCAM. 1000 parameter sets were sam-
pled (using latin hypercube sampling) from a parameter space constrained by defining
uncertainty ranges for each parameter, based on values from the literature, and it was
shown that these parameter sets predict varying αGTP time courses. The variations
included disparate basal levels (which could vary by factors of up to 350) and either
transient or sustained responses to agonist stimulation. Total G-protein GTOT and to-
tal receptor (RTOT) were implicated as the 1st and 3rd most important drivers of the
dynamics of αGTP, so they are key to understanding G-protein activation, which could
then have implications for the Ca2+ response. Hence this section considers the effects
of varying GTOT and RTOT, particularly on the transient αGTP (and βγ) peak.
RTOT and GTOT are sometimes quantified according to how many molecules are
present per cell. Ranges for RTOT and GTOT have been given as 10
2 − 105 per cell in the
literature [41]; conversion to moles per litre can be carried out by multiplying by the
number of cells per litre, and dividing by Avogadro’s number, NA = 6.022× 1023. As-
suming a typical value of 5× 109 cells per litre [86], 102 − 105 converts to 8.3× 10−13 −
8.3 × 10−10M. Obviously this conversion depends on the number of cells per litre,
which might vary across experiments, hence receptor and G-protein concentrations up
to 10−6M have also been reported [37]. An uncertainty range of 10−12 − 10−6M can
thus be defined for RTOT and GTOT.
The influence of G-protein concentration
The total G-protein concentration is now varied, while RTOT is fixed at 4.15× 10−10M.
Figures 2.3(a) and 2.3(b) show the [αGTP] and [βγ] time courses for various G-
protein concentrations; the peak concentrations of both subunits increase with GTOT,
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which can be seen more clearly in Figure 2.3(c), where the peak values are plotted
against log(GTOT/RTOT). In Figure 2.3(d), the size of the transient peak, quantified by
subtracting the plateau from the peak (Peak−Plateau), is plotted against log(GTOT/RTOT).
When the peak is sustained, Peak − Plateau= 0, but when it is transient, Peak −
Plateau> 0. The significant peak increases occur when log(GTOT/RTOT) lies between
1 and 3, while transience is lost after log(GTOT/RTOT) = 1 (which is when GTOT:RTOT
is 10:1). Also, around this value, the peaks become significantly slower, as illustrated
by Figure 2.3(e). Hence when G-proteins significantly outnumber the receptors, the re-
sponse increases but its qualitative nature changes. Hence, if the transience of the Ca2+
peak depends on the existence of a transient αGTP peak, it can potentially be removed
by expressing more G-protein than receptor.
In general, the dynamics of αGTP and βγ are strikingly similar; the only differences
occur at the lowest G-protein concentrations, when the peaks are relatively insignifi-
cant; in these cases, βγ takes longer to peak than αGTP (see Figure 2.3(e)).
The influence of receptor concentration
The total receptor concentration is now varied, while GTOT is fixed at 4.15× 10−10M.
Figures 2.4(a) and 2.4(b) show the [αGTP] and [βγ] time courses for various re-
ceptor concentrations; the peak values of both subunits increase with [RTOT], which
can be seen more clearly in Figure 2.4(c), where the peak values are plotted against
log(RTOT/GTOT). In Figure 2.4(d), (Peak− Plateau) is plotted against log (RTOT/GTOT).
The significant peak increases occur when log(RTOT/GTOT) lies between -1 and 2,
while transience is lost shortly before log(RTOT/GTOT) = 2 (which is when the RTOT:GTOT
ratio is 100:1). At this point the peaks also become significantly slower, as can be seen
in Figure 2.4(e). Hence, the qualitative nature of the response also changes when the
receptors significantly outnumber the G-proteins (and not just the other way round),
and if the peak hypothesis is true, these results suggest that the Ca2+ transient peak ob-
served in theM3muscarinic Gq pathway mobilisation experimentsmay also be remov-
able by increasing receptor expression. Hence, such experiments are worth designing.
An important observation is that, in general, the agonist generates less of a re-
sponse through receptor overexpression than it does through G-protein overexpres-
sion (compare Figures 2.3(c) and 2.4(c)). This is perhaps because of reaction (1.22)
(LR∗G
kGTP+−→ LR∗ + αGTP + βγ) which allows for instantaneous receptor ’recycling’. Af-
ter αGTP and βγ are released, the dissociated LR
∗ complex is free to bind to a different
unboundG-protein, andwhen the total G-protein concentration is high, manymore cy-
cles of G-protein activation are then possible. However, when RTOT is varied the effect
is not the same; at high receptor concentrations, the number of possible cycles is limited
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Figure 2.3: The effects of varying the total G-protein concentration (RTOT = 4.15 ×
10−10M) on αGTP and βγ after the addition of an agonist at t = 10000s, when the system
is at steady state. (a),(b) αGTP and βγ time courses; (c) αGTP and βγ peak values, which
increase with GTOT; (d) Peak−Plateau for αGTP and βγ; (e) the times taken to reach αGTP
and βγ peaks, which are very similar for the significant peaks.
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Figure 2.4: The effects of varying the total receptor concentration (GTOT = 4.15 ×
10−10M) on αGTP and βγ after the addition of an agonist. (a),(b) αGTP and βγ time
courses; (c) αGTP and βγ peak values, which increase with RTOT; (d) Peak−Plateau for
αGTP and βγ; (e) the times taken to reach αGTP and βγ peaks, which are very similar for
the significant peaks.
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by the relatively small G-protein concentration (GTOT = 4.15× 10−10M). The G-protein
does undergo recycling when αGDP, the product of αGTP hydrolysis (αGTP
kgd+−→ αGDP),
reassociates with βγ to reform the whole G-protein (αGDP + βγ
kRA+−→G), which can thus
bind again to another free receptor; however, because it requires two extra reactions,
this is a comparatively delayed recycling process. As the G-protein cannot bind as ef-
fectively to multiple receptors, as the receptor can to multiple G-proteins, G-protein
overexpression is a more effective measure. The receptor concentration is more rou-
tinely manipulated in experimental studies [41], but these results suggest that more
effort should also go into manipulating the G-protein concentration.
It has been shown that variations in the ratio of the total G-protein to receptor con-
centration can alter the transience of the peak response. The ratios were carried out
either with GTOT fixed at 4.15× 10−10M or RTOT fixed at 4.15× 10−10M. A more thor-
ough analysis may be carried out by simulating with various other GTOT : RTOT ratios
within the defined ranges. This kind of analysis will be covered by a more global pa-
rameter analysis on an extension of the cTCAM in Chapter 4.
2.2.3 The influence of ligand properties
The effects of ligand related properties, such as affinity and efficacy (and concentra-
tion), on the dynamics of G-protein activation are now considered. Pharmacological
GPCR experiments are often carried out by stimulating cells with various concentra-
tions of various agonists and measuring the response at a selected point in the path-
way. The ability of these ligands to increase the cellular response can then be observed.
The levels of response tend to depend on where response is measured in the pathway.
For instance, in the previous section it was seen that one active ligand receptor com-
plex (LR∗G) can activate multiple G-protein cycles (see reaction (1.22)), so the αGTP
response is considerably higher than the LR∗G one, as illustrated in Figure 2.5. Such
mechanisms, which take small signals and amplify their effect, occur along the path-
way, and the phenomenon is referred to as signal amplification.
At the University of Nottingham’s Institute of Cell Signalling, Dr Lauren May’s ex-
periments on the M3 Muscarinic receptor pathway measured Ca2+ levels induced by
a range of concentrations of four different agonists; these data are presented as Ca2+
time courses (see Figures 2.2(b)), and corresponding dose response curves, constructed
using the Ca2+ peak values as measures of the system’s response (Figure 2.8(c)). As
mentioned in Chapter 1, αGTP cannot be measured in such an experiment. The cTCAM
can be used to mimic these experiments, but with output at the αGTP level. Although
the cTCAM has previously been analysed in different ways [41, 86, 106], it does not
appear that it has been used to model specific agonists. Here, each agonist will be
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Figure 2.5: The αGTP response is considerably greater than the [LR
∗G] response, due
to signal amplification (GTOT = 4.15× 10−10M, RTOT = 4.15× 10−10M, klb+ = 8.4×
107M−1s−1, klb− = 0.37s−1, ζ =
ζ+
ζ− = 1000, [L] = 10
−7M.
modelled by adjusting the parameters that pertain to ligand binding (affinity) and ef-
ficacy. Comparing the simulated αGTP response with the Ca
2+ data then allows the
agonist’s effects at both levels of the pathway to be observed. In addition, since the
hypothesis of the previous sections is that the transience of the Ca2+ peak depends (in
somemeasure) on that of the αGTP peak, dose-response curves for the αGTP peak values
are compared to the Ca2+ dose-response curves from the experiments. In this section,
only αGTP, the mediator of Ca
2+ release in this receptor system, is considered.
The initial values of GTOT = RTOT = 4.15× 10−10M will be used in all the simula-
tions.
Modelling ligand-specific properties
The four agonists used in Dr May’s experiments are Oxotremorine-M, Carbachol, Pi-
locarpine and Bethanachol. Binding studies have been carried out on these agonists
which reveal that they have different affinities for the M3 muscarinic receptor, illus-
trated by the fact that their (experimentally estimated) binding and unbinding rate
constants, klb+ and klb− (which are shown in Table 2.2.1)) differ from each other [92].
Modelling affinity is then simply a matter of using these values in the simulations.
(Note that the experimental estimation method made use of a simplified model, which
excludes the active receptor state (R∗), hence the rate constants may not be completely
fine-tuned for the more detailed cTCAM. However, at the very least, they are useful for
comparing the different agonist affinities.)
Modelling efficacy is a less direct procedure. The parameter that controls ligand
efficacy in the cTCAM is ζ = ζ+ζ− , so each of the four agonists can have a different ζ
value. This is modelled by fixing ζ+ = 1 and assigning different ζ− values to each ag-
onist; ζ−, and not ζ+, is varied because experimental studies suggest that an agonist’s
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Agonist klb+(M
−1s−1) klb−(s−1) ζ
Oxotremorine-M klb+ = 2885.6 klb− = 0.14 543.48
Carbachol klb+ = 691.2 klb− = 0.14 294.11
Pilocarpine klb+ = 10222.2 klb− = 0.35 29.94
Bethanachol klb+ = 796.8 klb− = 0.26 49.5
Table 2.2.1: Rate constants for the association (klb+) and dissociation (klb−) of some ag-
onists, taken from the experimental studies of Sykes et al. [92], as well as estimates of
their efficacy, ζ.
efficacy might be governed by how slowly it dissociates [92]. ζ values for each agonist
can be estimated by converting experimentally estimated measures of relative efficacy,
τ, from the aforementioned study [92]; the τ values were obtained by fitting to Black
and Leff’s [9] operational model of agonism, given by
[L](Emax
τ
τ+1)
KD
τ+1 + [L]
, (2.13)
where Emax is the maximum possible response and KD is the dissociation constant of
ligand-receptor binding. It can be seen that, the higher its τ value ( ττ+1 → 1, KDτ+1 → 0),
the closer an agonist comes to producing the maximum response. There is no direct
way to make the conversions from τ to ζ, but since τ is a measure of relative efficacy,
a reasonable approach is to obtain corresponding ζ values which preserve the same
ratios as respective τ values. It is assumed that the agonist with the maximum efficacy
is represented by ζ = 1000, corresponding to the highest experimentally estimated τ
value, τmax = 42701 and then for the ith agonist:
τmax
τi
=
1000
ζ i
. (2.14)
Then,
ζ i− =
ζ+
ζ i
=
1
ζ i
. (2.15)
The ζ values obtained for each agonist are given in Table 2.2.1. Oxotremorine-M is
the most efficacious, with ζ = 543.48, while Pilocarpine, with ζ = 29.94, is the least.
Simulations
Figures 2.6 and 2.7 show that, for all the agonists, the simulated αGTP and experimen-
tal Ca2+ time courses are similar, and the αGTP and Ca
2+ peaks remain transient as
agonist concentration increases (although, as the previous section showed, receptor or
G-protein overexpression can remove the transience). Another similarity is that the
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simulated αGTP time-to-peak and the experimental Ca
2+ time-to-peak exhibit a simi-
lar dependence on the agonist concentration; Figures 2.8(c) and 2.8(d) show that both
times-to-peak decrease as each agonist’s concentration increases. It should be noted
that the times taken to reach the αGTP peak are generally longer than the times taken to
reach the Ca2+ peak in the experiments (Figure 2.8), which would seem to contradict
the transient peak hypothesis. However, the discrepancy might be explained by the
fact that αGTP’s interaction with PLC which occurs further down in the pathway is not
included in the model. PLC considerably accelerates αGTP hydrolysis (see section 1.1.1)
[27], and so would cause the αGTP peak to occur much earlier.
The main difference between the experimental Ca2+ peak and the simulated αGTP
one is that all agonists are able to produce the same maximal Ca2+ response (through
signal amplification), while they produce different maximal αGTP responses. In other
words, at the Ca2+ level, all four drugs are full agonists, but not at the αGTP level; this is
especially indicated by the fact that the Ca2+ curves are left-shifted, with smaller con-
centrations of agonist required to produce the maximal response. For instance, each
agonist, supplied at 10−5M, produces a small αGTP response, but the same concentra-
tion produces the maximal Ca2+ response. This indicates that beyond the G-protein
activation cycle, the pathway has other mechanisms which enable considerable signal
amplification. These mechanisms will be explored later in Chapters 3 and 4 when the
cTCAM is extended to include Ca2+ mobilisation.
Figure 2.9 shows that the maximal αGTP response increases with ζ; it is less influ-
enced by the ligand binding rate, klb+. For instance, even though Pilocarpine is by far
the fastest binding of the agonists (Table 2.2.1), it produces the smallest maximal αGTP
peak, because its ζ value does not favour the active receptor state as strongly as the
other agonists, making it the least efficacious agonist for the αGTP response. This is one
advantage of studying the G-protein model, the intrinsic pharmacological properties
of the drugs are more evident, before the signal is completely amplified.
2.3 The influence of subunit dissociation
The cTCAM and other mathematical models of GPCR signalling assume the widely
embraced hypothesis that the G-protein dissociates into αGTP and βγ on activation [37,
86, 106]. However, as discussed in section 1.1.1, another experimentally supported
hypothesis is that the activated subunits do not need to dissociate in order to mediate
downstream signalling [27, 79]; a variant of the cTCAM can be derived which reflects
the latter hypothesis. It is interesting and important to compare the models, looking
for parameter regimes under which they might or might not be interchangeable. In
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Figure 2.6: Ca2+ time courses from the experiments and simulated αGTP time courses
are qualitatively similar. (a) Ca2+ time courses for Oxotremorine-M; (b) Simulated αGTP
time courses for Oxotremorine-M (klb+ = 2885.6; klb− = 0.14; ζ = 543.48); (c) Ca2+
time courses for Pilocarpine; (d) Simulated αGTP time courses for Pilocarpine (klb+ =
10222.2; klb− = 0.35; ζ = 29.94).
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Figure 2.7: Ca2+ time courses from the experiments and simulated αGTP time courses
are qualitatively similar. (a) Ca2+ time courses for Carbachol; (b) Simulated αGTP time
courses for Carbachol (klb+ = 691.2, klb− = 0.14, ζ = 294.11;) (c) Ca2+ time courses
for Bethanachol; (d) Simulated αGTP time courses for Bethanachol (klb+ = 796.8, klb− =
0.26, ζ = 49.5).
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Figure 2.8: Comparing agonist effects seen in the Ca2+ data [54] with effects on simu-
lated αGTP (predicted by the cTCAM) (a) All four drugs are full agonists for the Ca
2+
peak response due to signal amplification; (b) partial agonism occurs for the αGTP peak
response; (c) Ca2+ times-to-peak decrease as the agonist concentrations increase ; (d)
αGTP times-to-peak do the same.
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Figure 2.9: The maximal αGTP peak increases with ζ.
essence, what is being explored is if one model of G-protein activation can be flexible
enough to account for both hypotheses.
An adapted version of the cTCAM is derived in which the G-protein does not disso-
ciate (called theNo-dissociation cTCAM). Bothmodels differ only in reactions pertaining
to the G-protein activation and deactivation cycle, outlined and named as follows:
cTCAM No-dissociation cTCAM
R∗G
kGTP+−→ R∗ + αGTP + βγ R∗G kGTP+−→ R∗ + GGTP (Activation step)
LR∗G
kGTP+−→ LR∗ + αGTP + βγ LR∗G kGTP+−→ LR∗ + GGTP (Activation step)
αGTP
kgd+−→ αGDP GGTP
ψkgd+−→ G (Deactivation step)
αGDP + βγ
kRA+−→ G (Re-association step)
where GGTP is the activated, undissociated G-protein. ψ is set to 1, based on the as-
sumption that the rate constant for the deactivation step is the same in the cTCAM and
No-dissociation cTCAM, as being bound to the βγ subunit is not expected to influence
the α subunit’s inherent GTPase ability.
The same agonist will be used to simulate both models (klb+ = 8.4× 107M−1s−1,
klb− = 0.37s−1, ζ =
ζ−
ζ+
= 1000). The initial values are RTOT = GTOT = 4.15× 10−10M.
Figure 2.10(a) shows that the αGTP and GGTP time courses are virtually indistin-
guishable, hence the cTCAM and the No-dissociation cTCAM make almost identical
predictions of the activated G-protein response. This is due to the quick re-association
of subunits, built into the cTCAM via a high value of kRA+, which at 1.2× 1010M−1s−1,
is the largest parameter in the model among those with units of M−1s−1. This is il-
lustrated in Figure 2.11(a), where [αGTP] decreases with the value of kRA+ in the range
1.2× 105 − 1.2× 1010M−1s−1. Between kRA+ = 1.2× 108 − 1.2× 1010M−1s−1, [αGTP]
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Figure 2.10: Comparison of the activated G-protein responses in the cTCAM and No-
dissociation cTCAM simulated with GTOT = 4.15× 10−10M, RTOT = 4.15× 10−10M
and kRA+ = 10
10M−1s−1 in the cTCAM. The responses in both models are similar for
this parameter set.
does not vary much, but below kRA+ = 1.2 × 108M−1s−1, begins to noticeably de-
crease, to the point where the response is insignificant at kRA+ = 1.2× 105M−1s−1. The
decrease in [αGTP] can be explained as follows. As re-association slows down, the G-
protein stays increasingly in the βγ and inactive αGDP forms, instead of re-forming the
intact G-protein G; this is evidenced by the fact that βγ and αGDP increase as kRA+ de-
creases (see Figures 2.11(b) and 2.11(c)); as a result, fewer and fewer G-proteins (G) are
available to re-associate with free receptors to form the active receptor-G-protein com-
plexes ([R∗G],[LR∗G]) from which αGTP is formed; this is illustrated in Figure 2.11(d),
where [R∗G] + [LR∗G] decreases with kRA+.
The cTCAM, under a parameter regime of fast subunit re-association, is thus equiv-
alent to the No-dissociation cTCAM. Outside of that regime, the αGTP response to an
efficacious agonist is much suppressed or trivial (see Figure 2.11(a)), which does not
seem likely. Therefore, it seems that if the subunits dissociate in cell membranes, they
re-associate quickly enough to ensure that the active G-protein response is similar to
a system in which the subunits do not dissociate. However, even though slow re-
association is less likely, it can be easily accounted for by the cTCAM, but not by the
No-dissociation cTCAM; so the cTCAM is the more flexible model.
The aim of this section was to determine which model is more suitable for mod-
elling G-protein activation. However, the results also suggest that agonist stimulation
experiments are worth designing, in which compounds that competitively and neu-
trally bind to either subunit are present; this would delay the rate of re-association,
and according to the cTCAM, potentially reduce the cellular response. Conclusions
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Figure 2.11: When the subunit re-association constant, kRA+, is decreased, [αGTP] and
the active receptor concentration decrease ((a), (d)), while [αGDP] and [βγ] increase and
accumulate ((c), (b)).
can then be drawn about the dependence of agonist potency on G-protein dissociation
dynamics.
2.4 Discussion
As a first step in the construction of a comprehensive model of GPCR-mediated mo-
bilisation of Ca2+ from intracellular stores, this chapter analysed models of G-protein
activation alone.
The cTCAM was used to analyse the αGTP and βγ response to agonist stimula-
tion. In virtually indistinguishable manners, [αGTP] and [βγ] both increased with the
G-protein and receptor expression levels (the previous section suggests however, that
the responsesmay not be so similar if subunit re-association is slow, see Figures 2.11(a)–
(b)). It was also seen that the effect of agonist stimulation is more enhanced by G-
protein overexpression than by receptor overexpression. This is because the receptor
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Figure 2.12: Partial agonism occurs for the Ca2+ response in the βγ-mediated A1 system
[53], unlike the αGTP-mediated M3 receptor system, where full agonism occurs.
has a more effective way of (sequentially) activating multiple G-proteins, and so more
G-protein activation cycles are made possible as the total G-protein concentration in-
creases. It thus seems that the manipulation of G-protein expression levels should be
the focus of more experimental work.
The effects of ligand-specific properties such as the binding rate and efficacy were
also explored, by comparing the responses induced by four different agonists. It was
seen that partial agonism occurs for the G-protein-level response, in contrast to the
full agonism which has been observed in experimental data obtained at the Ca2+ level,
suggesting that the M3 pathway is strongly amplifying, which is not always the case
with other Ca2+ mobilising pathways; for example, partial agonism occurs in the βγ-
mediated AdenosineA1 receptor system for the Ca2 response, as illustrated by the dose
response curves in Figure 2.12, which resemble the previously simulated αGTP curves
(Figure 2.8(b)).
The hypothesis that the transience of the Ca2+ peak is due to a transient αGTP peak
was explored. The simulated results suggest that G-protein and receptor overexpres-
sion, by removing the transient αGTP peak, may also remove the transient Ca
2+ peak,
replacing it with a sustained maximum response. The transient peak was more sen-
sitive to changes in the total G-protein concentration than the total receptor concen-
tration, suggesting that the same holds for the transient Ca2+ peak, if the hypothesis
is true. It should be noted that receptor desensitisation of the M3 muscarinic recep-
tor (which is not included in the cTCAM and would contribute to the transience of
the peak) is known to occur; therefore the peak might be more robust to changes in
the G-protein and receptor concentrations than the cTCAM suggests. The effects of re-
ceptor desensitisation will be explored when the model is extended in Chapter 3.The
simulated αGTP and experimental Ca
2+ transient peaks also responded similarly to in-
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creasing agonist concentrations, thus supporting the hypothesis, which will be further
explored in Chapter 3.
It was also shown that the cTCAM, a model of G-protein subunit dissociation, is
equivalent to one in which the subunits do not dissociate, under a parameter regime
of fast re-association. Outside of that regime, the αGTP response was either much re-
pressed or trivial (see Figure 2.11(a)), which is unlikely to be the case in the cell mem-
brane, as agonist efficacy would be greatly inhibited. This suggests that experiments in
which subunit re-association is delayed or inhibited could be carried out to determine
the dependence of agonist efficacy on subunit dynamics.
The cTCAM with fast subunit reassociation will be used to assemble the Ca2+
model, as either fast subunit re-association or no dissociation at all are what likely
occurs in the experimental system. The cTCAM is also more versatile than the No-
dissociation model, as it is able to account for the G-protein dynamics caused by slow
re-association.
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GPCR-mediated Ca2+ Mobilisation
Model
3.1 Introduction
As mentioned in Chapter 2, the activation of αGTP in the M3 pathway leads to the
mobilisation of Ca2+ from intracellular stores into the cytosol. Having carried out some
analysis on the G-protein activation model (cTCAM), that modelmay now be extended
to include details of the events leading to Ca2+ mobilisation.
Ca2+ is an essential and versatile secondmessengerwith roles in numerous physio-
logical processes (and consequently, pathologies), including muscle contraction, fertili-
sation, gene transcription and cell division [27]. In heart muscle cells for instance, acti-
vation of the GPCR’s, Ang-2 receptor-Type 1 and Type 2, elevates cytosolic Ca2+, which
activates the phosphatase, calcineurin, [17]; this can cause massive cardiac enlarge-
ment and lead to heart failure [24]. In the M3 muscarinic receptor pathway, agonist-
stimulated Ca2+ mobilisation influences function in bladder and intestinal smoothmus-
cle by mediating contraction; in disease conditions, such as diabetes, smooth muscle
is hypersensitive to Ca2+ [96]. The same pathway is also implicated in enhanced gene
transcription via the activation of the transcription factors, the early growth factor, Egr-
1, and activator protein, AP-1, both of which can mediate cell division [69]. Hence,
understanding the mechanisms behind Ca2+ mobilisation has implications for devel-
oping or improving therapies for many disease conditions.
There are two major ways by which the level of cytosolic Ca2+ is raised in non-
excitable cells, either via a GPCR-activated release from intracellular stores or an influx
from the extracellular environment across plasma membrane channels, activated when
the stores near depletion [27]. Organelles that can act as intracellular stores include
the endoplasmic reticulum (ER), the sarcoplasmic reticulum (SR), and the mitochon-
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Figure 3.1: GPCR activation leads to the production of IP3, which mediates Ca
2+ release.
dria. Agonist-stimulated Ca2+ release from the ER is a central process [27, 82] and so,
for simplicity, will be the focus of this work. There are mechanisms for removing ex-
cess Ca2+ from the cytosol, which could otherwise cause cell death or damage [94].
Excess Ca2+ can be transported back into the ER by the sarcoplasmic/endoplasmic
reticulum calcium ATPase (SERCA) pumps (located in the organelle membrane), or
removed from the cytosol into the extracellular environment by pumps located in the
plasmamembrane, called plasmamembrane Ca2+ ATPases (PMCA) [27]. Anotherway
in which the cytosolic Ca2+ concentration is regulated is via binding proteins, called
buffers, which thus decrease the concentration of free Ca2+ and inhibit the activation
of Ca2+-mediated processes [10].
In theM3 (Gq–coupled) pathway, αGTP binds to the enzyme Phospholipase C (PLC),
which is located in the plasmamembrane, to form αGTPPLC, which is then activated by
Ca2+. The signal generated by αGTPPLC is terminated by the α subunit’s intrinsic GT-
Pase activity, which is accelerated by PLC, resulting in the dissociation of the complex
into αGDP and PLC. There are three known PLC isoforms: PLCγ, PLCδ and PLCβ, the
last of which is activated by the Gq protein. The αGTPPLC complex hydrolyses its sub-
strate, phosphatidylinositol bisphosphate (PIP2), to produce inositol triphosphate (IP3)
and diacylglycerol (DAG). IP3 diffuses into the cytosol, eventually inducing Ca
2+ re-
lease from intracellular stores, and is subject to a multi-step degradation into an inositol
phosphate pool fromwhich PIP2 is re-synthesised [74]. DAG remains at themembrane
and causes the activation of Protein kinase C (PKC), which activates a pathway that can
involve the phosphorylation and consequent desensitisation of the GPCR, and can ex-
tend to the nucleus of the cell [55]. Other kinases might also mediate desensitisation
[105]. For simplicity, only the IP3 pathway (see Figure 3.1) will be explicitly modelled,
as it involves the main processes that lead to Ca2+ release.
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Figure 3.2: Ca2+ dependence of the IP3R open probability. Reproduced from [62]. Ini-
tially the open probability increases with [Ca2+] (pCa means |log[Ca2+]|), but past a
threshold value, begins to decrease.
IP3 diffuses through the cytosol to bind to receptors (IP3R) on the membrane of the
ER, which are ion channels that open on activation to release Ca2+ into the cytosol. The
IP3R consists of four subunits, each possessing binding sites for IP3 and Ca
2+, both
of which co-operatively regulate the channels. There are at least three IP3R subtypes,
designated type 1, type 2, type 3 – which differ in aspects of their regulation, and more
than one type may be expressed in the same cell [27]. All subtypes are believed to be
regulated in a biphasic manner by IP3-induced Ca
2+ [91]. The accepted theory is that
IP3R possesses three binding sites, one for IP3 and two for Ca
2+ – one stimulatory, the
other inhibitory. On binding, IP3 increases the Ca
2+ sensitivity of the IP3R’s, causing
them to bind to Ca2+ and open; this leads to an increase in cytosolic Ca2+, which when
high enough, causes the channels to begin to close again. In other words, Ca2+ first
exerts positive feedback on its own mobilisation, and then negative feedback. This
phenomenon is normally referred to as calcium-induced calcium release (CICR) [27,
82], illustrated in Figure 3.2.
3.2 Experimental studies of Ca2+ mobilisation
Agonist-stimulated Ca2+-mobilisation experiments are often carried out in either hu-
man or surrogate cells, which can be engineered to express a variety of Ca2+-activating
GPCR’s. Ca2+ is easily measured when the cells are loaded with high affinity indica-
tors that emit fluorescence when bound to Ca2+. These experiments can be carried out
in the presence or absence of extracellular Ca2+; the data that will be discussed here are
from the latter experimental setting, allowing for a simpler model which does not need
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Figure 3.3: Data from Ca2+-mobilisation (in the absence of extracellular Ca2+) exper-
iments performed at the University of Nottingham’s Institute of Cell Signalling (ICS)
[52]. Each point is the mean ± standard error (S.E.M) of the cell population, and is nor-
malised to the fluorescence due to stimulation by 10−4M of Carbachol (a) Time courses
for Ca2+-mobilisation induced by various concentrations of the agonist Oxotremorine-
M. (b) Dose response curves of various agonists for the Ca2+ peak response.
to include the influx of extracellular Ca2+.
Figure 3.3 shows data from the Ca2+ mobilisation experiments carried out at the
Institute of Cell Signalling [54], in which Chinese hamster ovary cells (CHO) are trans-
fected with the human muscarinic M3 receptor and loaded with a fluorescent indicator
that has a high affinity for Ca2+; the system is then left to settle down for 30 minutes,
and basal fluorescence is measured. Agonist treatment increases the fluorescence, indi-
cating the release of Ca2+ ions into the cytosol, to which the indicators rapidly bind. At
several time points, fluorescence is measured, and data for the average of the cell popu-
lation indicates that a transient Ca2+ peak occurring in 5− 20s is the response induced
by virtually all concentrations of the agonist Oxotremorine-M (Figure 3.3(a)), and Ca2+
tends to return to its basal concentration. Dose-response curves for Oxotremorine-M
and other agonists, Carbachol, Pilocarpine and Bethanecol (modelled in Chapter2) in-
dicate that they all act as full agonists, producing the same maximal Ca2+ response,
although at different concentrations (Figure 3.3(b)). The time courses for these agonists
are also similar (results not shown).
Studies have indicated that many fluorescent indicators, in their Ca2+-free forms,
are competitive antagonists for IP3 binding to IP3R, causing a concentration-dependent
inhibition of IP3 binding. Antagonism is only significant at unusually high concentra-
tions of the fluorescence indicators [64, 77], indicating that their binding dynamics do
not need to be included in the model.
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3.3 Existing mathematical models of Ca2+ dynamics
There are many models of Ca2+ signalling which have shown good agreement with
available experimental results. Many of the existing models were developed to inves-
tigate Ca2+ oscillations, and it should be noted that the timecourses in Figure 3.3(a)
are non-oscillatory, so oscillations are not the focus here. However, in other systems,
oscillations have been experimentally observed [94].
Early models of Ca2+ dynamics did not include explicit details of IP3R’s mecha-
nisms, because they had not yet emerged from experimental studies. The early models
were based on the knowledge that Ca2+ oscillations rely on the phenomenon of CICR,
and generally focused on the cytosolic aspects.
Themost influential of these early phenomenological models was by Goldbeter and
Dupont [26]; it assumes the existence of two intracellular Ca2+ stores, one sensitive to
IP3, the other sensitive to Ca
2+. IP3 causes the release of Ca
2+ from the IP3-sensitive
store; this increase in cytosolic Ca2+ then triggers release from the Ca2+-sensitive store.
Influx and efflux of Ca2+ across membranes is included in this model as well. Influx
is modelled as constant while efflux depends linearly on cytosolic Ca2+ [82]. A later
version of this model allowed for the existence of just one Ca2+ store. Both versions
predicted Ca2+ oscillations similar to those observed experimentally.
3.3.1 Models of the IP3 receptor
Later experimental studies uncovered the role of the IP3 receptor (IP3R) in CICR (that
it is activated by low Ca2+ concentrations and subsequently inactivated by high Ca2+
concentrations); hence, the relationship between the open probability of the channel
and [Ca2+] is bell-shaped (see Figure 3.2). Models subsequently incorporated mecha-
nistic details of IP3R interactions with IP3 and Ca
2+.
The De Young-Keizer [20] model was the earliest model to include details of IP3R
kinetics. It assumes that there are three IP3R subunits, each with three binding sites
for IP3, activating Ca
2+, and inhibiting Ca2+, which are allowed to bind in any order.
Hence there are eight possible receptor states. The notation Sijk, i, j, k = 0 or 1 may
be used to describe fractions of IP3R in particular states, with 1 corresponding to an
occupied site, and 0, to an unoccupied one; so the possible fractional states are S000,
S010, S001, S011, S100, S110, S101 and S111. The receptor is activated when in the state S110.
It is assumed that the channels open only when three subunits are activated, hence S3110
is the open probability. The model is a system of eight ODEs, seven representative of
the receptor states and derived from mass action kinetics; its Ca2+ ODE has a source
term proportional both to the Ca2+ gradient between the cytosol and ER and to the
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open probability of the channels, and its sink term is a Hill function modelling SERCA
flux, given by:
d[Ca2+ ]
dt
= vr(v1S
3
110 + v2)([Ca
2+
ER]− [Ca2+])−
p1[Ca
2+]2
[Ca2+]2 + p22
, (3.1)
where Ca2+ER is the concentration of Ca
2+ in the ER, vr is the ER to cytosol volume ratio,
and v1 and v2 set the maximal Ca
2+ fluxes. The factor vr accounts for the fact that the
flux is between the cytoplasm and ER, which have different volumes. Hence, fluxes
between these compartments do not cause the same concentration change.
d[Ca2+ER]
dt is
then given by (v1S
3
110 + v2)([Ca
2+
ER]− [Ca2+])− p1[Ca
2+]2
vr[Ca2+]2+p22
. Note that p1 is a composite
term including vr . The Hill function represents more complex mechanisms, in which,
after Ca2+ binds to the pump, it undergoes several transformations, including con-
formational changes which send Ca2+ back into the ER [94]. The Hill coefficient is 2,
representing two binding sites for Ca2+. Themodel was fit to steady state data to obtain
the rate constants, and was able to reproduce Ca2+ oscillations via a Hopf bifurcation
from a stable steady state [95]. No extracellular Ca2+ fluxes were modelled, so [Ca2+ER]
could be eliminated, [45].
The Li-Rinzel model is a simplification of the De Young-Keizer model, derived by
making assumptions of rapid kinetics for the binding of IP3 and stimulatory Ca
2+,
resulting in a two-dimensional system. This simplifiedmodel is able to reproducemost
of the qualitative predictions of the eight-state Keizer-De Young model [45].
Another simpler alternative to the Keizer-De Young model is the model by Othmer
and Tang [70], derived using the assumption that IP3, activating Ca
2+ and inhibitory
Ca2+ bind to the IP3R sequentially (an experimentally supported theory [91]) so that
the only possible IP3R states are S000, S100, S110, S111. As in the Keizer-De Youngmodel,
the active state is S110, but it is assumed that only one subunit needs to be active for the
channel to open. The Ca2+ rate is given by:
d[Ca2+ ]
dt
= (1+ vr)(γ0 + γ
′
1S110)(Ca
2+
AV − [Ca2+])−
p1[Ca
2+]4
[Ca2+]4 + p42
, (3.2)
where γ0 quantifies a basal leak, and γ
′
1, the maximal Ca
2+ flux. Ca2+AV is the volume
average concentration of the cell, the level cytosolic Ca2+ approaches if the ER network
is ruptured [36]; it is given by
[Ca2+]+vr[Ca
2+
ER]
1+vr
, and is assumed to be constant due to
no flux across the plasma membrane. Like the previous models, this one successfully
reproduces Ca2+ oscillations [70].
The above models do not include the details of ligand-receptor-G-protein dynam-
ics but merely utilise [IP3] as the input parameter. The literature also includes more
comprehensive models of GPCR-mediated Ca2+ mobilisation, which are discussed in
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the next section.
3.3.2 Comprehensive models of Ca2+ mobilisation
There are at least four relevant comprehensive Ca2+-mobilisation models in the liter-
ature, which incorporate details of signalling all the way from GPCR activation. Two
of these models cover events from agonist stimulation through to Ca2+ mobilisation
[37, 44], while the others go beyond to cover downstream processes: Ca2+-mediated
initiation of smooth muscle contraction via the phosphorylation of myosin II [48] and
the secretion of luteinizing hormone (LH) [6, 30].
Lemon et al. presented an ODE model of GPCR-mediated IP3 formation and con-
sequent Ca2+ mobilisation [44] in the PTY2 receptor system. This model took into
account the desensitisation, and subsequent recycling of the receptor, as well as PIP2
depletion and replenishment; assumptions of rapid kinetics were used to significantly
simplify the model equations. A rapid transient peak (≈ 25s) was predicted for αGTP,
IP3 and Ca
2+ over different rates of PIP2 replenishment. It was predicted that the de-
sensitisation of the ligand-receptor complex causes a decrease in αGTP on a time scale
of minutes.
Using the Virtual cell simulation and analysis suite software, Lukas [48] modelled
a Ca2+ signalling process of agonist binding through to Ca2+-mediated protein phos-
phorylation of the myosin light chain (MLC), which initiates contraction in smooth
muscle. G-protein activation was modelled similarly to the cTCAM (see Chapters 1
and 2) except that constitutively active receptors (R∗) were not included. Receptor de-
sensitisation is also included as an irreversible phosphorylation reaction by a G-protein
receptor kinase (GRK), hence there are five possible receptor states compared to eight
in Chapter 2’s G-protein activation model [48]. The model was simulated both with
generic parameters, and with parameters specific to the Bradykinin receptor. In both
cases, the Ca2+ response was a rapid, transient peak (see Figure 3.4 for the. When G-
protein-receptor pre-coupling was removed in the generic case, the peak was slower.
The model also predicted that the timing and magnitude of the downstream phospho-
rylation event is dependent on the agonist concentration.
Washington et al. [102] presented a model of GPCR-mediated Ca2+ mobilisation
leading to the secretion of luteinizing hormone (LH) (which triggers ovulation) in the
Gonadotropin-releasing hormone receptor (GnRH) system. In this model, the receptors
could bind to each other to form dimers, as has been experimentally observed in that
receptor system [30]. In addition to sustained hormone stimulation, the model also
considered the effects of stimulation applied in brief pulses, to mirror the way that
GnRH is secreted physiologically. Transient Ca2+ peaks were predicted, which could
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Figure 3.4: GPCR-mediated Ca2+ models in the literature predict the experimentally
observed transient Ca2+ peak. Shown are transients predicted by the Lukas model for
the bradykin receptor system [48]. The dotted line is the response to 3 × 10−6 M of
agonist, while the solid one is for 30× 10−6 M.
re-occur at each point of stimulation, provided the dose and frequency of stimulation
were low. Armstrong et al. [6] used the same model to show significant reduction of
the Ca2+ response at high GnRH receptor concentration, with the peaks much lower
after the initial stimulation.
Kang and Othmer [37] modelled agonist-induced Ca2+ mobilisation in the Glu-
tamate receptor (GPCR) system, incorporating details of the pathways activated not
only by IP3, but also by DAG. In this model, the DAG pathway activates PKC, which
phosphorylates PLC and the active ligand-receptor complex (LR∗), causing temporary
desensitisation. The receptor can only become activated when bound by the ligand, so
the R∗ state is not included in the model. All reaction rates are governed by mass ac-
tion, and the [Ca2+] ODE is based on the Othmer and Tangmodel of sequential binding
[70]:
d[Ca2+ ]
dt
= (1+ vr)(γ0 + γ1[IP3 IP3RCa
2+])(Ca2+AV − [Ca2+])−
p1[Ca
2+]2
[Ca2+]2 + p22
, (3.3)
The full model is thus a system of 25 coupledODEs, which was reduced to 19, using
equations of conservation.
The influence of PKC on the nature of the Ca2+ response was explored. The model
was able to reproduce oscillations and transient peak responses. A bifurcation analysis
showed that the transient peak occurs for high IP3 production rates and zero or low
PKC regulation, while oscillations occurred for intermediate IP3 production rates and
zero or low PKC regulation. Hence, oscillations are possible without the inclusion of
PKC dynamics, which is in accordance with the previously mentioned IP3R models.
The range of IP3 production rates for which oscillations occurred were widened by
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Figure 3.5: Dose-response curves from the experiments of Sykes et al. measuring αGTPγS
in the M3 Muscarinic receptor system [93] reveal that partial agonism occurs for the G-
protein response. The system thus has amplification machinery through which partial
agonists at that level of the pathway are full agonists at the Ca2+ level (compare Figure
3.3(b)).
increasing PKC activity. Hence, the model predicts that PKC, in conjunction with PLC,
can act as a switch between different Ca2+ response patterns, because of the ability to
modulate [IP3], which is the main determinant of response patterns.
The Kang and Othmer model is comprehensive, like the Ca2+ model to be con-
structed in this chapter, and models IP3R dynamics based on an experimentally sup-
ported (and model-simplifying) theory of sequential binding. Hence, out of existing
Ca2+ models in the literature, Chapter 2’s G-protein activation model (cTCAM) is ex-
tended using downstream details from the Kang and Othmer model.
3.4 Signal amplification
Chapter 2’s G-protein activation model predicted that partial agonism occurs for the
αGTP response, a result which is apparently supported by the experimental results in
Figure 3.5, which show partial agonism for αGTPγS, which is a non-hydrolysable ana-
logue of αGTP. The experimental study included the four agonists studied in Chapter
2, and three others, including the receptor’s endogenous ligand, Acetylcholine [93].
A typical pharmacological measure of agonist efficacy is the EC50, which is the
concentration of agonist that induces the half-maximal response [40]. A quantitative
measure of signal amplification is found by comparing the EC50 values (or variants
of it) of the αGTPγS and Ca
2+ responses. It is convenient to use the absolute value of
the logarithm of the EC50, referred to as pEC50 in pharmacology, and denoted here by
|logEC50|. The higher the value of an agonist’s |logEC50|, the more potent it is; for
instance, |logEC50| = 9 means that only 10−9M of an agonist is required to induce a
half-maximal response. The values that pertain to αGTPγS and Ca
2+ are shown in Table
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Agonist
|log EC50| of response
αGTPγS Ca
2+
Oxotremorine-M 5.59 8.76
Carbachol 4.64 7.98
Pilocarpine 5.05 7.72
Bethanechol 4.62 6.77
Table 3.4.1: |logEC50| values of the αGTPγS response and that of Ca2+ [93]. The values
that pertain to Ca2+ and the corresponding ones for αGTPγS always differ by at least 2.15,
indicating that signal amplification has occurred between these stages in the pathway.
3.4.1 [93], and it can be seen that, for each agonist, they differ by at least 2.15 (thus the
Ca2+ curves are more left shifted). This shows that the pathway has mechanisms for
amplifying the signal between the levels of αGTP production and Ca
2+ release, as was
concluded in Chapter 2.
None of the aforementioned comprehensive models attempt to model the signal
amplification that occurs between the αGTP and Ca
2+ levels of the pathway. A major
aim of the Ca2+-mobilisation model of this chapter will be to reproduce that pathway
feature, which is so evident in the data. This continues the pharmacologically flavoured
modelling from Chapter 2.
3.5 Extension of the G-protein activation model
Here, the full Ca2+ mobilisation model is assembled by extendingChapter 2’s G-protein
activation model to include the downstream processes which culminate in Ca2+ mobil-
isation. As previously mentioned, this is accomplished using relevant components of
the Kang and Othmer model.
The output of the cTCAM (see Chapter 2) is αGTP, and its role in activating the
cascade of processes that lead to Ca2+ release has been explained in section 3.1. These
processes are represented by the following reactions, after Kang and Othmer [37]:
αGTP + PLC
kPLCb+−−⇀
↽−−
kPLCb−
αGTPPLC (3.4)
Ca2+ + αGTPPLC
kPLCact−−⇀
↽−−
kPLCdeact
αGTPPLC
∗ (3.5)
αGTPPLC
∗ + PIP2
kPIP2b+−−⇀
↽−−
kPIP2b−
αGTPPLC
∗PIP2 (3.6)
αGTPPLC
∗PIP2
kIP3−→ αGTPPLC∗ + IP3 + DAG (3.7)
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αGTPPLC
∗ kPLCdis−→ αGDP + PLC + Ca2+ (3.8)
IP3
kIP3deg−→ 0 (3.9)
IP3 + IP3R
kIP3Rb+−−⇀
↽−−
kIP3Rb−
IP3 IP3R (3.10)
IP3 IP3R+ Ca
2+
k
Ca2+act+−−⇀
↽−−
k
Ca2+act−
IP3 IP3RCa
2+ (3.11)
IP3 IP3RCa
2+ + Ca2+
kCa2+inh+−−⇀
↽−−
k
Ca2+inh−
IP3 IP3RCa
2+Ca2+ (3.12)
d[Ca2+]
dt
= (1+ νr)(γ0 + γ1[IP3 IP3RCa
2+])(Ca2+AV − [Ca2+])−
p1[Ca
2+]2
[Ca2+]2 + p22
. (3.13)
Reactions (3.4) - (3.12) represent the processes from αGTP-PLC binding to IP3 pro-
duction and consequent binding to its receptor (IP3R), while equation (3.13) describes
the rate of change of cytosolic Ca2+, which is not modelled by mass action, but is based
on the Tang and Othmer model described in the previous section. Ca2+’s rate of release
from the ER is proportional to the concentration gradient between the cytosol and ER,
and the concentration of activated IP3R’s ([IP3 IP3RCa2+]). νr is the ER/cytosol ratio,
γ0 represents the basal Ca
2+ permeability of the ER, while γ1 is a measure of the sensi-
tivity of IP3R to IP3. The rate of Ca
2+ efflux into the ER is modelled by a Hill function
with exponent two, in which p1 represents the maximal rate of the SERCA pumps, and
p2 is the Michaelis constant.
As in Chapter 2, the law of mass action is used to convert the reactions into ODEs,
which when coupled to the G-protein activation model constitute the Ca2+ mobilisa-
tion model, a system of 22 ODEs, which can be found in Appendix B.3; the whole
pathway is illustrated in Figure 3.6. The G-protein activation model of Chapter 2 was
a model of 10 governing ODEs, so this represents a considerable increase in model
complexity. Complex models can sometimes be simplified based on timescale consid-
erations (using asymptotic analysis) [106], but this requires confidence in the accuracy
of the model parameters, which is rarely the case with biological models as many pa-
rameters cannot be measured experimentally, while some vary from cell to cell [41],
hence such model simplification is not attempted here.
The data being used to guide this modelling effort pertain to experiments carried
out in the absence of extracellular Ca2+; as a result, there is no need to model the mem-
brane channels which would normally facilitate influx to the cytosol. As previously
mentioned, efflux occurs via membrane pumps, but initially this is not modelled, as
cytosolic Ca2+ removal is already modelled via the SERCA pumps which may only
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Figure 3.6: Schematic representation of the Ca2+ model, which is derived by extending
the cTCAM [86] (see Chapter 2) using downstream details from the Kang and Othmer
model [37].
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require careful parameter choices to account for the action of the membrane pumps. In
addition, Ca2+ buffers are not modelled, for the sake of simplicity; however the model
can easily be extended by including the relevant binding reactions to buffers.
3.5.1 Parameter values
The parameter values used in Chapter 2’s G-protein activation model are retained,
while the remaining relevant parameter values are taken (or modified) from the Kang-
Othmer model [37]. The resultant set of parameter values is referred to as the prelim-
inary parameter set; it can be found in Table B.2.2, and will subsequently be subjected
to some data-motivated analysis. Stimulation will be by 10−7M of Oxotremorine-M,
unless otherwise specified.
3.6 Data-driven modelling aims
The aim of this model is to predict the key features of the experimentally observed
Ca2+ response to varying agonist concentrations, and so to understand the pathway
processes which drive these features. Figure 3.3(a) shows that, in response to the ago-
nist Oxotremorine-M (added after 50s) Ca2+ rapidly peaks (5-20s, depending on ago-
nist concentration), and then more slowly returns to a plateau level; hence Ca2+ release
is rapid and transient (three other agonists similarly tested in these experiments pro-
duced qualitatively similar time courses, which are not shown here). Figure 3.3(b) also
shows that all agonists produce the same maximal Ca2+ response, with high EC50 val-
ues, indicating that signal amplification (previously discussed in section 3.4) occurs.
Hence, there are three key features of the Ca2+ response that the model needs to reflect,
and which are summarised below:
1. Rapid time-to-peak
2. Transient peak
3. Signal amplification
3.7 Data-motivated parameter variation
The Ca2+ model is initially simulated with the preliminary parameter set, and subse-
quent adjustments motivated by the data are made to relevant parameter values in an
initial attempt to reflect the key features of the data.
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Figure 3.7: Time courses of some species in the Ca2+-mobilisation model, simulatedwith
the preliminary parameter set in Table B.2.2 (in the appendices) and varying kIP3Rb+. (a)-
(c) show the response to 10−7 (M) of Oxotremorine-M, while (d)-(f) show the response
to 10−4 (M). αGTP and Ca2+ are normalised to their basal levels.
3.7.1 Preliminary parameter set
The previously discussed experimental results pertain to the αGTP and Ca
2+ levels of
the pathway (see Figure 3.5), hence, for the sake of brevity, only model simulations of
αGTP and relevant downstream species will be discussed here.
With the preliminary parameter set, the model predicts that there is a small αGTP
response (Figure 3.7(a), solid line), and an insignificant Ca2+ response to 10−7M of
Oxotremorine-M, as Ca2+ hardly rises above its basal concentration (Figure 3.7(c), solid
line). This is contrary to what is seen in the data, in which this concentration of the
drug elicits the maximum Ca2+ response (see Figure 3.3). When a high concentration
(10−4(M)) is used, there is a significant αGTP response (Figure 3.7(d), solid line), and
a Ca2+ response which is small compared to the data, but qualitatively similar, being
rapid and transient (see Figure 3.7(f), solid line).
The simulated Ca2+ dose-response curves can now be directly compared to the ex-
perimentally generated ones, something that could not be done with just the G-protein
activation model in Chapter 2. Figure 3.8 shows the simulated curves (using the ligand-
specific parameters from Chapter 2); signal amplification is not predicted, since the
agonists do not all produce the same maximal response, acting as partial agonists in-
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Figure 3.8: Experimental dose response curves for the Ca2+ peak response show that
all four drugs are full agonists Dose-response curves simulated with the preliminary
parameter set in Table B.2.2 (kIP3Rb+ = 1.2× 107M−1s−1) do not predict full agonism for
all the agonists, unlike the experimental results (see Figure 3.3(b)).
stead. In contrast, agonist concentrations as low as 10−7M can produce the maximum
Ca2+ response in the data (see Figure 3.3(b)). Hence, with the preliminary parameter
set, the model does not reflect the experimentally observed signal amplification, and
so under-predicts agonist efficacy; therefore, parameters which influence the extent of
Ca2+ release need to be identified and manipulated in order to predict the desired level
of response.
3.7.2 Varying the binding rate of IP3 and its receptor
In the model simulations with the preliminary parameter set, the majority of the IP3
receptors (IP3R) are left unbound by IP3 (see Figures 3.7(b) and 3.7(e), solid lines),
which means that only a very small percentage of receptors can be activated by Ca2+,
even at high agonist concentrations; it is therefore unsurprising that the predicted Ca2+
response is insignificant, since only a very low concentration of IP3 receptors ever open
up to release Ca2+ into the cytosol. This suggests that, in order for the model to predict
a response comparable to the data, parameters in the preliminary parameter set that
can promote the binding of IP3 to its receptor should be varied appropriately.
The rate constants for the association and dissociation of IP3 and IP3R (kIP3Rb+ and
kIP3Rb− respectively) in the preliminary parameter set give a KD of ≈ 6.7 × 10−7M.
Experimental studies in which Ca2+-mobilisation was induced by directly transporting
IP3 to IP3 receptors purified from rat cerebellar membranes give the KD value of the
binding as 6.25 ± 0.4 × 10−9M [64], which is roughly 100 times smaller than in the
preliminary parameter set. Recall that the KD of a reversible reaction is given by the
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ratio of the forward rate constant to the backward one; the KD of the IP3-IP3R reaction
is then given by
kIP3Rb−
kIP3Rb+
, and to reduce its value in the preliminary parameter set, kIP3Rb+
can be fixed at its current value while kIP3Rb− is decreased, or kIP3Rb+ can be increased
while kIP3Rb− is fixed. The aim here is to promote the binding of IP3 to its receptor, and
the most direct way to do this is to increase the rate constant kIP3Rb+ alone (this should
also promote the binding of activating Ca2+, and consequently, Ca2+ mobilisation).
Using the KD value of 6.25± 0.4× 10−9M [64] as a boundary, the value of kIP3Rb+ can
be increased up to a hundred-fold.
A ten-fold increase in kIP3Rb+ (kIP3Rb+ = 1.2× 108M−1s−1) leads to a small increase
in the percentage of channels bound by IP3 when [L] = 10−7M (Figure 3.7(b), dashed
line), and so gives a trivial increase in Ca2+ release (Figure 3.7(c), dashed line). When
[L] = 10−4M, though the increase in IP3-bound receptors appears to be insignificant
(only ≈ 4%, see Figure 3.7(e), dashed line), the increase in the Ca2+ response is signifi-
cant: approximately 1.75 times more than basal (Figure 3.7(f)).
When kIP3Rb+ is increased a hundred-fold to 1.2× 109M−1s−1 (giving a KD value
of 6.67 × 10−9M, which fits the previously discussed published value of 6.25± 0.4×
10−9M [64]) and [L] = 10−7M, there is still no significant agonist-induced Ca2+ in-
crease (Figure 3.7(c), dotted line). However, the dynamics are significantly altered
when [L] = 10−4M (Figures 3.7(d)-3.7(e), dotted lines). The transient peak is no longer
exhibited by Ca2+, but still seen in αGTP. 50% of the IP3 receptors are now bound by
IP3, leading to the opening of more channels, and at three times over basal, a more
significant Ca2+ release. Also the time-to-peak is no longer rapid, as it is in the data.
Dose-response curves for this parameter set reveal that very high concentrations of
each agonist induce an almost-maximal Ca2+ peak (Figure 3.9(b)), but this is still dis-
similar to the the data, where the maximal peak occurs at lower concentrations.
In summary, by increasing the rate constant of the IP3 − IP3R binding reaction
(kIP3Rb+) a hundred-fold from its original value in the preliminary parameter set, as
guided by a published KD value of the reaction [64], a parameter set was obtained
under which the model predicts an approximately maximal Ca2+ response to all four
agonists, but at concentrations higher than in the data (i.e., without the left shift, com-
pare Figures 3.9(a) and (b)), and without the rapid, transient peak. The challenge is to
attempt to find, initially through this method of data-motivated parameter variation, a
parameter set that replicates all three key features at once: signal amplification, and the
rapid, transient peak.
At this point, the value of kIP3Rb+ in the preliminary parameter set (see Table B.2.2)
is replaced by 1.2× 109M−1s−1, because with this value the agonists induce non-trivial
Ca2+ responses, indicating that the G-protein activation model is better coupled to the
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Figure 3.9: Dose-response curves (a) αGTP peak response (b) Ca
2+ peak response , sim-
ulated with the preliminary parameter set in Table B.2.2 but with kIP3Rb+ increased a
hundred-fold to 1.2× 109M−1s−1
downstreammodules.
3.7.3 A theory of IP3R occupancy
With the various values of kIP3Rb+ utilised up until this point, the model has only been
able to predict significant agonist-induced Ca2+ peak responses at very high agonist
concentrations. However if the model is to agree with the data, an Oxotremorine-
M concentration of [L] = 10−7M should predict a maximal response (see Figures 3.8
and 3.9(b)). Hence the change made to the value of kIP3Rb+ is not sufficient; other
parameters need to be considered for variation.
Marchant et al. carried out experimental studies to compare the kinetics of Ca2+
mobilisation evoked by endogenous IP3, with those evoked by a stable analogue. In
independent experiments Ca2+-release was induced by transporting different concen-
trations of both analogues directly to IP3 receptors in rat hepatocytes [50]. The maxi-
mally effective concentrations of IP3 for Ca
2+ mobilisation were between 10−6M and
10−5M. It was reported that 99.8% of the receptors were bound when [IP3] was 10−5M,
suggesting that high occupancy occurs when Ca2+ release is maximal. Hence, for the
Ca2+ model it can be assumed that a high percentage of the IP3 receptors should be
occupied for a maximal Ca2+ release.
Based on this observation it becomes clear that a maximal Ca2+ release cannot be
expected at [L] = 10−7M with the adjusted value of kIP3Rb+ = 1.2× 109M−1s−1, since
the concentration of IP3 produced is enough to bind only 2.7% of the total IP3R con-
centration (see Figure 3.7(b)); therefore, the concentration of IP3 produced needs to be
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higher. There is a need to identify and adjust appropriate parameters that can promote
the production of more IP3.
One way to producemore IP3 would be to simply producemore αGTP, whichwould
increase the concentration of αGTPPLC available to hydrolyse PIP2, but this would shift
the αGTP dose-response curves unnecessarily to the left, predicting an overly amplified
signal at the wrong level of the pathway. In order to produce the desired concentra-
tion of IP3 therefore, some amplification is required somewhere in the steps between
αGTP production and IP3 production, that is, between reactions (3.4) and (3.9). The
maximum possible concentrations of the products of reactions (3.4) - (3.6) are limited
by the concentration of αGTP produced in reactions that occur earlier in the pathway;
that is, the production of the species αGTPPLC, αGTPPLC
∗ and αGTPPLC∗PIP2 cannot
be amplified. Hence, a higher IP3 concentration must be achieved directly; one way is
to increase the rate at which it is hydrolysed, via kIP3 in reaction (3.7); another way is to
increase the concentration of available αGTPPLC
∗PIP2 by decreasing kPIP2b− or increas-
ing kPIP2b+ in reaction (3.6); alternatively, it might be achieved by making kPLCdis small
in reaction (3.8) so that αGTPPLC can re-associate with PIP2, keeping αGTPPLC
∗PIP2
available to produce IP3; reducing the rate of IP3 degradation via kIP3deg in reaction
(3.9) might also be another way.
All the previouslymentionedmeasures to increase IP3 production, and consequently,
IP3R occupancy, lead to excessively high basal activity, as illustrated in Figure 3.10; this
is unsupported by the experimental data, in which the basal level is negligible relative
to the agonist-induced response (see Figure 3.3). This raises an interesting question:
what processes in Ca2+-activating pathways are responsible for ensuring that signal
amplification only occurs after the addition of agonist?
3.7.4 Data-driven analysis of G-protein parameters
The basal level of IP3 is driven by basal αGTP, which is produced from the R
∗G state
of the GPCR. This means that any parameters of the G-protein activation model which
control the extent of basal activity relative to the agonist-induced response need to be
identified, and appropriately adjusted. Hence, the parameters of the G-protein activa-
tion model will be re-assessed.
There is more than one way of lowering the basal production of αGTP in the G-
protein activation model. To facilitate the discussion of these possibilities, the rate
equations for some of the GPCR species and αGTP are reproduced below.
d[R∗]
dt
= kact[R]− kdeact[R∗]− θζ ζ+klb+[L][R∗] + θζ ζ−klb−[LR∗]
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Figure 3.10: Discussed changes in certain parameter values cause the basal response to
be excessively high, suggesting that some parameter fine-tuning needs to occur, in order
to maintain a significant peak-to-basal ratio.
−θµµ+kg+[R∗][G] + θµµ−kg−[R∗G] + kGTP+[R∗G] (3.14)
d[LR∗]
dt
= θζζ+klb+[L][R
∗]− θζζ−klb−[LR∗] + ζ+kact[LR]− ζ−kdeact[LR∗]
−θνµµ+ν+kg+[LR∗][G] + θνµµ−ν−kg−[LR∗G]
+kGTP+[LR
∗G] (3.15)
d[R∗G]
dt
= θµµ+kg+[R
∗][G]− θµµ−kg−[R∗G] + µ+kact[RG]− µ−kdeact[R∗G]
−θζνζ+ν+klb+[L][R∗G] + θζνζ−ν−klb−[LR∗G]
−kGTP+[R∗G] (3.16)
d[LR∗G]
dt
= θνµµ+ν+kg+[LR
∗][G]− θνµµ−ν−kg−[LR∗G]
+θζµζ+µ+kact[LRG]− θζµζ−µ−kdeact[LR∗G]
+θζνζ+ν+klb+[L][R
∗G]− θζνζ−ν−klb−[LR∗G]
−kGTP+[LR∗G] (3.17)
d[αGTP]
dt
= kGTP+[R
∗G]− kgd+[αGTP] + kgd−[αGDP] + kGTP+[LR∗G] (3.18)
The rate of αGTP formation from R
∗G could be slowed directly by reducing the
value of kGTP+ (see equation (3.18)); less directly, either the R
∗G formation rate could
be slowed by reducing the ratio
µ+
µ− (see equation (3.16)), or the rate of R
∗ formation
slowed by lowering the ratio kactkdeact (see equation (3.14)). However, all of these measures
would have a similar effect on the corresponding ligand-bound states, as can be seen
from equations (3.15), (3.17), (3.18), and consequently, the level of agonist-induced αGTP
production would also drop; that is, the peak-to-basal ratio would not necessarily be
increased. What is desired is a parameter change that would result in an increase of the
peak-to-basal ratio for [αGTP], resulting in the production of enough IP3 to cause full
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Figure 3.11: The αGTPγS model (represented by the figure without the dotted lines) is
derived, in order to mimic data from an αGTPγS assay [93]; it is a subset of the (cubic
ternary complex activation model) cTCAM, which is represented by the whole figure
(see Chapter 2).
occupancy of its receptors only after agonist stimulation.
The parameters in the preliminary parameter set which pertain to the G-protein
activation model can be re-assessed with the help of the αGTP-level data discussed in
section 3.4, which were obtained from a GTPγS binding assay [93]. The experiment
measures the level of agonist-induced G-protein activation by measuring the concen-
tration of the complex formed from the binding of the non-hydrolysable GTP ana-
logue, GTPγS to the α subunit of the G-protein (forming αGTPγS). Since GTPγS is
non-hydrolysable, there is no deactivation of αGTPγS into αGDP or subsequent reunion
with βγ to reconstitute the inactive G-protein. These experiments were carried out in
CHO-cells expressing the M3 Muscarinic receptor, the same system used to produce
the Ca2+ data of Dr Lauren May here at the University of Nottingham (see section
2.2.3). The αGTPγS response to several agonists, measured after one hour, is shown in
dose-response curves in Figure 3.5.
A model of the GTPγS binding experiment is derived by setting kgd+ = kRA+ = 0
in the G-protein activation model (see section 2.1). The relationship between the two
models is illustrated in Figure 3.11. Comparing the predictions of the αGTPγS model
with the αGTPγS data serves as a way to analyse some parameters in the preliminary
parameter set that pertain to the G-protein activation model.
Figure 3.12(a) shows the dose response curves predicted by the αGTPγS model with
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Figure 3.12: Dose response curves for αGTPγS predicted by the αGTPγS accumulation
model ((a)) simulated with the parameter set in Appendix B.2.1 but with kgd+ = kRA+ =
0, (b) simulated with the parameter set in Appendix B.2.1 but with kgd+ = kRA+ = 0 and
adjusted values kGTP+ = 0.001s
−1, ν = 100, which allow the curves resemble the data
more closely (compare Figure 3.5.
relevant parameters taken from the preliminary parameter set. In contrast to the data,
the model predicts that all of the agonists are full agonists, capable of producing the
maximum possible [αGTPγS], which is approximately equal to the total G-protein con-
centration (GTOT = 4.15× 10−10M). It is also clear from Figure 3.12(a) that over the dif-
ferent agonist concentrations, the model response range is very small, 4.135 − 4.15×
10−10M. In fact, in the absence of agonist, the system, via the R∗G state, is able to
produce almost the maximum possible αGTPγS response (result not shown); this is a
significant overestimation of the basal activity when compared to the data. These re-
sults then imply that one or more of the G-protein parameters require adjustment in
order to predict a more realistic basal response. Since all the parameters in the αGTPγS
model are also in the G-protein activation model and in the Ca2+ model, the conse-
quent parameter changes informed by the αGTPγS data can be applied to those models
as well.
The fact that the basal αGTPγS concentration is too high suggests that the rate of the
reaction R∗G
kGTP+−→ R∗ + αGTP + βγ is too fast, hence an obvious parameter to lower
is kGTP+. An examination of the αGTPγS rate equation
d[αGTPγS]
dt
= kGTP+([R
∗G] + [LR∗G]), (3.19)
indicates that lowering kGTP+ would lower the basal concentration of αGTPγS, produced
from R∗G, but also its agonist-induced peak concentration, produced from LR∗G. There-
fore lowering the value of kGTP+ on its own would not necessarily increase the peak-
to-basal ratio. From equations (3.16) and (3.17), it can be seen that if the value of ν+
is also increased, the effect would be to promote the LR∗G state of the GPCR while
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inhibiting the R∗G state; this counteracts the negative effect on the peak-to-basal ratio
of decreasing kGTP+.
With the adjusted values kGTP+ = 0.001s
−1 (previously kGTP+ = 1s−1) and ν+ =
100 (previously ν+ = 1) themodelmakes qualitatively similar predictions to the αGTPγS
data, predicting different maximal responses for each agonist (Figure 3.12(b)). The
model’s dose-response curves are steeper than those of the data, which means that the
predictions of efficacy for the agonists are overestimated. This may be accounted for
by the fact that mechanisms of receptor desensitisation are not included in the model.
Following previous modelling efforts, the model had so far assumed that the ago-
nist binds indiscriminately to the pre-coupled (RG and R∗G) and un-coupled states of
the GPCR (R and R∗); that is, ν = ν+ν− = 1 [86, 106]. The need to increase the value of ν+
suggests that this might not be the case. The model suggests that in reality, the agonist
might favour the pre-coupled state of the receptor.
The values kGTP+ = 0.001s
−1, ν+ = 100 have improved the qualitative predictions
of the αGTPγS model and as such replace their former values in the Ca
2+ model.
3.7.5 Final variation of the Ca2+ model parameters
As a reminder, the current parameter set has been derived by replacing relevant param-
eters in the preliminary parameter set with the new values: kIP3Rb+ = 1.2× 109M−1s−1,
kGTP+ = 0.001s
−1 and ν+ = 100. The last two parameter choices have the effect of keep-
ing the basal [αGTP] low, as illustrated by Figure 3.13(a), but (as would be expected) do
not necessarily increase the number of IP3-bound receptors (see Figure 3.13(b)), or con-
sequently, the Ca release (see Figure 3.13(b)). To maximally bind the IP3 receptors,
parameter adjustments that increase IP3 production need to be made.
In Chapter 2, it was shown that increasing the total G-protein concentration (GTOT)
up to ≈ 10−6M in the G-protein activation model also increases the maximum [αGTP]
(see Figure 2.3), and that increasing the total receptor concentration (RTOT) up to 10
−8M
has a similar effect (see Figure 2.4), all without significantly elevating the basal concen-
tration of αGTP. Hence, the new values, GTOT = 10
−6M and RTOT = 10−8M are now
used instead of their former values (GTOT = 4.15× 10−10M, RTOT = 4.15× 10−10M)
in the preliminary set; by increasing αGTP production, IP3 production can also be in-
creased, without unduly increasing the basal level. Any of the parameter changes dis-
cussed in section 3.7.3 can also be implemented to increase the production of IP3, since
the peak-to-basal ratio will be controlled by the values of new values of kGTP+, ν+,
GTOT and RTOT. The most direct parameter change is to increase the rate constant of
αGTPPLC and PIP2 binding, kPIP2b+ (see reaction 3.6), and consequently, the available
αGTPPLCPIP2 concentration, from which IP3 is hydrolysed.
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Figure 3.13: Time courses predicted by the Ca2+ model, simulated with the preliminary
parameter set in Table B.2.2 but with the adjusted values: kIP3Rb+ = 1.2× 109M−1s−1,
kGTP+ = 0.001s
−1, ν = 100. The changes in kGTP+ and ν only impact the αGTP peak-to-
basal ratio.
Increasing kPIP2b+ a hundred-fold, from 10
9M−1s−1 to 1011M−1s−1 does cause pro-
duction of enough IP3 to occupy nearly all receptors only after stimulation by 10
−7M
of Oxotremorine-M (see Figure 3.14(b), dashed line), and Ca2+ release is increased (see
Figure 3.14(a), dashed line), but it is not maximal (results not shown). This is because
of the way that the IP3-bound receptors are distributed between states; Figure 3.15(a)
shows that at any time after stimulation, more receptors are in the inhibitory state
([IP3 IP3RCa
2+Ca2+]) than the active state ([IP3 IP3RCa
2+]), which limits Ca2+ release.
This indicates that the value of the binding rate constant of inhibitory Ca2+, kCa2+ inh+
must be too large (or the unbinding rate constant too small). Figure 3.15(b) indicates
that lowering kCa2+ inh+ ten-fold, from 1.8× 106M−1s−1 to 1.8× 105M−1s−1 causes more
receptors to stay in the active, than the inhibitory state, without significantly changing
the total percentage bound to IP3R (see Figure 3.14(b), solid line); Ca
2+ release is also
increased (Figure 3.14(a), solid line). Figure 3.16 indicates that this Ca2+ release is max-
imal, and all other agonists are able to produce it. The simulated dose-response curves
thus resemble the data in predicting that all the drugs are full agonists.
All the parameter changes made to get to this point form a new parameter set found
in Table B.2.2, referred to as the derived parameter set. The model predicts signal am-
plification with these new parameters, but the rapid, transient peak has been lost.
3.8 Model extension: Effects of receptor desensitisation
So far, the model has not simultaneously predicted all the features of the Ca2+ data
with any of the parameter sets that have been tested. In each case (apart from the cases
where the response was trivial) either the rapid, transient peak was predicted without
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Figure 3.14: Time courses predicted by the Ca2+ model, simulated with the preliminary
parameter set in Table B.2.2 but with the adjusted values: kGTP+ = 0.001s
−1, GTOT =
4.15× 10−6M, RTOT = 10−8M, kPIP2b+ = 1011M.
signal amplification, or vice versa. With the preliminary parameter set (see Table B.2.2),
the Ca2+ removal process (carried out by SERCA pumps) was influential enough to
make the peak transient, probably because the Ca2+ response was not amplified (see
Figures 3.7 and 3.8); with the derived parameter set (see Table B.2.2) came the model’s
ability to predict signal amplification (see Figure 3.16), but at the cost of the transient
peak, with the action of the SERCA pumps no longer influential enough to bring the
peak down (see Figure 3.14).
The Ca2+ removal process is modelled by a Hill function, as similarly used in some
existing Ca2+ models [44, 48, 70]. It might be that varying the parameters p1 and p2
of the Hill function could enable the prediction of a transient peak, which will occur
when d[Ca
2+
dt ] is negative; that is, when,
(1+ vr)(γ0 + γ1[IP3 IP3RCa
2+])(Ca2+AV − [Ca2+]) <
p1[Ca
2+]2
[Ca2+]2 + p22
. (3.20)
Other upstream parameters might also modulate equation 3.20 by influencing the
production of IP3 IP3RCa
2+, thus influencing the lifetime of the peak. The next chapter
will attempt to identify such parameters.
However, there is an indirect process of Ca2+ removal which has not yet been in-
cluded in the model, but which may have a role in making the peak transient. In the
data, Ca2+ returns to its basal level, indicating that the signal from the agonist becomes
ineffective through desensitisation. Hence, it might be necessary to incorporate recep-
tor phosphorylation into the Ca2+ model, in order to predict the return from peak to
basal level. As previously mentioned, PKC, which is activated by DAG (a co-product
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Figure 3.15: When the model is simulated with the adjusted values: kGTP+ = 0.001s
−1,
GTOT = 4.15× 10−6M, RTOT = 10−8M, kPIP2b+ = 1011M, the response is not maximal
because kCa2+inh+ = 1.8× 106M−1s−1 is too high, favouring the inhibited IP3R state (a),
but when kCa2+inh+ is lowered to 1.8× 106M−1s−1, more active states are formed.
−11 −10 −9 −8 −7 −6 −5 −4 −3
3
4
5
6
7
8
9
10
11 x 10
−7 t
 
 
Carbachol
Oxotremorine−M
Pilocarpine
Bethanachol
C
a2
+
(%
10
0
µ
M
C
ar
b
ac
h
o
l)
Log [L]
Figure 3.16: Dose response curves for the peak [Ca2+] predicted by the Ca2+ model,
with the parameter set in Table B.2.2, but with the adjusted values: kGTP+ = 0.001s
−1,
GTOT = 4.15× 10−6M, RTOT = 10−8M, kPIP2b+ = 1011M, kCa2+inh+ = 1.8× 105M−1s−1.
with IP3 of PIP2 hydrolysis) causes GPCR desensitisation by phosphorylating GPCR’s
in the Gq pathway, and causing termination of the signal. In the Kang and Othmer
model, where the active, unbound receptor (R∗) is incapable of signalling, the phos-
phorylation reaction (in the terminology of this work) is given by
LR∗G + PKC
kPKLR−−⇀
↽−−
k−PKLR
LR∗desG. (3.21)
The DAG-PKC pathway will not be included in this chapter’s Ca2+ model, as
that would significantly increase model complexity. Instead, a simple desensitisation
scheme, which accounts for the fact that the lifetime of active GPCR’s is shortened by
PKC-mediated phosphorylation is incorporated by adding the following phosphoryla-
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tion reactions:
R∗G
kdes+−−⇀
↽−−
kdes−
R∗desG (3.22)
LR∗G
ρ+kdes+−−⇀
↽−−
ρ−kdes−
LR∗desG, (3.23)
where ρ+, ρ− are factors that potentially differentiate the rate constants of the desen-
sitisation and re-sensitisation of R∗G from LR∗G. Values for kdes+ are available from
a GPCR-mediated IP3 production model of Cooling et al. [17], which incorporates
receptor phosphorylation via the forward reaction in (3.23); in that model kdes+ =
6.22× 10−6s−1 and kdes+ = 4× 10−4s−1 were used to model phosphorylation in two
different GPCR systems. The forward rate constant in the Kang and Othmer model
(reaction 3.21) is not directly applicable because it has units of M−1s−1; however, the
reverse reaction, which is similar to those in reactions (3.22) and (3.23), makes use of
the value, k−PKLR = 0.1s−1 [37]. There are thus values in the literature that can be used
as guide for setting kdes+ and kdes−. Without evidence to the contrary, it is assumed that
the agonist-bound receptor is phosphorylated at the same rate as the unbound receptor,
so that ρ+ = ρ− = 1.
Suitable values of kdes+ and kdes− need to be found which permit the model to still
satisfy the IP3Rmaximal occupancy theory (see section 3.7.3). Hence, one criterion that
will be used to fine-tune these parameter choices is the percentage of bound IP3R,
IB =
100(IP3RTOT − IP3RP)
IP3RTOT
, (3.24)
where IP3R
P is the peak IP3R concentration. Another measure is the ratio,
PBP =
Peak− Plateau
Peak− Basal , (3.25)
which should be 1 if the plateau returns to the basal value. (Note that Peak−Basal 6= 0
in the parameter range explored).
Figure 3.17 shows three-dimensional plots of PBP and IB on the z axes with kdes+
and kdes− on the x and y axes. In Figure 3.17(a) there is a region in which IB is high,
while in Figure 3.17(b) there is one in which PBP ≈ 1. However, only small portions of
these regions intersect, meaning that only pairs in a constricted region of (kdes+,kdes−)
parameter space cause a post-peak return to basal and high IP3R occupancy. Figure
3.18 shows areas in space for which 0.95 ≤ PBP ≤ 1.04 and IP3R occupancy is high.
Only a very small area causes ≥ 90% IP3R occupancy or more (Figure 3.18(a)), and the
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Figure 3.17: The dependence of (a) the percentage of bound IP3 receptors and of (b)
Ca2+’s plateau relative to its basal (b) on the values of kdes+ and kdes−. Only a few pairs
kdes+ and kdes− cause a return to basal and high IP3R occupancy.
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Figure 3.18: Shown in black are areas of the kdes+-kdes− plane where PBP ≈ 1 and (a) IP3R
occupancy ≥ 90%, (b) IP3R occupancy ≥ 70%, (c) IP3R occupancy ≥ 50%.
area increases for ≥ 70% IP3R occupancy (Figure 3.18(b)) and ≥ 50% IP3R occupancy
(Figure 3.18(c)).
A pair of values, kdes+ = 5 × 10−3s−1 and kdes− = 5 × 10−6s−1, from the ≥ 90%
IP3R occupancy area (Figure 3.18(a)) are used to simulate the model. To illustrate the
role that the desensitisation reactions have on the model, Figure 3.19 compares the
GPCR states in the presence and absence of desensitisation. Figure 3.19(a) shows that,
in the absence of desensitisation, the majority of receptors are in the inactive RG state
before agonist stimulation. On stimulation, RG and R∗G get converted into the LRG
and LR∗G states, whosemaximum concentrations are sustained as the steady state (the
sustained Ca2+ response in Figure 3.14(a) might be explained by the fact that the active
state, LR∗G is sustained). However, when desensitisation is incorporated, the majority
of receptors are distributed between the inactive (RG) and desensitised (R∗desG) states
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Figure 3.19: (a)-(b) Receptor states in the model without desensitisation (kdes+ =
0, kdes− = 0) are shown; (c)-(d) With desensitisation, the states are re-distributed kdes+ =
5× 10−3s−1, kdes− = 5× 10−6s−1, with the majority ending up desensitised.
just before stimulation. On stimulation, the agonist bound states LRG and LR∗G start
to form, with the latter also being converted into the desensitised state, LR∗desG, which
accumulates, so that most receptors end up in that state. The transience of the LR∗G
state then causes the Ca2+ response to be transient, as discussed in the next paragraph.
Figure 3.20 shows the Ca2+ simulations. The response is a slow transient for higher
concentrations of Oxotremorine-M (Figure 3.20(a)), and is amplified for all agonists
(Figure 3.20(b)). Hence, with the incorporation of a minimal receptor desensitisation
process, the model predicts signal amplification and a transient, but not rapid, Ca2+
peak. This might suggest that the calcium-induced calcium release (CICR) mechanism
alone is not sufficient to produce the transient Ca2+ peak, in amplifying systems. How-
ever, the derived parameters for desensitisation cannot explain the rapid time to peak,
suggesting that they (and other parameters) require further analysis.
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Figure 3.20: The simulated time courses are now transient, with the incorporation of
desensitisation into the model, (a), qualitatively resembling the data (see Figure 3.3(a)),
but the peaks are not rapid. The simulated dose-response curves (b) resemble the data
(see Figure 3.3(b)), with all agonists producing the maximum response.
3.9 Discussion
In this chapter a Ca2+ model was assembled by extending the G-protein model of
Chapter 2, using relevant downstream reactions from an existing model [37]. The
model predicted a rapid, transient Ca2+ peak, but not signal amplification, when sim-
ulated with a preliminary parameter set assembled from the literature. Using available
data from experiments carried out at the University of Nottingham’s Institute of cell
signalling [52], and other experimental results from the literature [50, 93], adjustments
were made to the preliminary set to derive a parameter set with which the model could
predict signal amplification, but not the rapid or transient Ca2+ peak.
The model was then extended by incorporating GPCR desensitisation, which im-
proved the predicted Ca2+ response; the model predicted signal amplification and the
transient peak (with return to basal level, as in the data), but not its rapidity. This
extension of the model is what will subsequently referred to as the Ca2+ mobilisation
model.
GPCR pre-coupling
When the αGTPγS model (a subset of the Ca
2+ model) was fine-tuned to qualitatively
predict the αGTPγS data, the value ν+ = 1 in the preliminary parameter set had to be
changed to ν+ = 100, suggesting that the agonist favours the GPCR’s pre-coupled state
(RG, R∗G) over the uncoupled one (R, R∗). This suggests that agonist efficacy may be
dampened if pre-coupling (via reactions 1.13 and 1.14) is inhibited, a model result that
can be tested experimentally.
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Receptor desensitisation
To enable the simultaneous prediction of signal amplification and the transient peak,
receptor desensitisation had to be incorporated into the model. This might suggest that
the Ca2+-induced Ca2+ release mechanism alone is not sufficient to cause a transient
peak, when the Ca2+ response is amplified. This can be tested by measuring Ca2+
time courses in experiments where kinase/PKC-mediated desensitisation is blocked
by using commercially available PKC/kinase inhibitors [57, 88], and checking whether
the transient peak occurs.
Hints of a fine-tuned Ca2+ response
The fact that the model could not simultaneously predict signal amplification and the
rapid Ca2+ time-to-peakwith any of the parameter sets that were tested raises the ques-
tion of how the system fine-tunes the Ca2+ response, amplifying a signal without de-
laying the response. The method of model simulation interacting with experimental
data has not been sufficient to provide an explanation for this seemingly optimised
mechanism. However, it has provided a base parameter set around which to define
a reasonable parameter space, in which a more systematic parameter analysis can be
carried out; this will be the focus of the next chapter.
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Global sensitivity analysis of
parameters
4.1 Introduction to sensitivity analysis
In Chapter 3 an initial parameter analysis was carried out using a heuristic approach
that involved making data-guided adjustments to relevant parameters. With these ad-
justments, the model’s prediction of the Ca2+ response was improved, matching the
data more closely, but not completely. Since the parameter changes were not sufficient
to enable the model to reflect all the features of the Ca2+ data, a more systematic pa-
rameter analysis is carried out in this chapter using a method of sensitivity analysis.
Sensitivity analysis methods can quantify the impact of varying a parameter’s value
on specific model outputs, providing a parameter significance ranking. Such a method
of analysis is ideal for the Ca2+ model for the following reasons. Firstly, the Ca2+
model, like many large models of biological systems, has many parameters whose
values are uncertain. A sensitivity analysis would identify the subset of parameters
which are key drivers of particular model output features like the rapid, transient peak
response and signal amplification. Hence, unlike steady state analysis methods, sen-
sitivity analysis can be used to analyse such time-dependent behaviour as exhibited
in the Ca2+ data (see Figure 3.20). Secondly, if appropriate non-influential parameters
are identified, sensitivity analysis may open up the possibility of model simplification,
and perhaps, simplify or enable the use of other methods of analysis, simply by re-
ducing the number of parameters requiring further analysis. For instance, a process
like parameter estimation can potentially be significantly simplified, because the di-
mensionality of the parameter space can be reduced by fixing the values of relatively
non-influential parameters, and only estimating the rest.
Local sensitivity analysis (LSA) methods are carried out at a point in parameter
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space, and generally involve the use of partial derivatives to identify which parame-
ters have the greatest influence on the output. Given that the output of interest is rep-
resented by Y, and the ith parameter by Xi, a commonly used measure of sensitivity is
[80]:
Ci =
δY/Y
δXi/Xi
, (4.1)
which quantifies how changes in the parameter’s value influence the output; also, if
|Ci > 1|, the relative change in the output is greater than in the parameter. LSA meth-
ods are appropriate for situations in which the model parameters are known with rea-
sonable certainty. However, for nonlinear models with considerable uncertainty in the
parameters, sensitivity analysis methods applied to parameters as they change across
space are more appropriate [2, 81]. These are referred to as global sensitivity analysis
(GSA) methods.
4.2 GSA methods and applications
Global sensitivity analysis methods measure sensitivity at different points in param-
eter space, and so give an indication of each parameter’s average effect as it changes
simultaneously with other parameters. There are a variety of established GSAmethods
in the literature, as well as instances of their application to problems in various fields
of study.
Variance-basedmethods form a group of GSAmethods that quantify the percentage
that each parameter or combination of parameters (from pairs to highest order inter-
actions) contributes to the variance in the model output [81]. The parameters which
contribute little can thus be identified. Variance-based methods are called quantitative
because the contribution of each parameter to the variance of the output has a quanti-
tative measure, but they are computationally expensive and can become impracticable
when the number of parameters is large.
The method of elementary effects (EE) calculates for each parameter, at multiple
points in parameter space, the change in output relative to changes in that parame-
ter’s value, using the average of these ratios as the sensitivity measure. This measure
has been shown to be as effective as variance-based measures in identifying parame-
ters that contribute significantly to the variance of the output [15], but does not quan-
tify their exact contribution. The EE method is able to distinguish between parame-
ters which have effects that are (a) negligible, (b) linear and additive, or (c) nonlinear
and/or due to interactions (correlation) with other parameters [63]. The method of dis-
tinguishing between these effects will subsequently be clarified (see section 4.3.2). The
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EE method is computationally cheaper than variance-based methods, and suitable for
models with a high number of parameters.
Themethod of Partial rank correlation coefficients (PRCC) is another global method;
it measures the strength of the linear relationship between the output and a parameter
after the effects of the other parameters have been removed, and ranks the parameters
accordingly [41]. The method assumes that the relationship between parameters and
the model output is monotonic [41], and so is not applicable to every type of model.
Global sensitivity analysis methods have routinely been applied in the fields of en-
vironmental engineering [15] and finance [81]. Recently they have been applied to
mathematical models of biological systems, including the cubic ternary complex acti-
vation model (cTCAM) discussed in Chapter 2 [41], a gene transcription model [35], a
T cell receptor signalling model [107], and a GPCR-mediated IP3 activation model [17].
It does not appear that a (global) sensitivity analysis has previously been carried out on
an agonist-induced Ca2+ model, especially not with regard to pharmacological features
such as signal amplification. The applications to the cTCAM and the GPCR-mediated
IP3 activation model are of relevance, and are discussed in more detail below.
Kinzer-Ursem and Linderman [41] used the PRCC method to identify the parame-
tersmost correlated to the αGTP response in the cTCAM, and found both ligand-specific
and cell-specific parameters to be influential. The ligand-specific parameter most cor-
related with response generation was ζ, the extent to which the ligand favours the
receptor’s active state. The cell-specific parameters highly correlated with response
generation were: the total concentrations of receptor and G-protein, RTOT, GTOT; the
equilibrium of ratio of active (R) to inactive receptor (R∗), quantified by kactkdeact ; the extent
to which the active receptor binds more or less preferably to the G-protein than the
inactive receptor, µ; and the rate constants in the G-protein activation loop. Guided by
these results, it was found that changes in the cell-specific parameters, GTOT and
kact
kdeact
,
could produce the experimentally observed phenomenon of protean agonism (which
refers to the ability of a ligand to induce both positive and negative responses).
To understand why two different agonists, Endothelin-1 (ET-1) and angiotensin-II
(Ang-2), could produce different IP3 transients through essentially identical pathways
in the cardiac myocyte, Cooling et al. [17] used the method of elementary effects to
identify parameters that controlled the features of the transient. They found that the
rate constant for the phosphorylation of the active receptor and the rate constant for
the binding of ligand to pre-coupled receptors were among the most significant. The
differences in the ET-1- and Ang-2-induced IP3 responses could then be explained by
adjusting these two parameters (and a third, chosen because of its individual effect on
the IP3 peak).
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4.3 The method of elementary effects
Of the methods discussed above, the method of elementary effects is chosen to analyse
the Ca2+ model parameters because it is computationally efficient, hence suitable for
the model which has many (48) parameters. Also, no prior assumption needs to be
made about the model’s parameter-output relationship. The method is described in
detail below.
A parameter space is defined by specifying a range of uncertainty for each param-
eter. Let k be the number of parameters of interest, then the vector X = (X1,X2, ...,Xk)
represents a point in parameter space and the output of interest is represented by Y(X).
The parameters are not sampled directly from the actual parameter space, A ⊆ Rk. Ini-
tial values are randomly sampled from a discrete uniform distribution in the [0,1] in-
terval, so that the sampling space is a k-dimensional unit hypercube, Ω. Let a point in Ω
be given by x; its ith component, xi, is a randomly chosen value from {0, 1p−1 , 2p−1 , ..., 1}
(p ∈ N). Thus, the number of possible values is given by the choice of p. The x vector
is then transformed into a point in actual parameter space, X = (X1,X2, ...,Xk), accord-
ing to a specified distribution. For instance, if each parameter is to be selected from a
uniform distribution, the transformation to each Xi is as follows:
Xi = xi(UBi− LBi) + LBi, (4.2)
where LBi is the lower bound of the ith parameter’s range of values, and UBi its upper
bound.
A ratio pertaining to the ith parameter, referred to as an elementary effect (EE), is
calculated using two points in A, identical, except in their ith components which differ
by ∆i. For a given value of X, the elementary effect of the ith input factor on an output
of interest Y is defined as:
EEi(X) =
[Y(X1,X2, ...,Xi−1,Xi + ∆i, ...,Xk)− Y(X1,X2, ...,Xi−1,Xi, ...,Xk)]
∆
, (4.3)
where Xi ≤ 1− ∆.
If Xi > 1− ∆, the elementary effect is calculated as follows,
EEi(X
∆−) =
[Y(X1,X2, ...,Xi−1,Xi, ...,Xk)− Y(X1,X2, ...,Xi−1,Xi − ∆, ...,Xk)]
∆i
, (4.4)
where X∆− indicates that the elementary effect calculated is for X with ∆i subtracted
from its ith dimension.
Let δ ∈ { 1p−1 , 2p−1 , ..., 1− 1p−1} be a fixed amount by which xi can be increased (note
that thismeans the parameter change is not necessarily the same as the lattice sampling,
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since δ 6= 1p−1 is possible); the corresponding increase of Xi in the actual parameter
range is then given by:
∆i = δ(UBi − LBi). (4.5)
The ith parameter has a distribution, Fi, of p
k−1(p− δ(p− 1)) possible elementary
effects, if calculated at all possible sample points in Ω [63]. For high values of p and k,
calculating all the elements of Fi is an impractical computational effort. (For instance,
if for a model with k = 40 parameters, p = 10 is chosen, 1039(10− 9δ) total elementary
effects can be calculated.) Instead, a random sample of r representative elementary
effects is selected from Fi. The average of these elementary effects then provides a
measure of each parameter’s global influence on an output feature of interest.
4.3.1 Sampling strategy
Sampling the parameter space effectively involves selecting a sufficient number (r) and
spread of sample points, while minimising the number of model evaluations required
for the calculation of corresponding elementary effects. Each elementary effect requires
the output to be calculated at two points in parameter space (see equations (4.3) and
(4.4), thus requiring the model to be evaluated two times. The most straightforward
sampling strategy would require 2rk model evaluations, a linear function of the num-
ber of parameters being tested, k. This is an advantage of the method of elementary
effects; the required number of model evaluations always varies linearly with the num-
ber of parameters.
An even smaller number of model evaluations than 2rk can be used to calculate
the same number of elementary effects using a sampling strategy that requires only
r(k + 1) model evaluations [63]. This strategy considerably reduces the computational
expense (r(k − 1) fewer model evaluations required), and is especially advantageous
when applied to the Ca2+ model, which has many parameters. The strategy, which
exploits the fact that one of the 2 points used to calculate an elementary effect is used
in the calculation of the next one, is explained below.
A random starting point, X∗, is selected in parameter space, from which k other
points are generated, forming a trajectory. A trajectory can be represented by a ma-
trix, B′, with dimension (k + 1) × k, whose rows are the vectors X∗1,X(1)1 ,X(2)1 ,...,X(k)1 ,
X∗2,X
(1)
2 ,... representing consecutive points in the trajectory. k elementary effects can be
calculated using this matrix if every pair of consecutive rows only differs (by ∆i) in one
unique column. An example of such a matrix is
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B’ = Jk+1,kX
∗ + ∆B, (4.6)
where Jk+1,k is a (k + 1)-by-k matrix of 1’s and B is the (k + 1)× k strictly lower trian-
gular matrix of 1’s:
B =


0 0 0 . . . 0
1 0 0 . . . 0
1 1 0 . . . 0
1 1 1 . . . 0
. . . . . . . . . . . .
1 1 1 . . . 1


. (4.7)
B’ is then given by:
B′ =


X∗1 X
∗
2 X
∗
3 . . . X
∗
k
X∗1 + ∆ X
∗
2 X
∗
3 . . . X
∗
k
X∗1 + ∆ X
∗
2 + ∆ X
∗
3 . . . X
∗
k
X∗1 + ∆ X
∗
2 + ∆ X
∗
3 + ∆ . . . X
∗
k
. . . . . . . . . . . .
X∗1 + ∆ X
∗
2 + ∆ X
∗
3 + ∆ . . . X
∗
k + ∆


(4.8)
Note that sampling strategies can be chosen which generate points along the tra-
jectory that decrease by ∆; that is, a parameter’s value may change from Xi to Xi − ∆.
However, the elementary effect is always calculated as the effect of increasing a param-
eter by ∆; in such cases, equation (4.4) is used to calculate the elementary effect.
Given that D∗ is a k-dimensional diagonal matrix whose elements are either +1 or
−1 with equal probability, and P∗, a k-by-k random permutation matrix, a randomised
version of B’ is given by:
B∗ = (Jk+1,1X
∗ + (∆/2)[(2B− Jk+1,k)D∗ + Jk+1,k])P∗. (4.9)
D∗ determines, in a randommanner, whether the ith parameter changing by ∆ from
point to point along the trajectory increases, orwhether it decreases, while P∗ randomly
determines the order in which the parameters change in each trajectory. This randomi-
sation ensures that the shape of each trajectory is randomly selected, in keeping with
the statistical idea of random sampling. For illustrative purposes, the effects of the
randomisation scheme are considered in a design for which the number of parameters
is k = 2, number of grid points, p = 9, and number of trajectories, r = 5. Without
the random permutation matrix, P∗, or the random diagonal matrix, D∗, the design
is pre-determined. All trajectories from the starting points, X∗1-X∗5 would have to take
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Figure 4.1: Possible trajectories from the starting points X∗1-X∗5 for a sampling scheme
in which k = 2, p = 9, r = 5. (b) and (c) are possible results with the randomisation
scheme, while (a) is the result without randomisation.
the same shape, as in Figure 4.1(a), but with the randomisation scheme each trajec-
tory is able to take any of eight possible shapes, allowing the design to be randomly
determined. Figures 4.1(b) and 4.1(c) show forms that the randomisation scheme can
produce.
For r trajectories the matrix for the entire sample is given by:


B∗1
B∗2
...
B∗r


. (4.10)
Improving coverage of parameter space
Whatever the value of r chosen, trajectories can be chosen whose spread across param-
eter space is maximised with a strategy developed by Campolongo et al. [15]. A high
number (M > r) of trajectories is generated using the above strategy, and then the sub-
set of r trajectories with the maximum spread in the parameter space are selected, after
which model evaluations can be carried out using the optimised trajectories. Thus the
sampling of parameter space can be improved without increasing the number of model
evaluations required.
The concept of spread is based on the Euclidean distance between a pair of trajec-
tories, m and l:
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dz,l =


∑
k+1
j=1
√
∑
k
i=1
[
Xzj (i)− Xlj(i)
]2
for z 6= l,
0 otherwise,
(4.11)
where Xzj (i) is the ith coordinate of the jth point of the mth trajectory. This mea-
sure dz,l is used to calculate, for each possible combination of r trajectories, the quan-
tity D, which is the square root of the sum of the squared distances (dz,l)
2 between
all possible pairs of trajectories in that combination. For example, if there are M =
{1, 2, 3, 4, 5, 6, 7, 8} initial trajectories, D for the combination of trajectories 2, 3, 7 (r = 3)
is given by:
D2,3,7 =
√
(d2,3)2 + (d2,7)2 + (d3,7)2. (4.12)
The optimal sample matrix (of size r(k + 1)× k) for the whole design is the combi-
nation of r trajectories out of
M!
(M− r)!r! (4.13)
possible choices with the highest value of D [81].
The sample of r elementary effects that are obtained per parameter will usually
be few compared to the pk−1[p − ∆(p − 1)] number of possible effects; maximising
the spread of the trajectories across parameter space is therefore important, since the
trajectories should be as representative as possible. When the sensitivity analysis of
the model parameters is carried out later, two different values of r will be compared in
order to explore the effects of the sample size on the results obtained, and the utility of
this sampling strategy.
Figure 4.2 shows the samples obtained for each Xi by the optimised sampling strat-
egy and the original sampling strategy of Morris [63] for a scheme in which k = 4,
r = 20 and p = 4. The optimised strategy can sometimes reduce clustering across di-
mensions; this can be seen in the sample for X3, across which the spread is evidently
more uniform when the optimised strategy is used.
4.3.2 Sensitivity measures
The original method of elementary effects [63] uses two measures to quantify parame-
ter sensitivity: the average of elementary effects pertaining to the ith parameter,
mi =
1
r
r
∑
j=1
EE
j
i , (4.14)
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Figure 4.2: Histograms representing sample obtained for k = 4 parameters when
M = 1000, r = 20, p = 4 using the (a) original Morris sampling strategy [63] (b) sam-
pling strategy of Campolongo et al. [81]. The parameter samples have a more uniform
distribution in (b).
and its standard deviation,
σi =
√√√√ 1
r− 1
r
∑
j=1
(EE
j
i −mi)2. (4.15)
A σi value equal to or approximately zero, indicates that the EE
j
i values are constant
or (approximately constant) over all values of the ith parameter; hence that parameter’s
effects are linear. A value of σi > 0 implies that the EE
j
i values are a nonconstant func-
tion of Xi or one or more of the other parameters (Xj, j 6= i). Hence, the parameter’s
effects are nonlinear and/or due to interaction with other parameters. The latter inter-
pretation can be understood as follows. A high σi value indicates that a parameter’s
elementary effects are rather different from each other, which implies that its influence
is dependent on its location in parameter space, andmight thus be due to the particular
choice of one or more other parameters.
When a parameter has inverse and non-inverse effects on the output,mi can under-
estimate the parameter’s significance, due to the cancellation of positive and negative
values of EE
j
i . However, such a parameter would have a high σi value, and so, if con-
sidered together with the value of mi, the parameter can still be identified as influential
[63]. A revised version of mi was proposed by Campolongo [15], which calculates the
average of the absolute values of each elementary effect, serving as a single measure to
quantify and rank the influence of parameters,
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High σi Low σi
High mi/m
∗
i Non-linear effects and/or interactions Linear effects
Low mi Non-linear effects and/or interactions Negligible effects
Low m∗i — Negligible effects
Table 4.3.1: A summary of how the sensitivity measures m and σ are interpreted.
m∗i =
1
r
r
∑
j=1
|EEji |. (4.16)
m∗i identifies significant parameters even when their effect on the model output is
non-monotonic, since cancellation effects cannot occur with |EEji |. Hence, m∗i will be
the main measure used to rank the parameters in this chapter. A high value of m∗i
indicates that the parameter has considerable effects on the output, while a low value
unambiguously indicates that the ith parameter has negligible effects on the output.
However, mi is still useful in some cases, where m
∗
i > mi reveals that the parameter’s
effects occur in alternating directions (non-monotonic).
mi is a particularly useful measure for analysing the parameters of the Ca
2+ model,
because it will be important to identify the direction in which the parameters are sig-
nificant. mi > 0 means that, on average, an increase in the ith parameter leads to an
increase in the model output of interest, while mi < 0 means that, on average, an in-
crease in the parameter leads to a decrease in the model output. If |mi| = m∗i , then
mi > 0 means that, at all tested points, an increase in the ith parameter leads to an
increase in the model output of interest, while mi < 0 means that an increase in the
parameter leads to a decrease in the model output; hence, the effects of the ith parame-
ter are monotonic across parameter space. Parameters with opposite signed mi values
for the Ca2+ Time-to-Peak and Left-Shift are of special interest because changes in their
values might enable the simultaneous prediction of the rapid Time-to-Peak and signal
amplification, as discussed in Chapter 3.
The parameters of the Ca2+ model are ranked using m∗i , while mi and σi are used to
give qualitative information about the effects of the parameters. Table 4.3.1 summarises
how the sensitivity measures are interpreted.
4.4 Application of the EE method to the Ca2+ model
In the Ca2+-mobilisation experiments being modelled, the agonist concentration is reg-
ulated by the experimentalist. The same experiment is repeated for n agonist concen-
trations [L1], [L2], ..., [Ln], and the corresponding Ca
2+ peak values P1, P2, ..., Pn are used
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to construct the dose-response curves (see Figure 3.3(b)). In the same way, the sen-
sitivity analysis is carried out n times, using each agonist concentration. This makes
the required number of model evaluations for the sensitivity analysis nr(k+ 1) instead
of r(k + 1). Hence the value of r must be even more carefully chosen, in order for the
computational expense of the sensitivity analysis to stay affordable. The computational
cost of implementing the method for the Ca2+ model will be discussed in a later section
(see section 4.4.4).
The sensitivity measures (4.14) - (4.16) are then re-defined as an average over n
values:
mi =
1
n
n
∑
L=1
1
r
r
∑
j=1
EE
j
i,L (4.17)
m∗i =
1
n
n
∑
L=1
1
r
r
∑
j=1
|EEji,L| (4.18)
σi =
1
n
n
∑
L=1
√√√√ 1
r− 1
r
∑
j=1
(EE
j
i,L −mi,L)2. (4.19)
The key features of the Ca2+ response have been identified from the data, and will
be the outputs for which elementary effects are calculated. These are the Transient-
Peak, the Time-to-Peak, Left-Shift of the Ca2+ peak dose-response curves relative to the
αGTP ones (indicative of signal amplification) and Peak-over-Basal. These four features
can be quantified by f = 4 objective functions (Y1,Y2,Y3,Y4), explained below.
Ca2+ Peak-Over-Basal
The Ca2+ peaks in the data are significant because they represent a considerable rise
over the basal level (see Figure 3.3(a)); hence, the Ca2+ peak output is considered rela-
tive to the basal response, as defined by the following:
Y1 =
Peak− Basal
Basal
, (4.20)
where ’Peak’ and ’Basal’ are illustrated in Figure 4.3. Considering the peak value on its
own can be misleading, since a small percentage rise over a high basal value is likely to
make a higher contribution to the absolute peak value than a large percentage rise over
a lower basal value. Hence, the potency of an agonist is better quantified by Y1 than
the absolute peak value, as the higher the value of Y1, the more potent the agonist. Y1
can also be used to distinguish between types of drugs, since Y1 > 0 holds for agonists,
Y1 = 0 for antagonists, and Y1 < 0 for inverse agonists.
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Figure 4.3: Features of the Ca2+ peak response which are used to define output features
for the sensitivity analysis.
Peak values for which Y1 < 0.05 are not taken into consideration. In such cases,
’Peak’ is taken to be 0. This distinguishes between peaks that actually arise from the
model, and ’peaks’ that arise from small numerical errors of the ODE solver.
Ca2+ Transient-Peak response
The transience of the Ca2+ peaks in the data is also an important feature, and is quan-
tified as:
Y2 = Peak− Plateau, (4.21)
where ’Peak’ and ’Plateau’ are illustrated in Figure 4.3. Y2 indicates whether the
transient peak seen in the data occurs in a model simulation. When the peak response
is sustained, Y2 = 0, but when it is transient, (Peak− Plateau) > 0.
Ca2+ Time-to-Peak
The time taken to reach the peak Ca2+ concentration after agonist stimulation is also an
important feature. In the data it is rapid, 5− 20s, depending on [L] (see Figure 3.3(a)).
The Time-to-Peak,
Y3 = tp, (4.22)
is illustrated in Figure 4.3. In those cases where Y1 < 0.05, Y3 = 0.
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Figure 4.4: An illustration of features related to the dose-response curves, used in the
quantification of the Left-Shift (see equations (4.23) and (4.25)).
Left-Shift
Signal amplification is quantified by measuring how much the dose response curve
shifts from the αGTP level in the pathway to the Ca
2+ level; it is calculated by subtract-
ing the absolute value of the EC50 of the αGTP dose response curve from the EC50 of the
Ca2+ one, as follows:
Y4 = |log(ECCa2+50 )| − |log(ECαGTP50 )|, (4.23)
where log(ECCa
2+
50 ) is the log(EC50) of the Ca
2+ peak response and log(ECαGTP50 ) is that
of the αGTP peak response. Recall that the EC50 is the concentration of agonist that
induces the peak response halfway between the baseline (B) and the maximal response
(T) of the dose-response curves, as illustrated by Figure 4.4). Y4 > 0, this indicates a left
shift from the αGTP level to the Ca
2+ level, while a negative value implies a right shift.
A left shift is an indication of signal amplification, since it means a smaller agonist
concentration is required to generate the half-maximal Ca2+ response than the αGTP
one.
Y1,Y2 and Y3 above are easily calculated from outputs of the model’s numerical
solution, but the EC50 values used to calculate the dose-response shift require an ad-
ditional estimation process, since in many simulations, EC50 /∈ [L1], [L2], ..., [Ln], but
will normally lie between two of the discrete values. The EC50 values are estimated by
fitting the peak values for each parameter set (run n times, for each [L] value) to the
following sigmoidal function:
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S([Lc]; B, T, EC50, h) = B +
T − B
1+ ( EC50
[L]
)h
(4.24)
where c = 1, 2, ...n and h is the Hill slope, which describes the steepness of the curve;
this equation is standard in pharmacological practice. In pharmacology, the curve with
h = 1 is referred to as the standard curve which describes most receptor-response
systems, and is used to fit dose response curves with few points [65]; it was used to fit
theM3 Ca2+ data, hence h is fixed at 1. The fminsearch function ofMATLAB,which uses
the Nelder-Mead simplex search method to estimate the local minimum of a function
without the use of gradients [51], is used to find values that minimises the following
function:
n
∑
c=1
(Pc − S([Lc]; B, T, EC50, h))2, (4.25)
where Pc is the c
th element of the Ca2+ peak values, P = [P1, P2, ...Pc, ...Pn], correspond-
ing to the cth ligand value [Lc]. Throughout this chapter n = 10 ligand concentrations
will be used.
The half maximal peak is given by:
P1
2
=
T + B
2
, (4.26)
where B and T are illustrated in Figure 4.4. Given that Pc < P1
2
< Pc+1, either Lc or
Lc+1 is chosen as the initial guess EC50 for the search method, depending on whether
Pc or Pc+1 is closer in value to P1
2
. L1 and Ln are chosen to ensure a wide range, so that
B = P1, and T = Pn are expected; hence, only EC50 needs estimation.
4.4.1 Selection of the GSA parameters
The choices made for the EE method and sampling strategy parameters, p, δ,M and r
require careful consideration in order for the sensitivity analysis to be efficiently imple-
mented, because they influence how representative a sample of elementary effects will
be.
The value of δ will depend on that selected for p. It has been shown that choosing
p to be even and
δ =
p/2
(p− 1) , (4.27)
is a convenient choice [63]. This can be illustrated as follows. When δ = p/2(p − 1),
the [0,1] interval can be divided into two subsets of equal length
p
2 , as follows:
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Figure 4.5: (a) A sampling scheme in which p = 6, and δ = p/2
(p−1) =
3
5 allows each point
to be sampled with equal likelihood. (b) If, instead, δ =
p/3
(p−1) =
2
5 is chosen, points
2
5
and 35 are more likely to be sampled than the others.
S1 = {0, 1/(p− 1), 2/(p− 1), ..., 1− δ }
S2 = {0+ δ, 1/(p− 1) + δ, 2/(p− 1) + δ, ..., (1− δ) + δ } (4.28)
It becomes clear that the pair of initial samples from Ω which will be transformed into
the ith components of the two points in parameter space required for the calculation of
any elementary effect (see equations (4.3) and (4.4)) will either be (xi ∈ S1, xi + δ ∈ S2)
or (xi ∈ S2 and xi − δ ∈ S1). Thus all elements in S1 and S2 have an equal probability
of being chosen.
A scheme in which p = 6 is used to further illustrate. Figure 4.5(a) shows the
resultant spacing in the [0, 1] interval. Each double-headed arrow points to a pair of
possible points for the calculation of an elementary effect when δ = p/2(p−1) =
3
5 is chosen;
the possible pairs are
(
0, 0 + 35
)
,
(
1
5 ,
1
5 +
3
5
)
,
(
2
5 ,
2
5 +
3
5
)
and there is no bias to sample
any particular point more than any others. Figure 4.5(b) shows that if δ = p/3
(p−1) =
2
5
is chosen instead, 25 and
3
5 are more likely to be sampled than the others, illustrated by
the fact that they have two arrows pointed at them.
A choice of p = 10 (δ = p/2(p−1) =
5
9 ) for the Ca
2+ model parameters affords a rela-
tively dense grid which allows even wide ranges (e.g., four orders of magnitude) to be
well explored with a log spacing (see next section). The choices made for r and M are
discussed below in section 4.4.4.
The value of k is the number of parameters included in the sensitivity analysis.
Some initial assumptions are made to reduce the number of parameters for consider-
ation. The thermodynamic constants θνµ, θζµ, θζν are fixed and assumed to be 1. In a
sensitivity analysis carried out on the cubic ternary complex model (cTCAM)’s 16 pa-
rameters, these parameters were shown to be non-influential to the G-protein activa-
tion response [41]. Also, based on discussions with experimental collaborators, [Ca2+AV ]
is fixed at its value in the base parameter set, which gives an initial ER Ca2+ concentra-
tion in middle of the micromolar range (4.88× 10−6M); the basal permeability of the
ER, γ0, chosen to be small, is also fixed, while the ER/cytosol ratio, νr , is also fixed at
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Figure 4.6: The advantage of using the log-uniform distribution (b) over the uniform
distribution (a), illustrated using the values obtained with the upper and lower bounds
of the parameter RTOT. Note the log scale of the y-axes.
its value in the base parameter set, as published in [1]. The Ca2+ model has 47 param-
eters in total, but with the previously discussed assumptions, k = 40. With p = 10, the
sampling space is then a 40-dimensional grid with 10 levels.
4.4.2 Log-uniform sampling
The ranges of uncertainty for some of the Ca2+ model parameters can be several or-
ders of magnitude, therefore a log-uniform spacing is preferred over a uniform one
to transform the initial x samples from Ω into X values in the actual parameter space
A [35]. The random sample xi ∈ {0, 1/(p − 1), 2/(p − 1), ..., 1} is transformed to a
corresponding value, Xi ∈ [LBi,UBi], in the ith parameter’s log-uniform spaced range:
Xi = 10
xi(logUBi−logLBi)+logLBi . (4.29)
Using a range of four orders of magnitude, defined for the total receptor concentra-
tion, RTOT, Figure 4.6 illustrates how the log-uniform distribution samples the param-
eter range more effectively than the uniform distribution, when the range is wide.
The spacing δ is also transformed from its value in the sampling space, Ω, into the
dimensionless
∆i = δ(logUBi − logLBi), (4.30)
whose value is thus dependent on the width of the ith parameter’s range.
The elementary effect of the ith parameter is then given by
80
CHAPTER 4: GLOBAL SENSITIVITY ANALYSIS OF PARAMETERS
EEi(X) =
[Y(X1,X2, ...,Xi−1,Xi + ∆i, ...,Xk)−Y(X)]
∆i
, (4.31)
so that its unit is the same as that of the output Y.
4.4.3 Constraining parameter space
The particular way that the parameter space is constrained could influence the results
of the sensitivity analysis. Some parameters, such as molecular concentrations, may
be more likely to vary from cell to cell, requiring a wider range to be defined. Sen-
sitivity analyses of the Ca2+ model parameters will be carried out in two differently
constrained parameter subspaces. The effect that the different constraints have on the
sensitivity analysis will then be explored by comparing results from the two subspaces,
which are constrained as follows.
Parameter Subspace 1
The parameters are grouped according to their type, which determines the widths of
the ranges from which they are sampled (about their values in the base parameter set,
unless doing so would take them out of biologically reasonable range) as follows:
• Molecular concentrations: 4 orders of magnitude
• Rate constants: 2 orders of magnitude
• Thermodynamic constants: 1 order of magnitude
• Ca2+ flux parameters 1: 4 orders of magnitude
Here, the range of values defined for molecular concentrations is wider because it
can be argued that expression levels can vary from cell to cell [41], and less routinely
characterised than rate constants [75]. The Ca2+ flux parameters, γ1, p1, p2, are varied
over four orders of magnitude because they have not necessarily be experimentally
measured; their base values were taken from the Kang and Othmer model [37], where
they were chosen to match experimental data; hence, they are considered to be more
uncertain. The thermodynamic constants µ+, µ−, ν+, ν−, ζ+ and ζ− are only varied
over one order of magnitude because there are constraints on the values their ratios
µ = µ+µ− , ν =
ν+
ν− and ζ =
ζ+
ζ− can take. These ratios should be > 1; in the case of
ζ, only (positive) agonists are used in the data (see section 1.3.2); in the case of ν, it
is assumed that the agonist binds preferably to the pre-coupled states of the receptor
1These are: γ1, p1, p2.
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(RG, R∗G) over the uncoupled states (based on Chapter 3’s results); in the case of µ,
it is assumed that the receptor’s inactive state is not able to bind more preferably than
its active state to the G-protein. The rate constants are only varied over 2 orders of
magnitude because they are less likely to vary from cell to cell. This actually allows
corresponding KD values to vary over four orders of magnitude.
Parameter Subspace 2
The ranges defined for the parameters are as follows:
• Molecular concentrations: 2 orders of magnitude
• Rate constants: 2 orders of magnitude
• Thermodynamic constants: 1 order of magnitude
• Ca2+ flux parameters: 2 orders of magnitude
Here, all parameters are varied over two orders of magnitude, except the thermo-
dynamic constants (for the same reasons outlined above). Hence, all parameters except
the thermodynamic constants are assumed to have the same level of uncertainty.
4.4.4 Computational expense
The size of Fi, that is, the number of possible elementary effects for the ith parameter,
pk−1[p− ∆(p− 1)], increases with p, so presumably, the higher the value of p chosen,
the higher the value of r (the sample size of Fi) should be. However, the Campolongo
sampling strategy, which maximises the spread of the samples, ought to minimise the
need for higher and higher values of r, by producing samples that are good representa-
tives even at low values of r. To further explore this, two values of r, high and low, are
used in two separate sensitivity analyses and the results are checked for consistency.
M = 2000 was chosen as a high number of initial trajectories. Sensitivity results
from r = 20, r = 50, r = 100 and r = 150 trajectories were initially compared, and
acceptable agreement was found between results from r = 100 and r = 150. These
trials also gave an idea of the computational cost. Hence, r1 = 150 and an even more
thorough r2 = 1000 were chosen as values with which computationally affordable anal-
yses could be carried out, while covering parameter space well. Two sets of r1 and r2
trajectories were generated.
The computation time of the analysis may be divided into three: the time taken to
obtain r optimised trajectories, tot, which is a function of M, r, p, k (tot(M, r, p, k)), the
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time taken to carry out nr(k+ 1) model evaluations, tme, and the time taken to calculate
the elementary effects and sensitivity measures (m∗,m, σ), tsm.
The time taken to obtain r1 = 150 optimised trajectories from an initial sample of
M = 2000 on aDell PowerEdgeR610with two Intel Xeon X5570 processors (8 processor
cores total) with 48GB memory was t1ot ≈ 5.3h, while the time taken to generate r2 =
1000 optimised trajectories was t2ot ≈ 41.2h (approximately t2ot = t
1
otr2
r1
). The time taken
to carry out the model evaluations is highly dependent on the parameter sets that are
obtained with the trajectories – a few parameter sets may require the ODE solver to
take far smaller time steps. For instance, for the first set of r = 150 trajectories, tme was
approximately 67.6 hours, while the second set had tme ≈ 131.9 hours. On the other
hand, for the first set of r = 1000 trajectories, tme was lower than for both r = 150 runs at
approximately 29.2 hours, while the second set took 354.1 hours. Since the parameter
sets are randomly chosen, the model evaluation times are unpredictable. The times
taken to calculate the sensitivity measures, for both r1 and r2, were trivial.
4.5 GSA results: Influential parameters
The forty parameters for analysis are labelled 1− 40, as specified in Table C.1.1. In each
subspace, two sets of trajectories are used to produce two sets of sensitivity results (run
1 and run 2) and the average sensitivity measures taken, so that they are given by
mi =
1
2
(mi,1 +mi,2), (4.32)
m∗i =
1
2
(m∗i,1 +m
∗
i,2), (4.33)
σi =
1
2
(σi,1 + σi,2), (4.34)
where the subscript i, o refers to the ith parameter and the oth run.
4.5.1 Key drivers of individual features
Below, the parameters to which the individual output features are most sensitive are
discussed. The results from parameter subspace 1 are considered here; they are later
compared to those from parameter subspace 2. The sensitivity results obtained when
r2 = 1000 are analysed here, as they provide the more thorough coverage of parameter
space; the results from that scheme will later be compared with results from one in
which r1 = 150 (see section 4.8).
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Figure 4.7: Sensitivity analysis results for the Ca2+ Peak-over-Basal. m∗i ranks the pa-
rameters (a), the sign of mi indicates the direction of a parameter’s average effect (b),
m∗i − |mi| > 0 indicates that a parameter exerts non-monotonic effects (c). σi is the stan-
dard deviation of the elementary effects.
Sensitivity of the Ca2+ Peak-over-Basal
The m∗i values for the Ca
2+ Peak-over-Basal are shown in Figure 4.7(a), from which it
may be said that the feature is relatively insensitive to all but six parameters. These
are (parameter numbers indicated before colon): the rate constant for IP3 degradation,
26:kIP3deg; the rate constant of the GPCR desensitisation reaction, 36:kdes+; the rate con-
stant of PLC activation, 23:kPLCact; the maximal rate of the SERCA pumps, 39:p1; the
concentration of PIP2, 5:[PIP2]; and the rate constant for GPCR deactivation, 12:kdeact.
As mentioned previously, the Ca2+ Peak-over-Basal quantifies the ability of an drug to
induce a response; hence changes in these parameters can alter agonist potency.
Figure 4.7(c) shows that 26:kIP3deg, 36:kdes+, 39:p1, 5:[PIP2] can all exert nonmono-
tonic effects, since m∗26 − |m26|, m∗36 − |m36|, m∗39 − |m39| and m∗5 − |m5| are greater than
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Figure 4.8: The Ca2+ % Peak-over-Basal changes nonlinearly in response to variations in
some of the significant parameters. These parameters were selected to illustrate mono-
tonic and biphasic nonlinearity.
0. This ability to exert either inverse or non-inverse effects may depend on the values
of other parameters, and/or on the fact that they themselves act in a nonlinear fashion
which is nonmonotonic. This can be seen in Figures 4.8(a), (b) and (d), where varying
those four parameters from the base parameter set influences the Peak-over-Basal in a
biphasic manner. This suggests that the rate of IP3 degradation, the rate of GPCR de-
sensitisation, the maximal rate of the SERCA pumps and the concentration of PIP2 all
have optimal values (or ranges of values), outside which the nature of agonist efficacy
can alter dramatically. These parameters might be able to determine whether a drug
acts as an agonist (Ca2+ Peak-over-Basal> 0) or antagonist (Ca2+ Peak-over-Basal= 0).
The reason that these parameters act in a biphasic fashion may be understood by
considering their effects on the peak and basal separately, which are shown in Figure
4.9, where 26:kIP3deg and 5:[PIP2] are used to illustrate. In Figure 4.9(a), both the peak
and basal decrease monotonically as 26:kIP3deg increases. Initially the relative change
in peak is greater than the relative change in basal, which causes the Peak-over-Basal
to increase; however, the basal level soon becomes constant, while the peak continues
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Figure 4.9: The individual effects on the Ca2+ Peak and Basal of varying (a) 26:kIP3deg,
(b) 5:[PIP2].
to decrease, hence Peak-over-Basal starts to decrease. In Figure 4.9(b), both the peak
and basal increase monotonically as 5:[PIP2] increases, and initially the relative change
in peak is greater than the relative change in basal, causing the Peak-over-Basal to in-
crease; however, the relative change in peak becomes small before the relative change
in basal, causing the Peak-over-Basal to start to decrease.
12:kdeact exerts increasing monotonic effects at all points tested across parameter
space, since m∗12 − |m12| = 0 (see Figure 4.7(c)). When varied in the base parameter
set, 12:kdeact, as well as, 23:kPLCact, exert increasing monotonic effects on the Peak-over-
Basal (Figure 4.8(c)), meaning that the reactions they are involved in are important to
maintaining the Peak-to-Basal ratio. In other words, they are important determinants
of an agonist’s potency. 23:kPLCact is the rate constant for the reaction in which Ca
2+
activates PLC (see (3.5)), so that it can go on to hydrolyse IP3 from PIP2, leading to Ca
2+
release. This Ca2+ release exerts a positive feedback, since it leads to the activation of
more PLC, which will be more pronounced after the addition of the agonist. Hence the
peak is more significantly influenced, while the basal could remain relatively constant.
12:kdeact is the rate constant for the reactions in which the active GPCR species are
deactivated (see reactions (1.9), (1.12), (1.17), (1.18)); it determines the ratio of inactive
to active GPCR’s at equilibrium. The sensitivity of the Ca2+ Peak-over-Basal to kdeact
suggests that an agonist’s potency increases as the ratio of inactive to active GPCR’s at
equilibrium does. This is to be expected, as a high ratio of active to inactive GPCR’s
would mean that the system could generate a high response in the absence of agonist,
diminishing the agonist’s role. Hence the lifetime of the active GPCR species may also
be a determinant of agonist potency.
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Figure 4.10: Sensitivity analysis results for the Ca2+ Transient-peak. m∗i ranks the pa-
rameters (a), the sign of mi indicates the direction of a parameter’s average effect (b). σi
is the standard deviation of the elementary effects. Several parameters are identified as
significant.
Sensitivity of the Ca2+ Transient-Peak
Unlike the Ca2+ Peak-over-Basal, the Ca2+ Transient-Peak only has a few parameters to
which it is relatively insensitive (Figure 4.10(a)). This means that, though there may be
dominant mechanisms which control the Transient-Peak, the system has other mecha-
nisms that can significantly contribute. The significant parameters are a combination
of parameters from the G-protein activation cycle, and from further downstream in the
pathway.
The most influential parameter is 39:p1, the maximal rate of the SERCA pumps,
which is unsurprising, since it is the maximal rate at which Ca2+ can be removed from
the cytosol back into the ER, potentially making the Ca2+ peak transient. 40:p2, as the
Ca2+ concentration at which half-maximal pumping occurs, can also exert a similar
influence by determining how sensitive the pumps are. Being two of the three most
sensitive parameters, they imply that the mechanism of the SERCA pumps is crucial to
the Transient-peak response.
Cell-specific parameters are also influential, such as: the total IP3R concentration,
4:IP3RTOT; the total PIP2 concentration, 5:[PIP2]; the total G-protein concentration,
2:GTOT; and the total receptor concentration, 1:RTOT. Differences in their expression
levels can occur from cell to cell [41], even in the same line, which might explain dif-
ferences in Ca2+ time course profiles, when taken from individual cells in the same
experiment [27].
Rate constants of several reactions are also significant. 36:kdes+ affects the rate at
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which desensitisation occurs; desensitisation is responsible for reducing the number
of active receptor-G-protein complexes available to signal, hence it has a role in mak-
ing the IP3 response, and consequently the Ca
2+ response, transient. Recall that PKC
mediates desensitisation, so its dynamics would influence the shape of the transient.
The rate constants of IP3-IP3R binding and unbinding, 30:kIP3Rb+, and 31:kIP3Rb− and
the rate constant for the binding and unbinding of activating Ca2+, 32:kCa2+act+ and
33:kCa2+act−, respectively are also significant. This means that the dynamics of IP3-IP3R
binding, as well as positive and negative Ca2+ feedback in CICR can also contribute to
the transience of the Ca2+ signal.
αGTP dynamics are also important. The rate of αGTP production is an important fac-
tor (as its rate constant, 16:kGTP+ is among the six most significant parameters), while
the lifetime of αGTP is also a relatively important factor, since the rate constant of the
PLC-mediated αGTP hydrolysis reaction, 25:kPLCdis, has a significant m
∗ value.
Some of the parameters which strongly effect the Transient-peak also significantly
influence the Peak-over-Basal response (5:[PIP2], 26:kIP3deg, 39:p1 and 36:kdes+). 23:kPLCact,
and 12:kdeact are not among the most significant parameters for the Transient peak,
which means that they control the Ca2+ Peak-over-Basal without significantly altering
the Transient-Peak.
Sensitivity of the Ca2+ Time-to-Peak
Figure 4.11 shows them∗i values for theCa
2+ Time-to-Peak; this feature, like the Transient-
Ca2+-Peak, can only be considered insensitive to a few parameters (see Figure 4.11a).
This means that though there are dominant mechanisms which control the timing of
the peak, the system has other mechanisms that may significantly contribute. 40:p2
and 39:p1 are the most influential parameters, suggesting that the dominant mecha-
nism controlling the Ca2+ Time-to-Peak is the action of the SERCA pumps.
The sensitivity of the IP3 receptor to IP3, quantified by 38:γ and the binding rate
of IP3, 30:kIP3Rb+ are significant. The binding and unbinding rates of activating Ca
2+
(32:kCa2+act+, and 33:kCa2+act−, respectively) are also significant, suggesting that the dy-
namics of the IP3 receptor are also key to the timing of the peak.
The rates of IP3 degradation, and of GPCR desensitisation, quantified by 26:kIP3deg
and 36:kdes+ respectively, can affect the timing of the Ca
2+ peak by preventing further
IP3-mediated Ca
2+ release, through direct degradation of IP3 or desensitisation of ac-
tive GPCR’s respectively.
Cell-specific parameters like the total IP3R concentration, 4:IP3RTOT, total PIP2
concentration, 5:[PIP2] and the total receptor concentration, 1:RTOT are also influential.
As previously mentioned, differences in their expression levels can occur from cell to
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Figure 4.11: Sensitivity analysis results for the Ca2+ Time-to-peak. m∗i ranks the param-
eters (a), the sign ofmi indicates the direction of a parameter’s average effect (b). σi is the
standard deviation of the elementary effects. Several parameters have significant effects
on this feature.
cell, and might thus explain differences in Ca2+ time courses, when taken from individ-
ual cells in the same experiment.
As with the Transient-Peak, hydrolysis of αGTP can also be an important mecha-
nism, either mediated by αGTP itself (via 18:kgd+ in reaction 1.24) or PLC (via 25:kPLCdis
in reaction 3.8).
Sensitivity of the Left-Shift
Figure 4.12(a) shows the ranking of the parameters for the Left-Shift. The dominant
mechanism in signal amplification is also the action of the SERCA pumps, as 40:p2 and
39:p1 are the highest ranked parameters. This illustrates how signal amplification is
system- and not just ligand-dependent. m40 and m39 are negative, which means that
on average, 40:p2 and 39:p1 exert inverse effects on the Left-Shift. Hence, regardless
of the strength of signal applied, if the SERCA pumps are too sensitive, Ca2+ release
can be strongly inhibited, thereby reducing the agonist’s ability to generate a response
irregardless of the agonist’s intrinsic efficacy.
The dynamics of constitutive GPCR activity are also shown to be significant, since
13 : kact and 12 : kdeact are influential. Together, these parameters determine the ratio of
active to inactive GPCR’s at equilibrium, implying that signal amplification is highly
dependent on this ratio. This is in agreement with the sensitivity results for the Peak-
over-Basal, where it was seen that the agonist potency depended on the ratio of inactive
(R) to active GPCR’s (R∗).
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Figure 4.12: Sensitivity analysis results for the Left-Shift, which is quantifies signal am-
plification, using equation (4.23). m∗i ranks the parameters (a), the sign of mi indicates
the direction of a parameter’s average effect (b). σi is the standard deviation of the ele-
mentary effects.
The total receptor concentration, 1:RTOT, and the total G-protein concentration,
2:GTOT, are also significant parameters. These parameters can be experimentally ma-
nipulated, indicating that these results can be readily tested.
Nonlinearity and interaction among parameters
Across all the output features, the relationship between m∗i and σi is always approxi-
mately linear, which indicates that the larger a parameter’s influence, the more non-
linear it is, and/or due to interaction with other parameters (see Figures 4.7(a), 4.10(a),
4.11(a), 4.12(a)). Hence, none of the influential parameters exert linear effects on the
Ca2+ Peak-over-Basal, Transient Ca2+ Peak, Ca2+ Time-to-Peak or the Left-Shift. This
highlights the importance of using a global sensitivity analysis over a local sensitivity
analysis (LSA), since an LSA’s ability to identify parameters of significance is highly
dependent on what point in parameter space is analysed. Of course, if the parameters
represented by that point are known with certainty, then an LSA should be the method
of choice, as its computational expense is relatively trivial.
4.5.2 Key drivers of the overall Ca2+ response
A useful way to quantify the overall influence of the parameters is to define a repre-
sentative sensitivity measure, across all the output features, for each parameter. Given
that the vector of m∗ values for the f th objective function is given by m∗ fi , the average
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Ranking Parameter Description SAR
1 40:p2 [Ca
2+] for half-maximal rate of SERCA 0.76
2 39:p1 Maximal rate of SERCA 0.75
3 36:kdes+ On-rate for GPCR desensitisation 0.72
4 4:IP3RTOT Total IP3R concentration 0.72
5 26:kIP3deg Rate constant for IP3 degradation 0.63
6 5:[PIP2] Total [PIP2] concentration 0.62
7 33:kCa2+act− Off rate for IP3R-activating Ca2+ 0.57
8 38:γ1 Sensitivity of IP3R 0.57
9 28:kPIP2b+ On-rate for PIP2 and αGTPPLC
∗ 0.53
10 27:kIP3 Rate constant for IP3 hydrolysis 0.52
Table 4.5.1: The ten most significant parameters of the Ca2+ model, as quantified by SAR
(see equation (4.36))
relative sensitivity of the ith parameter is given by,
S
′
AR =
1
q
q
∑
f=1
m
∗ f
i
max(m∗ f )
, (4.35)
which is adapted from [17]. q = 4, since four features are considered in the sensitivity
analysis. S
′
AR is a dimensionless measure, and is used to rank the parameters of the
Ca2+ model according to significance. The maximum value that a parameter can score
is 1, which would be the case if it was the most significant for all features.
S
′
AR values can be calculated for both parameter subspace 1 (S
′
AR1
) and subspace 2
(S
′
AR2
). An average of the two,
SAR =
S
′
AR1
+ S
′
AR2
2
, (4.36)
is used to provide the main overall ranking for the model. The individual rankings for
each subspace will be compared in section 4.5.3.
The ten parameters with the highest score (SAR) are listed in Table 4.5.1, identified
as the key parameters controlling the Ca2+ response and signal amplification. The
complete list of all parameters and their average relative sensitivity scores can be found
in Table C.2.1 in the appendices.
Investigating the amplified, yet rapid Ca2+ response
In this section, the mechanisms which might be responsible for the amplified, yet rapid
Ca2+ response, are investigated by considering the particular effects of the ten high-
est ranked parameters on the Left-Shift and the Ca2+ Time-to-Peak. The ten parame-
ters can be divided into those that have monotonic increasing effects on both features,
shown in Figure 4.13; those that have monotonic decreasing effects on both, shown in
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Figure 4.14; and those which have biphasic effects on either feature, shown in Figures
4.16 and 4.15.
The SERCA pump parameters 40:p2 and 39:p1 have similar sensitivity scores and
are the most significant parameters. This is because the SERCA pumps play a direct
role in determining the rate at which Ca2+ is removed from the cytosol back into the ER,
and so they influence the timing and magnitude of the (basal and peak) Ca2+ response.
Increasing the 40:p2 means that the concentration of Ca
2+ required for half-maximal
pumping increases; this makes the pumps less sensitive and the Ca2+ re-entry into
the ER slower, increasing both the Left-shift and the Time-to-peak (Figures 4.13(a) and
4.13(b)). On the other hand, increasing 39:p1, the maximal rate of the SERCA pumps
decreases both the Left-shift and the Time-to-peak (Figures 4.14(a) and 4.14(b)). This
is because the pumping capability increases with 39:p1, hence Ca
2+ can be transported
more quickly back into the ER, decreasing both the peak and Time-to-Peak.
Figures 4.13(c) and 4.13(d) show that increasing 4:IP3RTOT increases the Left-Shift,
as well as the Ca2+ Time-to-Peak. The increase in the Left-Shift is explained by the
fact that increasing 4:IP3RTOT increases the probability of forming IP3 IP3R and the
activated (open channel) state, IP3 IP3RCa
2+, thus increasing Ca2+ release. However, it
takes more time to bring down the increased Ca2+ peaks, probably because over time,
far more receptors enter the IP3IP3RCa
2+ state than leave it.
The Ca2+ Time-to-Peak and the Left-Shift also increase with 38:γ1 (Figures 4.13(e)
and 4.13(f)). The increase in the Left-Shift is due to a higher Ca2+ release, because of
the increased contribution of the source term involving 38:γ1 to the Ca
2+ ODE (see
Equation (3.13)). It then takes longer for the action of the SERCA pumps to bring down
the Ca2+ peak.
5:[PIP2] is a participant in reaction (3.6), which produces αGTPPLC
∗PIP2; therefore,
as [PIP2] increases, so does [αGTPPLC
∗PIP2]; this leads to the production of more IP3,
and consequently a higher Ca2+ release and greater Left-Shift (Figure 4.13(g)). How-
ever, Figure 4.13(h) shows that the Ca2+ Time-to-peak increases in the process. Increas-
ing another top ten parameter, 28:kPIP2b+, has similar effects on the Left-Shift and the
Time-to-Peak, since it is the rate constant for the binding of [PIP2] (which is assumed
constant) and αGTPPLC
∗ in reaction (3.6).
The identification of [PIP2] among the most significant parameters might have im-
plications for the assumption in the model that [PIP2] is constant; in reality, [PIP2] is
depleted but replenished, but there is no evidence that it is rate-limiting [104]. How-
ever, since it has been identified as one of the most important parameters, the cost of
this assumption might be reconsidered, by incorporating the dynamics of [PIP2] re-
synthesis into the model, and considering the effects on the Ca2+ response; this will be
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Figure 4.13: Varying significant parameters which have similar effects on the Ca2+ Time-
to-Peak and signal amplification. Increasing 40:p2, 5:[PIP2], 4:IP3Rtot and 38:γ1 increases
the Left-Shift (1st column, (a,c,e,g)), but also the Time-to-Peak (2nd column, (b,d,f,h)).
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done in Chapter 5.
Increasing the IP3 degradation rate constant, 26:kIP3deg, decreases the Left-Shift and
also shortens the Ca2+ Time-to-Peak (Figures 4.14(c) and 4.14(d)). This is as would
be expected; increasing 26:kIP3deg heightens the rate of IP3 degradation, and so Ca
2+
release, which is mediated through IP3, is inhibited, hence the decrease in the Left-
Shift. The Time-to-Peak is also shortened, since the signal for Ca2+ release (IP3), is
terminated more quickly.
When 33:kCa2+act−, the rate constant for the dissociation of activating Ca2+ and IP3R
(reaction (3.11)), is increased, the Left-Shift and the Time-to-Peak are increased as well.
This is because increasing the rate of this reaction shortens the lifespan of the activated
IP3 receptor (IP3 IP3RCa
2+); hence, Ca2+ release is inhibited, causing the decrease in
the Left-Shift and Time-to-Peak.
36:kdes+, although a G-protein level parameter, is one of the four parameters to
which the Ca2+ response is most sensitive (see Table 4.5.1). It is the rate constant for
the reactions in which the active GPCR’s are desensitised, thereby reducing the num-
ber available to signal for IP3-mediated Ca
2+ release. As a result, a higher 36:kdes+
decreases the Ca2+ Time-to-Peak, as can be seen in Figure 4.15(b). The effect on the
Left-Shift, however, is biphasic. Initially, it rapidly decreases as 36:kdes+ increases, up
to a threshold value, after which it starts to increase slowly. The Ca2+ Time-to-Peak
decreases up to a minimal value of ≈ 200s, so changing 36:kdes+ cannot account for the
rapid, yet amplified response.
Varying the parameter 27:kIP3 influences the Ca
2+ Time-to-Peak and Left-Shift dif-
ferently than varying the other parameters. Increasing 27:kIP3 has a monotonic increas-
ing effect on the Left-Shift and a biphasic effect on the Time-to-Peak (Figure 4.16). Ini-
tially, the Ca2+ Time-to-Peak increases with 27:kIP3 , until a threshold value, after which
it begins to decrease, following the IP3 Time-to-Peak.
Since no minimal value is reached for the Time-to-Peak within 27:kIP3 ’s defined
range for the GSA, the Time-to-Peak can decrease further if 27:kIP3 is increased beyond
that range. Thus, increasing the rate of IP3 production can potentially account for the
Ca2+ response seen in the data, in which the signal is amplified to produce a maximal
response, without delaying the Time-to-Peak. This will be explored in a later section.
Non-influential parameters
Not only is it useful for the sensitivity analysis to identify influential parameters, the
non-influential parameters that come to light also provide important insight. The rela-
tively insignificant parameters identified might not require further analysis, effectively
reducing parameter space by many dimensions. In addition, they are parameters that
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Figure 4.14: Varying significant downstream parameters which have similar effects
on the Ca2+ Time-to-Peak and signal amplification. Increasing 39:p1, 26:kIP3deg and
33:kCa2+act− decreases the Time-to-Peak (1st column, (a,c,e)), but also the Left-Shift (2nd
column, (b,d,f)).
95
CHAPTER 4: GLOBAL SENSITIVITY ANALYSIS OF PARAMETERS
0 0.05 0.1 0.15 0.2 0.25
0.9
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
L
ef
t
sh
if
t
36 : kdes+(s
−1)
(a)
0 0.05 0.1 0.15 0.2 0.25
200
300
400
500
600
700
800
C
a2
+
T
im
e-
to
-P
ea
k
(s
)
36 : kdes+(s
−1)
(b)
Figure 4.15: The effects of varying the significant G-protein level parameter 36:kdes+
on the Ca2+ Time-to-Peak and signal amplification. Increasing kGTP+ exerts a biphasic
effect on the Left-Shift, while reducing the Time-to-Peak.
experimentalists can consider as not crucial to measure, or test as drug targets. For
instance, the concentration of PLC, 3:[PLCTOT], is not an easily measured parame-
ter, but since it has been identified as a relatively noninfluential parameter, it can
be concluded that it is not crucial to measure. The range defined for 3:[PLCTOT] is
0.8× 10−6 − 0.8× 10−6M; as PLC works by binding to αGTP, which is converted from
G, it is likely that PLC is in excess if only small amounts of αGTP are formed, hence
variations in [PLCTOT] would not matter much. These results suggest that PLC might
not be a worthwhile drug target, and it might be possible to test this hypothesis exper-
imentally, by making use of available PLC inhibitors [73, 90].
The ten least significant parameters of the Ca2+ model are listed in Table 4.5.2. It is
informative to investigate why the rate constants identified are insensitive, and what
can consequently be learnt about the reactions in which they are involved. For instance,
are any of these parameters insensitive because relevant reactions reach equilibrium
quickly? Are their forward reactions so fast that they are essentially irreversible?
15:kg+ and 14:kg− are the rate constants for receptor pre-coupling (reaction (1.13)),
19:klb+ and 20:klb− are the rate constants for ligand binding (reaction 1.10), 34:kCa2+ inh+
and 35:kCa2+ inh− are the rate constants for the binding and unbinding of inhibitory Ca2+
to IP3R respectively (reaction (3.12)), and 24:kPLCdeact is the rate constant for the deac-
tivation of PLC (reaction (3.5)). Simulations show that none of these reactions reach
equilibrium quickly (see Figure C.1 in the appendices), and that setting 14:kg− = 0 and
24:kPLCdeact = 0 has no discernable effect on the response (see Figure 4.17), which might
mean that receptor pre-coupling and the activation of PLC by Ca2+ are irreversible pro-
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Figure 4.16: The effect of varying the significant downstream parameter 27:kIP3 on the
Ca2+ Time-to-Peak and signal amplification. Increasing 27:kIP3 increases the Left-Shift,
while exerting a biphasic effect on the Time-to-Peak.
Ranking Parameter Overall score
1 kRA+ 0.01
2 kg+ 0.04
3 kg− 0.05
4 klb− 0.06
5 klb+ 0.06
6 kPLCdeact 0.07
7 ζ− 0.07
8 ν− 0.07
9 kCa2+inh+ 0.08
10 kCa2+inh− 0.08
Table 4.5.2: The ten least significant parameters of the Ca2+ model.
cesses, at least when the base parameter set is used; the model might thus be slightly
simplified by excluding their backward reactions.
The insensitivity of the Ca2+ response to the ligand binding parameters means that
the Ca2+ features are robust to changes in their values. Recall that the ranges of ζ+ and
ζ− were restricted so that they only represented positive agonist values (see section
4.4.3). This result only means that positive agonists produce similar Ca2+ responses; if
one agonist produces a particular response pattern, then changes in klb+, klb− and ζ−
do not significantly alter that pattern, due to signal amplification. This is in agreement
with the data, where four different agonists induce the maximal response (see Figure
3.3(b)). However, it is important to note that the location of the Ca2+ dose-response
curve depends on the values of klb+, klb− and ζ− (see Figures 3.3(b) and 3.20(b)). This
is probably not reflected in the sensitivity analysis results because the Left-Shift only
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Figure 4.17: G-protein pre-coupling (reactions (1.13)-(1.16)) and Ca2 activation of PLC
(reaction (3.5)) appear to be effectively irreversible reactions, as setting the backward
rates, kg− and kPLCdeact respectively, to 0 has no distinguishable effect on the Ca2+ re-
sponse.
quantified the location of the Ca2+ dose-response curve relative to the αGTP one.
4.5.3 Comparing results from parameter subspaces 1 and 2
Figure 4.18 compares the parameter sensitivity rankings from the runs carried out in
Subspace 1 and Subspace 2, and it can be seen that there is reasonable correlation be-
tween the rankings. The box in the bottom left contains parameters that were iden-
tified in the top 10 of both subspaces, and there are six such parameters. The rate
constants 27:kIP3 , 28:kPIP2b+, 31:kIP3Rb− and 32:kCa2+act+, are identified in the top ten
significant parameters of Subspace 2, where all parameters, apart from the thermo-
dynamic constants, are varied over two orders of magnitude, but not in Subspace 1,
where the molecular concentrations and Ca2+ flux parameters are varied over four or-
ders of magnitude (see section 4.4.3). On the other hand, the molecular concentrations,
1:RTOT and 5:[PIP2], the rate constant 30:kIP3Rb+, and the Ca
2+ flux parameter, 38:γ1 are
identified among the top ten significant parameters of Subspace 1, but not Subspace 2.
The total receptor concentration, 1:RTOT, is a parameter that can vary from cell to
cell, and the fact that it is higher ranked in Subspace 1 (where it has a wider range) may
imply that the Ca2+ response is more affected when receptor expression levels vary
widely. This implies that if receptor expression levels are experimentally manipulated
to be approximately uniform across cells, time courses for individual cells might also
be more uniform.
From the base parameter set, increasing 1:RTOT increases the Left-Shift, and has the
previously discussed biphasic effect on the Time-to-Peak; this is illustrated in Figure
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Figure 4.18: Sensitivity results (S
′
AR) from subspaces 1 and 2 are compared. There is
reasonable correlation between both sets of results.
4.19. Therefore, at least qualitatively, it can be seen how in systemswhere they can vary
widely, the receptor expression levels can have a role in shaping the Ca2+ response seen
in the data, in which signal is amplified without delaying the Time-to-Peak. Also, the
biphasic effect that increasing 1:RTOT has on the Ca
2+ Time-to-Peak explains how low-
expressing receptor systems which amplify Ca2+ more weakly can still have a rapid
Ca2+ Time-to-Peak comparable to those of high-expressing systems [42]. In Chapter 2
it was seen that the receptor and G-protein expression levels influence the level of the
αGTP response, and it was speculated that they would similarly influence the Ca
2+ re-
sponse. The sensitivity analysis results from Subspace 1 have validated the significant
sensitivity of the Ca2+ response to the total receptor concentration, while the medium
sensitivity of 2:GTOT in both subspaces confirms the influence of the G-protein con-
centration. However, the rate constant of desensitisation, 36:kdes+ —another G-protein
level parameter— is always higher ranked than 1:RTOT and 2:GTOT; kinetic models of
G-protein activation alone tend not to include receptor desensitisation [13, 86, 100], but
these results suggest that they should.
The box in the top right of Figure 4.18 contains parameters identified in the bottom
ten ranking of both subspaces; the results are very consistent, as there are 9 parameters
in the box.
Though there is good agreement between the results from parameter subspaces 1
and 2, it cannot necessarily be said that the few discrepancies are insignificant. The
averaging of the overall scores from each subspace (see equation 4.36), would have
evened out some of the discrepancies.
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Figure 4.19: The effect of varying the total receptor concentration 1:RTOT on the Ca
2+
Time-to-Peak and signal amplification. Increasing 1:RTOT increases the Left-Shift, while
exerting a biphasic effect on the Time-to-Peak.
4.5.4 Implications for parameter fitting
It is reasonable to assume that the most significant parameters are those which most re-
quire estimation, as variations in their valuesmost significantly alter theCa2+ response;
all other parameters may then be fixed at any value in their ranges of uncertainty. A
dimensionally reduced parameter space is then obtained in which a parameter estima-
tion routine can be applied, probably at a lower computational cost, in order to locate
the parameter set with which the model best fits the data. Since the computational ex-
pense of many parameter estimation routines increases with the number of parameter
space dimensions, reducing the parameter space can make the parameter estimation
process more practicable. This will be considered in Chapter 6.
4.6 The key driver of the amplified, yet rapid Ca2+ response
Of the parameters that have opposite effects on the Time-to-Peak and the Left-Shift,
27:kIP3 is the only one which, when varied within its defined range of uncertainty, did
not reach a lower bound for the Ca2+ Time-to-Peak (see Figure 4.16(b)). When 27:kIP3
is increased to 50000 s−1 (beyond 1000 s−1, the upper bound of its originally defined
range), this leads to a far more rapid Time-to-Peak of 50 seconds for the higher agonist
concentrations (Figure 4.20(b)), while themaximal response is predicted for all agonists
(Figure 4.20(c)). This is because the rate of reaction αGTPPLC
∗PIP2
kIP3−→ αGTPPLC∗ +
IP3 + DAG increases with the value of 27:kIP3 . Hence, the rapid, yet amplified Ca
2+
response cannot be explained by any of the reactions in which the other nine significant
100
CHAPTER 4: GLOBAL SENSITIVITY ANALYSIS OF PARAMETERS
(a)
0 1000 2000 3000 4000 5000
−20
0
20
40
60
80
100
120
 
 
[L]=10−11 M
[L]=10−10 M
[L]=10−9 M
[L]=10−8 M
[L]=10−7 M
[L]=10−6 M
[L]=10−5 M
[L]=10−4 M
C
a2
+
(%
10
0
µ
M
C
ar
b
ac
h
o
l)
Time (s)
(b)
−11 −10 −9 −8 −7 −6 −5 −4
0
20
40
60
80
100
120
 
 
Carbachol
Oxotremorine−M
Pilocarpine
Bethanecol
P
ea
k
C
a2
+
(%
10
0
µ
M
C
ar
b
ac
h
o
l)
Log [L]
(c)
0 100 200 300 400 500
−20
0
20
40
60
80
100
120
 
 
C
a2
+
(%
10
0
µ
M
C
ar
b
ac
h
o
l)
Time (s)
(d)
Figure 4.20: (a) Ca2+ time course data. When kIP3 = 50000s
−1, (a) the Times-to-Peak at
the higher agonist concentrations are rapid, ≈ 50s and (c) dose-response curves show
that signal amplification occurs. (d) Under a transformation of the original timescale,
the time courses better resemble the timescale of the data, with Times-to-Peak ≤ 50s.
parameters are involved, but by a rapid IP3 production rate via a high value of 27:kIP3 ,
through the enzymatic action of PLC∗. This means that PIP2 is rapidly hydrolysed to
produce IP3, which binds very quickly to its receptors, to release Ca
2+ from the ER.
The fast reaction rate also increases the probability that the dissociated αGTPPLC
∗ will
bind (sequentially) to several free PIP2 molecules, especially as [PIP2] is not depleted.
Thus, small amounts of αGTPPLC
∗ cause significant IP3 production, which explains the
significant Left-Shift.
The biphasic dependence of the Ca2+ Time-to-Peak on 27:kIP3 is less easy to explain.
The first thing to recognise is that, as Figure 4.21 shows, as 27:kIP3 varies, the shape of
the Ca2+ transient (as well as IP3 IP3R and IP3 IP3RCa
2+) follows the IP3 one, so under-
standing the IP3 Time-to-Peak sheds light on the Ca
2+ Time-to-Peak. It is important
to keep in mind that the IP3 peak occurs when
d[IP3 ]
dt = 0, whose individual rates are
given by:
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Figure 4.21: The shapes of the IP3 IP3R, Ca
2+ IP3 IP3R and Ca
2+ transients follow that of
IP3.
R1 = kIP3 [αGTPPLC
∗PIP2] (4.37)
R2 = kIP3deg[IP3] (4.38)
R3 = kIP3Rb−[IP3 IP3R] (4.39)
R4 = kIP3Rb+[IP3][IP3R]. (4.40)
In the case of a transient peak,
d[IP3]
dt = 0 occurs the first time that R1 = R2 and R3 =
R4 (see Figure 4.22). Figure 4.23 shows the time courses of d[IP3 ]dt for values of 27:kIP3
in the range 10− 1000s−1, and it can be seen that the maximum d[IP3 ]dt always increases
with kIP3 (causing increased IP3 concentrations and signal amplification); however, the
time taken for IP3 to peak depends on the time taken to descend to zero velocity, which
initially increases with kIP3 , but after a threshold value (around kIP3 = 316s
−1), starts to
decrease, as shown in Figure 4.23. Figure 4.22(c) shows that this rapid descent occurs
because at high values of kIP3 , the initial velocities of IP3 degradation (R2) and IP3-
IP3R association (R3) and dissociation (R4) peak more quickly, so that R1 = R2 and
R3 = R4 holds at an earlier time. Hence, increasing kIP3 has a biphasic effect on the
Ca2+ Time-to-Peak because it has the same effect on the IP3 time-to-peak (see Figure
4.23(b)).
This explains why kIP3 is the only significant parameter downstream of G-protein
activation which can have this amplifying, yet quickening effect on the Ca2+ peak re-
sponse, by speeding up R1 (IP3 production) past some threshold rate which quickens
the timescales of R2 − R4. Increasing either 5:[PIP2] or 28:kPIP2b+ (two other signif-
icant parameters, see Table 4.5.1) can also promote IP3 production by increasing the
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Figure 4.22: The evolution of the individual terms of
d[IP3]
dt for different values of kIP3 .
R1 and R4 are not visible on this scale.
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Figure 4.23: (a) The evolution of
d[IP3]
dt for different values of kIP3 . (b) The IP3 and Ca
2+
Times-to-Peak depend almost identically on kIP3 .
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concentration of αGTPPLC
∗PIP2 but not past the threshold rate, because the concentra-
tion of αGTPPLC
∗PIP2 is limited by that of αGTPPLC∗. Hence increasing 5:[PIP2] (or
28:kPIP2b+) can only mimic the first portion of the biphasic curve of the Ca
2+ Time-to-
Peak versus 27:kIP3 (compare Figures 4.13(h) and 4.16(b)).
The value kIP3 = 50000s
−1 suggests that the enzyme αGTPPLC∗ is in the same class
as some of the fastest known enzymes, such as: carbonic anhydrase, which catalyses
the hydration of carbon dioxide at rates of up to 106s−1 [47]; acetylcholinesterase, which
hydrolyses acetylcholine at a rate of 25, 000s−1 [99]; and catalase, which hydrolyses hy-
drogen peroxide into water and oxygen at rates up to 1.6× 107s−1. However, this result
may be hard to test, as PLC and PIP2 experiments are usually carried out, not in whole
cells, but in buffer solutions; in one such experiment [76], the PIP2 hydrolysis rate was
783.33s−1, which is quite different from kIP3 = 50000s−1, but this might be accounted
for by the differences in experimental conditions. An informative experiment would
be to observe the effects of slowing down the rate of PIP2 hydrolysis on the features of
the Ca2+ response.
4.6.1 Refining the Ca2+ Time-to-Peak prediction
The previously discussed parameter change allowed the Ca2+ Times-to-Peak at the
three highest Oxotremorine-M concentrations to occur in ≤ 50s. To improve the quan-
titative prediction, especially at the lower agonist concentrations, the timescale of the
Ca2+ model can be transformed to quicken the dynamics without changing their pat-
tern. If the Time-to-Peak is to be shortened by a factor of b, the time variable and the
ODE system can be transformed as follows:
θ =
1
b
t (4.41)
dC
dθ
= b
dC
dt
, (4.42)
where C is the vector of all model variables, and θ is the new time variable. When b is
set to 10, the Ca2+ response is quickened without changing qualitatively, as shown in
Figure 4.20(d)).
The Ca2+ time course predictions have been improved by parameter variations
guided by the sensitivity analysis results. However, an aspect of the simulated re-
sponse does not match the data; in the simulations, the transients for the higher agonist
concentrations decay more quickly than those for the lower concentrations, whereas,
in the data, the decay is slower for the higher concentrations (compare Figures 4.20(a)
and (d)). Since the decay of the transient indicates extrusion of cytosolic Ca2+, aspects
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Figure 4.24: m∗ values are used to quantify the sensitivities of the Ca2+ and αGTP
Transient-Peak.
of the model that regulate that process might need to be re-considered, which will be
done in the next chapter.
No further manual parameter variation will be attempted at this stage; the chal-
lenge of matching the data quantitatively is left to a parameter estimation study later
in Chapter 6.
4.7 Transient peak hypothesis
In Chapter 2, the peak hypothesis, which states that the transientCa2+ Peak depends on
the existence of a transient αGTP Peak, was proposed, due to results from the analysis
of the G-protein activation model. Identifying parameters to which the features are
sensitive can shed light on (but not necessarily prove) the hypothesis. To do this, the
sensitivity of an additional model output, the αGTP Transient-Peak, which is analogous
to the Ca2+ Transient-Peak (see equation 4.21), is considered.
Some parameters to which the Ca2+ Transient-Peak and the αGTP Transient-Peak
are both significantly sensitive are: 16:kGTP, the αGTP production rate constant; 36:kdes+,
the on-rate for GPCR desensitisation; and 2:GTOT, the total G-protein concentration, as
shown in Figure 4.24). Their effects on both features will be analysed. Parameters to
which either feature is highly sensitive will also be analysed. As Figure 4.24 shows,
the Ca2+ Transient-Peak alone is highly sensitive to 40:p2, the Ca
2+ concentration for
half-maximal SERCA pumping, and 4:IP3RTOT, the total concentration of IP3 receptors,
while the αGTP Transient-Peak alone is highly sensitive to 18:kgd+ , the rate constant of
αGTP hydrolysis, and 7 : ζ+, the ligand efficacy parameter.
Figure 4.25 compares [αGTP] and [Ca
2+] time courses for different values of the pa-
rameters to which both features are highly sensitive, while Figure 4.26 compares the
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Figure 4.25: The effects of varying parameters to which the Ca2+ Transient-Peak and the
αGTP Transient-Peak are both significantly sensitive.
time courses for different values of the parameters to which only αGTP is highly sen-
sitive. In these cases, [αGTP] and [Ca
2+] evolve similarly; they increase together, and
flatten synchronously. The uniting factor is that αGTP is sensitive in both cases, which
supports the peak hypothesis.
In Figure 4.27, the [αGTP] and [Ca
2+] time courses are compared for different val-
ues of the parameters to which only the Ca2+ Transient-Peak is highly sensitive, and
some non-intuitive behaviour occurs. Increasing 40:p2 and 4:IP3RTOT increases the
Ca2+ response, but decreases the αGTP one (although αGTP is relatively insensitive to
4:IP3RTOT). As both parameters are rather directly linked to Ca
2+ release, it appears
that in these cases, the Ca2+ response modulates the αGTP one. This is probably be-
cause of increased Ca2+ binding to the αGTPPLC
∗ form, via Ca2+ + αGTPPLC
kPLCact−−⇀
↽−−
kPLCdeact
αGTPPLC
∗ (see reaction (3.5)), which decreases the amount of free αGTP. It is important
106
CHAPTER 4: GLOBAL SENSITIVITY ANALYSIS OF PARAMETERS
0 200 400 600 800 10000
1
2
3
4
5 x 10
−14
 
 
0.01 s−1
0.1 s−1
1 s−1
[α
G
T
P
](
M
)
Time (s)
(a)
0 1000 2000 3000 40000.5
1
1.5
2
2.5
3 x 10
−7
 
 
0.01 s−1
0.1 s−1
1 s−1
[C
a2
+
](
M
)
Time (s)
Varying 18:kgd+
(b)
0 200 400 600 800 10000
0.2
0.4
0.6
0.8
1
1.2 x 10
−13
 
 
0.1
1
10
[α
G
T
P
](
M
)
Time (s)
(c)
0 1000 2000 3000 40000.5
1
1.5
2
2.5
3
3.5 x 10
−7
 
 
0.1
1
10
[C
a2
+
](
M
)
Time (s)
Varying 7:ζ+
(d)
Figure 4.26: The effects of varying parameters to which only the αGTP Transient-Peak
is highly sensitive. Compare with Figure 4.25, where [αGTP] and [Ca
2+] also evolve
similarly.
to note however, that the Ca2+ transient peak still does not occur without the αGTP one;
they therefore appear strongly linked.
4.8 The dependence of GSA results on the sample size, r
The sensitivity results from parameter subspace 1, which were carried out with r2 =
1000 optimised trajectories, are now compared with results from the same subspace,
carried out with r1 = 150 trajectories, in order to consider the effect of the sample size
on the results.
Figure 4.28 shows the parameter rankings obtained for both runs, using S
′
AR (see
equation 4.35), and there is reasonable correlation between both sets of results. Param-
eters 1, 26, 28 and 36 are significantly more highly ranked by the r2 = 1000 run; on
the other hand, 19, 25, 31-33, 35, and 37 are noticeably lower ranked. It could be that
a smaller sample of elementary effects, such as that obtained with r1 = 150 overesti-
mates the relative significance of a parameter because it underestimates the significance
of some of the other parameters.
In general, the r1 = 150 run does well to identify the most significant parameters.
Among its ten most significant parameters are seven of those found by the r2 = 1000
run (see the bottom left box in Figure 4.28). The r1 = 150 run identifies the least sen-
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Figure 4.27: The effects of varying parameters to which only the Ca2+ Transient-Peak is
highly sensitive.
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Figure 4.28: Results fromparameter subspace 1, carried out with the two values r1 = 150
and r2 = 1000. Parameters are ranked using S
′
AR, quantified in equation 4.35.
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Optimal r = 1000 Optimal r = 150 Non-optimal r = 150
p1 p1 kPIP2b+
p2 kCa2+act− kPLCdis
IP3RTOT kCa2+act+ IP3RTOT
kdes+ IP3RTOT kIP3Rb+
kIP3deg γ1 p2
[PIP2 ] p2 γ1
γ1 [PIP2] p1
kIP3Rb+ kPKCdes− kCa2+act+
kCa2+act− kIP3Rb+ kGTP+
RTOT kPLCdis [PIP2]
Table 4.8.1: Sensitivity analysis results obtained using r2 = 1000 optimal, r1 = 150
optimal, and r˘1 = 150 non-optimal trajectories are compared. The ten most sensitive
parameters for each run (in subspace 1) are shown here.
sitive parameters almost as well as the r2 = 1000 run, since nine of the ten least sig-
nificant parameters of both runs are in common (see the top right box in Figure 4.28).
Therefore, for this model, if the computational expense of a higher sample size run is
too expensive, a lower sample size such as r = 150 could be used.
The importance of optimising the sampling strategy (as discussed in section 4.3.1)
is also considered by comparing the results obtained from r˘1 = 150 non-optimal trajec-
tories with those obtained from the r1 = 150 run. The results from the r2 = 1000 run
are taken to be the best results, and used to judge the performances of the r1 = 150 and
r˘1 = 150 runs.
In terms of identifying the ten most sensitive parameters, the r1 = 150 and r˘1 = 150
runs perform similarly; the former identifies seven of the parameters found by the
r2 = 1000 run, while the latter identifies six, as shown in Table 4.8.1. However, the pa-
rameters identified as the twomost sensitive in the r˘1 = 150 run are not even identified
among the top ten of the r2 = 1000 run. Since the top two parameters identified by
the r1 = 150 are in the top ten of the r2 = 1000 run (both runs also identify the same
parameter as the most sensitive), it is concluded that the optimisation strategy results
in a better ranking of the parameters. This becomes crucial in circumstances where only
a handful of the most sensitive parameters are sought.
4.9 Discussion
In this chapter, a global sensitivity analysis has been carried out on the parameters of
the Ca2+ model, identifying which of them are most significant, and providing insight
into the pathway dynamics. The problem of finding a good balance between thor-
ough exploration of parameter space and computational affordability when applying
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a global sensitivity analysis to a model as detailed as the Ca2+ mobilisation model was
also considered.
Global sensitivity analysis and computational efficiency
The method of elementary effects was carried out using both r1 = 150 and r2 = 1000
optimal trajectories, and the results from both were agreeably consistent; this means
that in situations where computational resources are more limited, results generated
from using a lower number of optimised trajectories such as r1 = 150 can give accept-
able results. Also, if the sensitivity analysis from the more expensive r2 run leads to
insight that requires a further sensitivity analysis (that is, extra, unexpected computa-
tional expense), the lower number of trajectories could be used for this.
The time taken to generate 1000 optimal trajectories from 2000 (≈ 41.2h) may be
considered too high, but it was carried out because the available computational re-
sources were sufficient. In addition, because each parameter is initially sampled from
the [0,1] interval, the process needs to be carried out only once, and the trajectories
could be used repeatedly for differently defined and constrained parameter spaces, as
long as they have the same number of dimensions. For instance, the same r1 = 1000
trajectories were used to generate the sensitivity results for the two subspaces earlier
defined (see section 4.5.3). (The same trajectories are also used to generate new sensi-
tivity results later, in Chapter 6.)
Insight into pathway dynamics
Parameters controlling agonist potency
Agonist potency, as quantified by the Ca2+ Peak-over-Basal function (equation (4.20)),
was relatively insensitive to all but six parameters: 26:kIP3deg, the rate constant of IP3
degradation, 36:kdes+, the rate constant of theGPCR desensitisation reactions, 23:kPLCact,
the rate constant of PLC activation, 39:p1, the maximal rate of the SERCA pumps,
5:[PIP2], the concentration of PIP2 and 12:kdeact, the rate constant for GPCR deactiva-
tion. Guided by these results, agonist potency experimentsmight be designed in which
any of the relevant reactions are inhibited, or one in which [PIP2] is varied. In particu-
lar, the hypothesis that such experimental manoeuvres can cause known agonists to act
as antagonists should be tested. This might provide an explanation for unexpected fail-
ures when agonists are used in therapy strategies, since parameters such as [PIP2] and
PKC concentration, which mediates the desensitisation process (abstracted in the Ca2+
mobilisation model by the reactions involving 36:kdes+, see reactions 3.22 and 3.23), can
vary from cell, and cellular variability could be conceptualised to represent patient to
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patient variability [31].
Understanding the amplified, yet rapid Ca2+ response
The rate constant for PIP2 hydrolysis, 27:kIP3 , was identified as the only parameter
which could individually account for the amplified yet rapid response seen in the data.
Individual changes in the other significant parameters could account either for the Left-
Shift or the rapid Ca2+ Time-to-Peak, but not both. A high value of 27:kIP3 (50000s
−1),
was required to simultaneously predict the two features, suggesting that the enzyme
αGTPPLC
∗, which mediates PIP2 hydrolysis, could be in the same class as some of the
fastest known enzymes.
The most sensitive parameters
The three most sensitive parameters are the SERCA pump parameters, 39:p1 and 40:p2,
and the GPCR desensitisation on-rate 36:kdes+. These are pathway components that the
design of pharmacological (agonist) experiments do not typically prioritise, yet these
results suggest that new experiments should be designed that explore the robustness of
the agonist-induced Ca2+ response to changes in these particular pathway processes.
The availability of inhibitors for the pump [61], and for PKC, which mediates the de-
sensitisation process makes such experiments feasible [14].
PIP2, is also a significant pathway component, since its concentration was ranked
6th overall; interestingly, the concentration of PIP2’s enzyme was only ranked 24th.
This implies that, even though both compounds participate in the same reaction, PIP2
might be a far more promising drug target.
The fact that there are several sensitive points in the pathway with components
that are potential drug targets may also suggest co-drugging opportunities in Ca2+
pathways.
Model simplification
It was shown that two of the least significant parameters 14:kg− and 24:kPLCdeact can
be set to zero, without altering the Ca2+ response, suggesting that GPCR pre-coupling
and Ca2+ positive feedback on PLC are irreversible reactions. Hence, in addition to
providing insight into pathway dynamics, the results of the Global sensitivity analysis
could be used to slightly simplify the model.
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Variant Ca2+-mobilisation models
5.1 Introduction
This chapter considers modelling questions that arose from the previous chapter. The
results of Chapter 4’s global sensitivity analysis (GSA) guided parameter changeswhich
resulted in a parameter set (here referred to as the GSA-guided parameter set, found in
Table B.2.2) with which the Ca2+-mobilisation model predicted key features of the ex-
perimental data (the transient, rapid peak, and signal amplification, see section 4.6).
However, a feature of the Ca2+ data came to prominence that had not previously been
highlighted; while in the Ca2+ data the descent from peak to steady state occurs in rel-
atively short times for [L] = 10−9–10−4M, the descent is slow for [L] = 10−9–10−7M in
the simulated time courses, as illustrated in Figure 5.1. In other words, it became clear
that the steepness of the Ca2+ curve after the peak is also an important feature.
Since the descent from peak indicates the removal of Ca2+ from the cytosol, the role
that extra removal mechanismsmight have in determining the steepness of that descent
is considered here, by incorporating plasma membrane pumps (ATPases), which facil-
itate Ca2+ efflux to the extracellular environment, into Chapter 4’s Ca2+-mobilisation
model (hereafter referred to as the original CM). This change results in a variant of the
original CM, which will be referred to as the Ca2+-mobilisation model with membrane
pumps (CMMP). Parameter variation will be carried out on this extendedmodel to ob-
serve the role that membrane pumps could play in determining the steepness of the
descent from peak.
The second question that arose from Chapter 4 is whether the total concentration of
PIP2 should be assumed constant, since it was identified by the GSA as the 6th most
significant parameter. In reality, PIP2 undergoes a cycle of depletion and re-synthesis
(described in section 3.1) which does affect its concentration, hence this chapter also
considers another extension of the original CM, which takes PIP2 dynamics into ac-
count.
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Figure 5.1: A comparison of (a) experimental Ca2+ data and (b) corresponding simula-
tions obtained with the GSA-guided parameter set. In the data, the time to steady state
appears to increase with the agonist concentration, while the reverse is the case in the
simulations.
5.2 Ca2+-mobilisation model with membrane pumps
The original CM is extended into the Ca2+-mobilisation model with membrane pumps
(CMMP) by accounting for the fact that the cytosolic Ca2+ concentration can be de-
pleted due to the action of plasmamembrane Ca2+ ATPases (PMCA). The rate at which
the pumps transport Ca2+ from the cytosol into the extracellular medium is modelled
by a Hill function, following previous studies [87, 95, 101]. The cytosolic Ca2+ rate
equation for this extended model is then given by (compare with equation (3.13)):
d[Ca2+]
dt
= νr(γ0 + γ1[IP3.IP3R.Ca
2+])([Ca2+ER]− [Ca2+])
− p1[Ca
2+]2
[Ca2+]2 + p22
− VP[Ca
2+]2
K2P + [Ca
2+]2
, (5.1)
where VP is the maximal rate of the membrane pumps, and KP is the concentration
of Ca2+ at which half-maximal pumping occurs. Also, note that [Ca2+ER] + [Ca
2+] is no
longer constant, as cytosolic Ca2+ is pumped out via the PMCA pumps; hence, [Ca2+ER]
is included as a variable in the model, whose ODE is given by:
d[Ca2+ER]
dt
=
1
νr
(
p1[Ca
2+]2
[Ca2+]2 + p22
)
− (γ0 + γ1[IP3.IP3R.Ca2+])(Ca2+ER − [Ca2+]). (5.2)
(
d[Ca2+ER ]
dt is multiplied by the cytosol/ER volume ratio,
1
νr
, to account for the fact that cal-
cium flux from the cytoplasm causes a greater concentration change in the ER (because
of its smaller volume) than it does in the cytoplasm.)
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Figure 5.2: (a) A comparison of the rates of the SERCA (p1 = 6 × 10−6Ms−1, p2 =
0.45× 10−6M) and membrane pumps (VP = 28× 10−6Ms−1, KP = 0.425× 10−6M). (b)
There is no Ca2+ response to 10−7M of Oxotremorine when VP = 28× 10−6Ms−1 and
KP = 0.425× 10−6M.
5.2.1 Fine-tuning membrane pump parameters
The initial values given to VP and KP are 28× 10−6Ms−1, and 0.425× 10−6M respec-
tively, taken from a previous study [87], in which they were estimated by fitting an
IP3-stimulated CICR model to Ca
2+ data. The original CM and the CMMP have all
other parameters in common, and their values in the GSA-derived parameter set are
retained (see Table B.2.2) since they were shown to predict key features of the data in
Chapter 4.
Figure 5.2(a) shows how the SERCA and plasma membrane Hill functions vary
with [Ca2+] for the aforementioned VP and KP values. These values give the mem-
brane pumps a far higher pumping capacity than the SERCA pumps over most Ca2+
concentrations. As a result, there is no discernible Ca2+ release in response to 10−7M
of Oxotremorine-M, as illustrated in Figure 5.2(b). This prediction is opposed to that of
the original CM, in which (as with the data) 10−7M of Oxotremorine-M induces a max-
imal Ca2+ release (see Figure 4.20(d)). This strongly suggests that more fitting values
of VP and/or KP need to be found for the CMMP. Since values which allow significant
responses to agonist stimulation are sought, the Ca2+ Peak-Over-Basal feature, as used
in Chapter 4, and reproduced here:
PB =
Peak− Basal
Basal
, (5.3)
will also monitored in the process of finding suitable values for VP and KP. Non-zero
values of PB indicate that there is a response to agonist stimulation.
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Figure 5.3: The steepness of the Ca2+ descent from peak is an important feature in this
chapter. The descent phase of the transient is referred to as the ’Ca2+-Tail’.
To also ensure that the response is transient,
PMP = Peak− Plateau, (5.4)
(also used in Chapter 4) will also be calculated; thus, when PMP = 0 it can be known
that the response is no longer transient.
As this chapter is concerned with fine-tuning the steepness of the descent from the
Ca2+ peak, that feature is mathematically quantified in the next section.
Quantifying the rate of the transient decay
The Ca2+ descent from peakwill be referred to as the steepness of the ’Ca2+-Tail’, which
is illustrated in Figure 5.3. There are different ways to quantify the steepness of the tail;
the most suitable way is more easily chosen when the exact form of the transient is
known. For example, the transient may be assumed to undergo exponential decay, and
then fit to an exponential function such as,
Ca2+(tp)e
−zt, (5.5)
where time t is measured from the occurrence of the Ca2+ peak, tp; zmay then be taken
as a measure of the Ca2+-Tail steepness (which increases with z). However, there are
at least two disadvantages of such an approach. Firstly, the assumption of exponential
decay may not apply to some (or all) of the time courses. Secondly, a computation-
ally inexpensive fitting method might be needed to estimate z; such a method would
generally require a good initial guess for z, which might be hard to provide.
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An alternative approach will be employed here; instantaneous gradients of the
Ca2+-Tail are used to quantify steepness, and so does not require an assumed func-
tional form for the transient. The following equation is used to calculate a normalised
instantaneous gradient:
IG =
|d[Ca2+ ]/dt|
[Ca2+](0)
. (5.6)
The gradients are normalised to the basal level to account for the way the Ca2+
data have been normalised in Figure 5.1(a); these are the same data that were used in
Chapters 3 and 4, where they were normalised to the (Peak - Basal), due to stimulation
by 10−4M of Carbachol). The normalisation was changed to the present form to prevent
dividing by zero when some VP,KP values cause Peak− Basal = 0 (as in Figure 5.2(b)).
After the addition of the agonist, the model is run until steady state. The Ca2+-Tail
is measured up to when the transient falls to 95% of the (Peak− Plateau) value. IG is
measured every second of the tail, and the average, TS, is a measure of steepness, given
by:
Ts =
1
nt
nt
∑
i=1
IGi , (5.7)
where nt is the number of time points to go from the peak value to 95% of the (Peak−
Plateau) value.
Parameter variation
A region of VP–KP space constrained by the ranges VP = 28× 10−14 − 28× 10−6Ms−1
and KP = 0.425× 10−7− 0.425× 10−5M is searched to identify coordinates which cause
significant Ca2+ responses. Parameter variation is carried out for two agonist concen-
trations; firstly, at 10−9M, which is the low agonist concentration, for which the Ca2+
steady state in the data is reached within the shorter timeframe of ≈ 40s; secondly, at
10−5M, which is representative of the higher agonist concentrations (10−8 − 10−4M) at
which Ca2+ removal occurs within the longer timeframe of ≥ 50s (see Figure 5.1(a)).
Figures 5.4(a)–(c) show the values of the Ca2+-Tail steepness (TS), the Ca
2+ Peak-
Over-Basal (PB) and the (Peak−Plateau) (PMP) in response to 10−5M of Oxotremorine-
M, for various values of KP andVP; for each curve KP has a fixed value, whileVP varies.
In Figure 5.4(a), all the curves have the same basic shape, with steepness initially in-
creasing up to a maximum value, and subsequently decreasing until it reaches zero.
The higher the value of KP, the further right the curve is located. The first curve (solid
lines), where KP = 0.425× 10−7M, represents the most sensitive setting of the pumps
(in the defined range), where only 0.425× 10−7M is required for half-maximal pump-
ing, and the maximum Ca2+-Tail steepness occurs when the maximal rate is given by
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VP = 2.168 × 10−12Ms−1, which is on the lower end of its defined range. However,
when KP = 0.425× 10−6M (dashed lines), making the pumps less sensitive to [Ca2+],
a higher maximal pumping rate (VP = 1.353× 10−11Ms−1) is required to produce the
maximum steepness. When the pumps are at their least sensitive (KP = 0.425× 10−5M,
thick solid line), the curve is also shifted forward, as an even higher maximal rate
(VP = 1.724× 10−9Ms−1) is now required to produce the maximum steepness. A simi-
lar correlation between KP and VP also influence the PB and PMP, with higher maximal
pumping rates compensating for lower Ca2+ sensitivities. For each curve, there are
threshold values ofVP, after which PB and PMP start to decrease until they become zero.
This means that, after the threshold value, as the maximal pumping rate increases, the
transient starts to flatten, until it is completely flat.
Figures 5.4(f)–(h) show individual plots of both PB and TS for single KP values, as
VP varies. This makes it easy to observe what is happening to the size of the agonist-
stimulated response as the steepness of the Ca2+-Tail changes (note that each curve has
been normalised by its peak value to allow PB and TS, which are of different orders,
to be seen clearly when plotted together). For all KP values (that is, in all five plots)
PB and TS respond similarly to changes in VP. In general, the maximum steepness (TS)
occurs together with the maximum Peak-Over-Basal.
When [L] = 10−9M, the changes in TS, PB and PMP, as KP and VP vary, are similar
to those that occur when [L] = 10−5M, as shown in Figures 5.5(a)–(c). The aforemen-
tioned correlation between KP and VP is also evident here, as the curves shift forward
with each increase in KP. As would be expected, the values of PB and PMP are lower
than they were for the higher agonist concentration. However, the fact that the TS
values are lower means that the Ca2+-Tail tends to be less steep at the lower agonist
concentration.
It is therefore clear that the incorporation of membrane pumps allows for modu-
lation of the Ca2+-Tail steepness, but also the size of the response to agonist stimula-
tion. This is further illustrated by plotting time courses with VP = 0, KP = 0 (rep-
resenting the original CM model), and time courses using one of the (KP, VP) pairs
(KP = 0.425 × 10−6M, VP = 1.6786 × 10−11Ms−1, marked ’*’ in Figures 5.4(a) and
(b)) which simultaneously caused maximum steepness and Peak-Over-Basal at both
agonist concentrations.
Figure 5.6(a) shows the response to 10−9M of Oxotremorine-M, while Figure 5.6(b)
shows the response to 10−5M. The influence of the membrane pumps is more pro-
nounced when [L] = 10−5M; the action of the membrane pumps causes the peak re-
sponse to stimulation (relative to basal) to significantly increase, as well as the steep-
ness of the tail, so that the time to steady state is shortened. When [L] = 10−9M, the
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Figure 5.4: (a)-(c) Curves for the Ca2+-Tail steepness (TS), Ca
2+ Peak-over-Basal (PB) and
Ca2+ (Peak - Plateau) (PMP) for various KP and VP values, when [L] = 10
−5(M). (d)–(h)
TS and PB (each curve normalised to its maximum) have been plotted together for each
KP value; it can be seen that both features respond similarly to changes in VP and KP.
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Figure 5.5: (a)-(c) Curves for the Ca2+-Tail steepness (TS), Ca
2+ Peak-over-Basal (PB) and
Ca2+ (Peak - Plateau) (PMP) for various KP and VP values, when [L] = 10
−9(M). (d) –(h)
TS and PB (each curve normalised to its maximum) have been plotted together for each
KP value; it can be seen that both features respond similarly to changes in VP and KP.
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Figure 5.6: Comparing Ca2+ time courses from the original CM (solid line) and the
CMMP (dashed line) for (a) [L] = 10−9M (b)[L] = 10−5M. In both cases, the action of
the membrane pumps can increase the steepness, as well as Peak-Over-Basal, but when
[L] = 10−9M, the change is not significant.
membrane pumps cause the peak response (relative to basal) to slightly decrease, but
increase the steepness of the tail, although not significantly enough to resemble the
data, where the steady state is reached within 40 seconds (see Figure 5.1(a)). The time
courses for all agonist concentrations are plotted in Figure 5.7, where it can be seen that
compared to the data (shown again in the same figure), the descent from peak is still
much slower at the lower agonist concentrations.
This section has shown that although the action of membrane pumps can influence
the steepness of the Ca2+-Tail, the effect is not enough to allow the simulated Ca2+ tran-
sients for the lower agonist concentrations resemble corresponding ones in the data. It
therefore seems that the extension to the original CM is not necessary.
5.3 PIP2 depletion and replenishment
As previously mentioned, the results of Chapter 4’s GSA indicated that the total con-
centration of PIP2 is one of the parameters with the strongest impact on the Ca
2+ re-
sponse; hence, fluctuations in its value might alter the Ca2+ response. This section
considers another variant Ca2+-mobilisation model, which incorporates a basic PIP2
depletion and resynthesis cycle into the original CM, allowing the effects of such a
cycle to be explored.
Following a previous study [44], it is assumed that the product of PIP2 cleav-
age, IP3, is degraded into a phosphate pool, PHOS, from which PIP2 can then be re-
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Figure 5.7: A comparison of (a) experimental Ca2+ data and (b) corresponding simula-
tions of the CMMP with VP = 1.6786× 10−11Ms−1, KP = 0.425× 10−6M. At the lower
agonist concentrations, the descent from peak is still much slower in the simulations
than in the data.
synthesised, as follows:
IP3
kIP3deg−→ PHOS kPIP2rep−→ PIP2. (5.8)
The relevant ODEs are then given by:
d[PIP2]
dt
= kPIP2b−[αGTPPLC∗PIP2]− kPIP2b+[αGTPPLC∗][PIP2]
+ kPIP2rep[PHOS] (5.9)
d[PHOS]
dt
= kIP3deg[IP3]− kPIP2rep[PHOS] (5.10)
This is a simplification of the cycle of PIP2 depletion and resynthesis, but should
be sufficient to address the concern of this section, which is to explore what effects
fluctuations in PIP2’s concentration might have on the Ca
2+ response. Equations (5.9)
and (5.10) allow [PIP2] to drop when it is hydrolysed, and subsequently be replenished
from the phosphate pool. Since PIP2 depletion might affect the lifetime of the Ca
2+-
activating IP3 signal, its effect on the steepness of the Ca
2+-Tail is also considered.
This extendedmodel, referred to as the Ca2+-mobilisation model with [PIP2] deple-
tion and replenishment (CMPDR), only has one additional parameter to those of the
original CM: kPIP2rep, which controls the rate at which PIP2 again becomes available
after depletion (see equation 5.10). A previous study used the values 0.015, 0.1, 10s−1
[44], which are used here as a guide to vary kPIP2rep between 10
−6 − 1s−1. (The range
was adapted because the dynamics are not sensitive in the range 0.1− 10s−1.)
Figure 5.8 shows the Ca2+ transients in response to both 10−9M and 10−5M of
Oxotremorine-M, as kPIP2rep varies between 10
−6s−1 and 1s−1; the time courses of [PIP2]
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and [PHOS] are also shown. When [L] = 10−5M and kPIP2rep is highest (1 s−1), the ef-
fect is virtually the same as having [PIP2] constantly available at a high concentration;
as a result, the phosphate pool is hardly filled (see Figures 5.8(d) and (f)). There is sig-
nificant [PIP2] depletionwhen kPIP2rep is lower, at 0.1s
−1 or 0.01s−1, which is temporary
as [PIP2] is subsequently replenished; however, when kPIP2rep = 10
−3s−1 for instance,
[PIP2] is hardly recoverable by replenishment in the 120 second timeframe. Hence,
one effect of [PIP2] fluctuations is on the steepness of the Ca
2+-Tail, which increases as
kPIP2rep decreases from 0.1 – 10
−4s−1 (see Figure 5.8(b)).
In response to 10−9M of Oxotremorine-M, the [PIP2] and [PHOS] concentrations
do not significantly change from their basal values, regardless of the value of kPIP2rep
(Figures 5.8(c) and 5.8(e)), as there is not enough agonist to drive [PIP2] depletion. As
a result, the steepness of the Ca2+-Tail at [L] = 10−9M is not significantly impacted by
changes in the value of kPIP2rep. As observed when the previous model (CMMP) was
analysed, the steepness of the Ca2+-Tail at [L] = 10−9M is not as sensitive as it should
be in order to match the data.
Agonist efficacy can be diminished if the rate of PIP2 replenishment is slow; at
kPIP2rep = 10
−5s−1 and kPIP2rep = 10−6s−1, the dose-response curves of the Ca2+ peak
shift considerably to the right, as shown in Figure 5.9. Hence, it seems that the most
reasonable values for kPIP2rep are between 10
−4− 0.1s−1. It is also important to note the
effect that the rate of replenishment has on the Ca2+ Peak-over-Basal, which is largest
when kPIP2rep = 10
−5s−4. However, the corresponding dose-response curve is more
right-shifted than those which pertain to higher kPIP2rep values.
This section has shown that the original CM, which assumes that [PIP2] is constant,
is roughly equivalent to the CMPDR when its rate constant of PIP2 replenishment is
very high. At intermediate values of kPIP2rep (when [L] = 10
−5), the Ca2+ Peak-over-
Basal and the steepness of the Ca2+-Tail can be influenced by the rate of replenishment.
At the low values of kPIP2rep agonist efficacy is significantly diminished, suggesting
that they do not represent realistic rates of PIP2 replenishment. Hence, the dynamics
of PIP2 may be important for fine-tuning the Ca
2+ Peak-over-Basal and the Ca2+-Tail
steepness at the higher agonist concentrations. However, the CMPDR does not neces-
sarily offer improved predictions of the Ca2+ data, particularly at [L] = 10−9; there-
fore, it might be more reasonable to find an optimal value for the constant [PIP2] in
the original CM, which is the simpler model. Indeed merely by varying [PIP2] in the
original model, a similar modulation of the can be achieved Ca2+ Peak-over-Basal and
the Ca2+-Tail steepness, as shown in Figure 5.10 (compare with Figures 5.8(a) and (b)).
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Figure 5.8: The effects of varying kPIP2rep on [Ca
2+] (a-b), [PIP2] (c-d) and [PHOS] (e-f),
in response to 10−9M and 10−5M, of Oxotremorine-M. Within a range of faster PIP2 re-
plenishment rates, the Ca2+ responses do not change much; outside this range, features
like the Ca2+ Peak-over-Basal, and Ca2+-Tail steepness can significantly change. Fast
rates of PIP2 replenishment are acceptably approximated by the assumption that [PIP2]
is constant.
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Figure 5.10: The effects of varying [PIP2] in the original CM on [Ca
2+] in response to
(a) 10−9M and (b) 10−5M, of Oxotremorine-M. Features like the Ca2+ Peak-over-Basal,
and Ca2+-Tail steepness can be sensitive. Fast rates of PIP2 replenishment are acceptably
approximated by the assumption that [PIP2] is constant.
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5.4 Discussion
In this chapter, two extended versions of the original CM were derived and analysed
to address modelling questions that arose in Chapter 4.
The first variant model, the CMMP, incorporated the action of membrane pumps
as an additional source of cytosolic Ca2+ removal, which was solely carried out by the
SERCA pumps in the original CM.
Parameter variation was carried out to identify the PMCA pump parameter values
(VP and KP) which had the strongest impact on the Ca
2+-Tail steepness. Even though
there were VP and KP values which could increase the steepness of the Ca
2+-Tail, they
were not significant enough to make the tails at the lower concentrations anything as
steep as they are in the data. This suggests that it is not crucial to include themembrane
pumps in the model, and that the original CMmight just need parameter optimisation
to better predict the Ca2+-Tails.
The second variant model, the CMPDR, unlike the original CM did not assume that
[PIP2] was constant; it was derived by incorporating a basic cycle of PIP2 depletion
and replenishment into the original CM. It was shown that, if not fast enough, the rate
of PIP2 replenishment can diminish the Ca
2+ response, and thus agonist efficacy. It
was also seen that at the higher agonist concentration, [L] = 10−5 M, the Ca2+ Peak-
over-Basal and the Ca2+-Tail steepness can be sensitive to changes in the rate constant
of PIP2 replenishment. Similar changes in those features could be achieved by vary-
ing [PIP2] in the original CM. Hence, the the models can be considered as roughly
equivalent. This suggests that the better modelling strategy is to optimise the value
of constant [PIP2], rather than model depletion and replenishment, which makes the
model slightly more complex.
Neither of the variants considered here drastically improve the predictions of the
original CM; in particular, they do not improve the prediction of the Ca2+-Tail steep-
ness when [L] = 10−9 M. Therefore, as it is simpler than its variants, the original CM
will be retained as the model for further analysis in the next chapter, where a global
parameter optimisation is performed.
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Parameter optimisation
6.1 Introduction
In Chapter 4, a global sensitivity analysis (GSA) was used to rank the parameters of the
Ca2+-mobilisation model according to their influence on the Ca2+ response. Guided by
the GSA results, parameter adjustments were made to the base parameter set (found in
Table B.2.2), which resulted in the best qualitative predictions of the Ca2+ response
made by the model so far. The resulting parameter set (which can be found in Table
B.2.2) will be referred to as the GSA-guided parameter set. In this chapter, a systematic
parameter optimisation is carried out to improve the quantitative fit to the Ca2+ data,
and gain more insight into pathway dynamics.
Parameter estimation is an optimisation problem, since the parameter setwithwhich
the model output least deviates from the data is sought. Specifically, it is a minimisa-
tion problem, which can be stated as follows: find the n-dimensional vector, x∗ that
minimises an objective function,
F(x) : Rn → R, (6.1)
where, given that Y˜l is a vector of experimental data measured at k time points in the
lth experiment,
F(x) =
m
∑
k=1
d
∑
l=1
(Y˜l,k −Yl,k(x))2 =
d
∑
l=1
‖Y˜l − Yl(x)‖2. (6.2)
Equation (6.2) is also often referred to as the least squares function. For the available
experimental Ca2+ data (discussed in previous chapters, and reproduced in Figure 6.1),
the number of time points is given by k = 34 and the number of experiments is d =
8, since each time course represents an experiment with stimulation by one of eight
agonist concentrations.
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Figure 6.1: The Ca2+ data, to which the model will be fitted [52]; Ca2+ fluorescence
is normalised to the basal level. The number of time points, counted from the time of
agonist stimulation (t = 0), is k = 34.
6.2 Optimisation methods
For nonlinear models such as the Ca2+-mobilisation model, there often exist many so-
lutions to the minimisation problem, that satisfy the following:
F(x∗) < F(x) ∀ x ∈ S ⊆ Rn (6.3)
F(xl) ≤ F(x) ∀ x ∈ Ss ⊂ S, (6.4)
where S (referred to as the search space) is the region of parameter space to which the
search is confined and Ss is the set of points in the neighbourhood of x
l . x∗ is the global
minimum, while xl is a local minimum. It is common for some nonlinear models to
have multiple local, and even global minima. In such cases, the objective function is
said to be multimodal. The results of the global sensitivity analysis (GSA) in Chapter
4 show that there are many parameters to which the output is relatively insensitive,
meaning that these parameters can vary over orders of magnitudewithout significantly
changing the value of the cost function. The Ca2+ model can thus be expected to have
either multiple local minima for F and/or flat sections on its surface, over which its
value is approximately invariant.
6.2.1 Local optimisation methods
Local optimisation methods use local properties of the objective function to guide the
search, and so when the cost function is multimodal, easily converge to the minimum
closest to the starting point of the search [60]. These methods may be divided into two
classes: gradient-based, which use function derivatives to guide the search, and direct
search, which make use of only function evaluations.
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A popular direct search method is the Nelder-Meadmethod, which is a typical sim-
plex search method (a simplex is an nth-order generalisation of a triangle). A simplex
of n + 1 vertices is generated in S ⊂ Rn, and the function is evaluated at each ver-
tex. The vertex with the worst value is replaced, creating a new simplex by reflection,
expansion or contraction, and the search is continued. A sequence of simplexes with
improving function values at the vertices is generated, until the minimum is found, or
some other specified criterion is met [66].
There are many gradient-based optimisation methods which are known to quickly
converge to a local minimum, such as the Levenberg-Marquardt, and Gauss-Newton
Methods, used for least squares functions. Starting from an initial guess x0, the Gauss-
Newton method takes iterative steps towards the minimum, as defined by xa+1 =
xa + ha. Let Y˜l − Yl(x) = rl(x), then equation (6.2) can be written as:
F(x) =
d
∑
l=1
rl(x)
Trl(x). (6.5)
Using a Taylor function-linearisation of F(xa + ha), it can be shown that
JT(xa)J(xa)ha = −JT(xa)rl, (6.6)
where J is the Jacobian matrix, which contains the first-order partial derivatives of rl.
ha is calculated from equation (6.6), and the iterations are repeated until the minimum
is reached [67].
The Levenberg-Marquardt method modifies the Gauss-Newton method by adding
a step size modifier as follows:
(J(xa)JT(xa) + λI)ha = −JT(xa)rl, (6.7)
where I is the identity matrix [67]. This is an improvement on the Gauss-Newton
method because when the iterate is far from the minimum, the step size can be ad-
justed in the direction of the gradient. Other optimisation methods are discussed in
detail elsewhere [25, 68].
Local optimisation methods, while effective in situations where there is only one
minimum, or a good guess for the global minimum is known, are not appropriate oth-
erwise, as they simply converge to the minimum closest to x0. On the other hand,
global optimisation methods, which take larger parts of the search space into account,
are more likely to escape local minima; hence, such a method is preferred for the Ca2+-
mobilisation model.
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6.2.2 Global optimisation methods
Global optimisation (GO) methods can be divided into two classes: deterministic and
stochastic. Deterministic methods often use information about the mathematical struc-
ture of the problem to carry out the search for the optimum. For example, trajectory
methods use search strategies that generate paths such that at least one global mini-
mum lies on one path. The paths tend to be differential equation-based, generated by
an equation of motion, such as Newton’s law for a particle of mass in a potential, sub-
ject to a dissipative force [21]. Trajectory methods aim to visit and enumerate all the
stationary points of the objective function, thus identifying all global and local min-
ima; this means that they are generally computationally demanding, and impractical
for high order problems [72].
Another class of deterministic methods are branch and bound methods, which do
not necessarily require mathematical properties of the objective function to be known.
Branch and bound methods have been implemented in various ways, but are based on
a general underlying principle.
An upper bound for the objective function, FU, is set; this can be done by picking a
random value, or more systematically —for example, choosing a local minimum, using
a local optimisation method, such that FU = F(xl). A lower bound is also estimated
using established methods (convex relaxation, duality, Lipschitz or other bounds [11]).
The search space is then partitioned into a family of sets, using a selected method.
Lower bounds and upper bounds are estimated for each subset, and those sets whose
lower bounds are greater than the upper bound (hence not containing any elements
that give an objective function value less than FU) are eliminated, and permanently
ignored. The upper bounds and lower bounds are then updated. Among the remain-
ing sets, the one which contains an element giving the lowest function value is re-
partitioned, and the upper bound is updated with this function value. The previous
steps are then repeated until no sets containing elements with lower objective function
values can be found [12].
A key idea of this algorithm is that time is saved by exploring the most promising
regions of the search space first, but in the worst cases, the search effort grows expo-
nentially with the problem size.
In theory, deterministic methods are guaranteed to converge to the global optimum;
in practice however, as parameter space dimensionality increases, deterministic meth-
ods are unable to converge in finite time [59]. Deterministic methods tend to carry out
the search through space sequentially, while stochastic methods such as evolutionary
algorithms tend to carry out parallel searches through space using a diverse set of trial
solutions. On the other hand, stochastic methods use probabilistic rules to guide the
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search, which involves random elements, and so are not guaranteed to find the global
optimum; however, they often find very good solutions (in the vicinity of the global
optimum) in finite time [59, 60].
In an informative study [59], representative GOmethods were compared by testing
their performance when estimating the parameters of a benchmark problem: an eighth
order nonlinear ODE model of a metabolic pathway with thirty six parameters. Being
a high-dimensional search space, this represents a challenging optimisation problem,
with which the ability of existing GO methods to handle difficult estimation problems
can be tested. The deterministic methods: Global optimisation using the DIRECT algo-
rithm (GBLSOLVE), Multilevel Coordinate Search algorithm (MCS) were tested. Both
these algorithms are related; they are similar to Branch and bound methods, as they
divide the search space into smaller and smaller, non-intersecting hyperrectangles, but
they do not make use of bounds [34]. MCS adds a heuristic aspect to the basic deter-
minist approach [59]. The following stochastic methods were also tested: Differential
evolution (DE), Integrated Control Random Search algorithm (ICRS), Unconstrained
evolution strategy (uES), Evolution strategy using stochastic ranking (SRES) and the
Evolution strategy with covariance matrix adaptation (CMA-ES) [59].
Pseudo-experimental data were generated by simulating the benchmark problem
with a fixed parameter set, so that in this case the solution to equation (6.1), x∗, was
known. Sixteen sets of data were produced using various initial concentrations of sub-
strate and product. The Evolution strategy using stochastic ranking (SRES) produced
the best results of the tested methods. With SRES, all 36 parameters were estimated
with error less than 17%, the majority being estimated with less than 3% error, show-
ing that convergence was towards the global minimum. The other methods, with the
exception of uES, perfomed relatively poorly, as shown in Figure 6.2. Based on these
results, this chapter uses SRES (which is described in the next section) to address the
minimisation problem of the Ca2+ model.
6.3 Evolutionary algorithms
The evolution strategy using stochastic ranking (SRES) is one version of the stochastic
group of GO methods called evolution strategies, which in turn belongs to the group
of stochastic GO methods referred to as Evolutionary algorithms.
Evolutionary algorithms iteratively apply ideas from the biological theory of evo-
lution, such as selection, reproduction, crossover (or recombination), and mutation,
to improve trial solutions, in hopes of approaching the global optimum. The general
scheme of an evolutionary algorithm consists of (1) below, (2)–(4) in variable order, and
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Figure 6.2: Results of a study in which several global optimisation methods were com-
pared. The evolution strategies, uES and SRES,were by far the best performingmethods.
The figure was taken from [60].
(5):
1. INITIALISATION:Generate randomly or deterministically chosen trial solutions,
collectively referred to as the population; population members are often referred
to as individuals.
2. FITNESS: Evaluate the fitness of population members, using an objective mea-
sure such as F(x).
3. REPRODUCTION: Create offspring from all, or selected individuals (called par-
ents), using either or both of the following:
(a) MUTATION: Produce randomly altered forms of the parents.
(b) RECOMBINATION/CROSSOVER: Combine traits of parents to form new
individuals.
4. SELECTION: Select parents and offspring with best fitness and use them to update
the population (for evolution strategies, this is referred to as the (µ+λ) strategy);
or select only highest ranked parents to reproduce for the next generation (for
evolution strategies, referred to as the (µ,λ) strategy). The latter strategy allows
for a more diverse population, as it prevents original parents from surviving into
the next generation [23].
5. TERMINATION: Repeat (2)–(4) until a specified criterion, such as an acceptable
error or maximum number of generations, is reached.
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Many evolution strategies use all of the above steps. uES performs recombination
and mutation before using selection to update the population; SRES on the other hand,
performs selection before recombination and mutation, so that only the best individu-
als are allowed to reproduce. This might explain why SRES converged more quickly
than uES in the aforementioned study [59] (see Figure 6.2).
In step 3(a), strategy parameters are used to determine the extent to which parents are
mutated, and a unique feature of evolution strategies among evolutionary algorithms
is that thesemutation parameters are adaptive; they are part of the trial solutionswhich
evolve across generations. Hence, a vector of the strategy parameters, σ, is included in
each member of the population, which is represented by (x,σ). Each σj (j = 1, 2, ..., n)
is subject to mutation and is used to define the mutation step size of the jth parameter.
The particular way in which SRES implements steps (1)–(5) above is explained in the
next section.
6.3.1 Evolution strategy using stochastic ranking (SRES)
An initial population of λ trial solutions, xi, i = 1, ...,λ, is randomly generated from
an n-dimensional uniform distribution (allowing an unbiased spread across the search
space), while for the strategy parameters initial guesses are given by:
σ
(0)
i,j =
x j − x j√
n
, i ∈ {1, ...,λ}, j ∈ {1, ..., n}, (6.8)
where xj is the upper bound of the jth parameter, while x j is its lower bound; hence,
the initial step size decreases as the dimension of the search space increases. The super-
script in σ
(0)
i,j in equation (6.8) is the generation counter, g; the value of zero indicates
that this is the value of σi,j before the first generation.
F(xi) is calculated for each population member, (xi,σi), and they are ranked ac-
cordingly. The next operation is selection, by which the highest ranked µ (out of λ)
individuals, (x′i ,σ
′
i ), ∀i ∈ 1, 2, ..., µ are chosen as parents, while all others are discarded.
The population is then completely updated, with each (x′i ,σ
′
i ) replicated PS =
λ
µ times
on average, as illustrated in Figure 6.3. (The population size (λ) thus remains constant.)
The ratio, PS, is normally referred to as the selection pressure and, because it determines
the number of parents that survive to reproduce, influences the regions of space in
which the search is carried out. If PS is too high and the population size is too small,
diversity will be lost, and the search will tend to be carried out in subregions of the
search space [8]; the choice of these parameters can therefore influence the efficiency of
the search.
After selection, global intermediate recombination [78] is carried out on the updated
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P
(x1,σ1) = (x′1,σ
′
1)
(x2,σ2) = (x′2,σ
′
2)
...
(xµ,σµ) = (x′µ,σ
′
µ)
(xµ+1,σµ+1) = (x′1,σ
′
1)
(xµ+2,σµ+2) = (x′2,σ
′
2)
...
(x2µ,σ2µ) = (x′µ,σ
′
µ)
(x2µ+1,σ2µ+1) = (x′1,σ
′
1)
...
Figure 6.3: An illustration of the process by which the population is updated with the
fittest individuals (selection), which then go on to reproduce for the next generation
(reproduction).
strategy parameters according to the following rule:
σˆ
(g)
i,j = (σ
(g)
i,j + σ
′(g)
k j ,j
)/2, i = 1, ...,λ, kj ∈ {1, ..., µ}, (6.9)
where kj is an index generated at random and anew for each j. Hence, a strategy param-
eter may be replaced by its average with another randomly chosen strategy parameter
from the parent population. For instance, the jth dimension (parameter) in the first in-
dividual could be updated by σˆ
(g)
1,j = (σ
(g)
1,j + σ
′(g)
2,j )/2 or σˆ
(g)
1,j = (σ
(g)
1,j + σ
′(g)
5,j )/2, etc; or
it could be unchanged via the choice, σˆ
(g)
1,j = (σ
(g)
1,j + σ
′(g)
1,j )/2. This step allows traits of
the good strategy parameters to spread across the population. It has been shown that
recombination can increase the rate at which the offspring population converges to its
lowest average fitness value [97].
The population for the next generation is obtained by mutation, which is first car-
ried out multiplicatively on each strategy parameter, and additively to each (model)
parameter, as follows:
σ
(g+1)
i,j = σˆ
(g)
i,j exp(N(0, τ´) + Nj(0, τ)) (6.10)
x
(g+1)
i,j = x
(g)
i,j + Nj(0, σ
(g+1)
i,j ), (6.11)
where N(0, ∗) is a random number from a normal distribution with mean, 0, and
standard deviation, ∗; Nj(0, ∗) is similar, but generated anew for the jth parameter.
exp(N(0, τ´)) and exp(Nj(0, τ)) in equation (6.10) are thus numbers from the lognor-
mal distribution; the former applies the same mutation to each component, while the
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Figure 6.4: (a) Scaling factors of σ in equation (6.10) are taken from the lognormal distri-
bution (exp(N(0, τ))), which makes smaller mutations more likely than larger ones (at
the tails of the curve). Smaller values of τ increase the probability of exp(N(0, τ)) values
close to 1. (b) The step sizes in equation (6.11) are taken from the normal distribution,
making small values more likely. The spread of the normal distribution N(0, σ) is con-
trolled by its standard deviation, σ. Smaller σ values increase the probability of a step
size close to 0.
latter applies dimension-wise mutation. The (multiplicative) mutation factors for σˆi,j
(see equation (6.10)) are taken from the lognormal distribution because smaller scal-
ings (gathered around the peak) are more likely than larger ones (found at the tails), as
shown in Figure 6.4(a). τ´ and τ are called learning rates, and as illustrated in Figure
6.4(a), the smaller they are, the more likely that exp(τ´N(0, 1)) and exp(τNj(0, 1)) will
be close to 1. Hence, τ´ and τ influence which the speed at which σ
(g+1)
i,j is adapted. The
values τ´ = 1√
2
√
n
and τ = 1√
2n
have been recommended based on theoretical and prac-
tical considerations, and have been shown to be efficient in somemultimodal problems
[8, 83].
The additive step sizes (see equation (6.11)) are taken from the normal distributions
because smaller values are more likely, as shown in Figure 6.4(b). If mutation takes
a parameter value outside its defined bounds, it is re-tried up to ten times; if these
attempts are unsuccessful, the parameter is left unmutated to limit computational ex-
pense. Since each x
(g+1)
h,j is derived by taking a step size determined by a mutated value
of σˆ
g
i,j, the worst mutations will be rejected in the next generation when only the fittest
µ offspring are selected. Hence, the step sizes evolve to optima as well as the model
parameters.
The cycle is repeated until some specified user criterion is met (for example, maxi-
mum number of generations, or minimum objective function value).
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SRES was designed with constrained optimisation in mind, hence it can also use a
penalty function to penalise trial solutions which violate known parameter constraints.
The method then adjusts the balance between the contributions of the penalty function
and the objective function to the ranking of an individual’s fitness [78]. The only con-
straints used for the Ca2+-mobilisation model are the parameter ranges, thus SRES is
used with the value of the penalty function as zero.
6.4 Searching with SRES for known global minima
In this section, the ability of SRES to find a known global minimum is first tested, the
results of which will be used to interpret its performance when fitting the Ca2+ model
to actual experimental data later in section 6.5.2.
6.4.1 Generation of pseudo-data
The Ca2+ model is used to generate what is referred to as pseudo-data, which is the Ca2+
response when the model is simulated with a chosen parameter set, whose members
are then referred to as the ’nominal’ values. Hence, a global minimum, x∗ (chosen to
be the GSA-guided parameter set in this case) for this particular estimation problem is
known, and the accuracy of the estimates found by SRES can be assessed. In this case,
the data in equation (6.1) is then given by Y˜l = Yl(x
∗), and the objective function by:
F¯(x) =
d
∑
l=1
‖Yl(x∗)− Yl(x)‖2. (6.12)
To mimic actual experimental data, which often have measurement errors, a noisy
version of the pseudo-data, Y˜nl , is also generated using the following:
Y˜nl = Y˜l(x
∗) + Θ · Y˜l , (6.13)
where Θ is a k-length vector of random numbers between -0.05 and 0.05, randomly
chosen from the uniform distribution. The Ca2+ pseudo-data are generated at the
same time points, and for the same ligand concentrations, as the experimental data,
in order to set up a test case as close as possible to the actual optimisation prob-
lem; it is then more straightforward to make some direct comparisons. The pseudo-
data have been normalised using the basal value, so that F is dimensionless; hence
Yl = [Ca
2+]/[Ca2+(0)].
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Ranking Parameter
1 kCa2+act−
2 kPIP2b+
3 kIP3Rb−
4 p1
5 kIP3Rb+
6 kdes+
7 [PIP2 ]
8 kdeact
9 p2
10 RTOT
Table 6.4.1: The ten most sensitive parameters, identified by a GSA carried out in a
parameter space confined around the GSA-guided parameter set. These 10 parameters
are referred to as the GSA Top 10.
6.4.2 Reduction of search space dimension
Using the method of elementary effects (as described in Chapter 4), a global sensitivity
analysis (GSA) was carried out in a parameter subspace constrained around the GSA-
guided parameter set, since it will serve as the base set around which the search space
S is constrained. Table 6.4.1 lists the ten parameters (out of forty) to which the Ca2+ re-
sponse is most sensitive, and, as discussed in section 4.5.4, they are assumed to be the
ones whose values most need to be determined by parameter estimation; consequently,
the dimensions of the search space can be significantly reduced, so that S ⊆ R10 instead
of S ⊆ R40. This assumption will be scrutinised in a later section, by comparing opti-
misation results from both search spaces.
The results are similar to those obtained for the previous base set in Chapter 3, with
six parameters in common. The newly identified parameters are kIP3Rb+, kIP3Rb−, kdeact
and RTOT, replacing IP3RTOT, kIP3deg, γ1 and kIP3 .
Let the W ∈ {1, 2, ..., 10} most sensitive parameters in Table 6.4.1 be referred to as
the GSA Top W, then corresponding subspaces SWG ⊂ RW (or hyperplanes in R40) can
be defined, by fixing all other parameters at their nominal values (the subscript G refers
to the fact that the GSA TopW serve as the axes in the subspace). The higher the value
of W, the more dimensions there are to explore, hence lower values ofW simplify the
estimation problem.
The main minimisation problem in this section will be that solved in S10G . However,
SRES is first used to search in S2G ⊂ R2 for the nominal values of the GSA Top 2. The
objective function surface in this subproblem can be visualised, and thus provide in-
sight into the performance of the algorithm, as well as the topology of the search space.
The search is then carried out in S4G, for the nominal values of the GSA Top 4, before
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finally being carried out in S10G for all the values in Table 6.4.1. Hence, the dimensions
of the solution, x∗, vary in this section. By first tackling these subproblems, a sense of
the computational cost attached to the main problem and of suitable SRES search pa-
rameter values, such as the population size and number of generations, can be gained.
The full search space, S ⊂ R40 is defined according to parameter space 2 in sec-
tion 4.4.3, except with molecular concentrations varying over four orders of magnitude
around their base values in the GSA-guided parameter set in Table B.2.2.
6.4.3 SRES search parameters
As with most stochastic algorithms, there are no fixed rules for choosing values for the
SRES search parameters: the population size, λ, the number of generations, G, and the
selection pressure PS (or equivalently, the number of parents, µ); there is an element of
trial and error involved in selecting them. It is also important, when choosing them,
to remember certain factors that may influence the performance of the routine. For
instance (as noted before) the value of PS can influence how well the search space is
explored. Several publications have recommended a selection pressure of 7 [43, 78, 97],
which will be used as a starting value here. The size of the population also influences
how well the search space is explored [8], and should be adjusted according to the
dimension of the search space.
The aforementioned study [60], in which SRES was the best performing global op-
timisation method, used the search parameters λ = 350, G = 8000 and PS ≈ 11 for the
eight order benchmark problem, which has thirty six parameters. These values are not
practical for the Ca2+ model, which is being fit to data from d = 8 experiments (see
Figure 6.1), and would require λ × G × l = 22, 400, 000 model evaluations. Moreover,
when the sensitivity analysis was implemented in Chapter 4, it was seen that there are
parameter combinations that significantly increase model evaluation time (see section
4.4.4); hence, a model evaluation could take anything from one tenth of a second to tens
of seconds. Large values of λ and G would thus make the optimisation computation-
ally unaffordable. However (at least initially) only estimates for the≤ 10most sensitive
parameters are sought, so it is unlikely that a population size as large as λ = 350 is re-
quired. Different λ values will be tested, depending on the number of parameters being
estimated. The choices for G will be discussed as the runs are implemented.
The Ca2+-mobilisation model has 24 variables, and available data are for 1 variable
([Ca2+]), while the aforementioned benchmark model had 10 variables, and data for
each variable, generated from 16 different initial conditions. Hence, parameter estima-
tion for the Ca2+ model is a significantly more challenging problem.
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Ranking Parameter
1 p2
2 kCa2+act+
3 kGTP+
4 kIP3Rb+
5 RTOT
6 kPIP2b+
7 [PIP2 ]
8 kCa2+act−
9 kIP3Rb−
10 kIP3deg
Table 6.4.2: The ten most sensitive parameters, identified by a local sensitivity analysis
(LSA) carried out at the point in space which corresponds to the GSA-guided parameter
set. These 10 parameters are referred to as the LSA Top 10.
6.4.4 Local sensitivity of F¯
In this section a local sensitivity analysis (LSA) is carried out at the point in parame-
ter space which corresponds to the GSA-guided parameter set. Determining the most
sensitive parameters at that point gives an indication of the coordinate-wise landscape
of F¯ in the vicinity of the global minimum, x∗; thus, the steepest F¯ changes along the
axes can be estimated. It is useful to have such information because flatness in some
parameter directions around the global minimum can make those parameters hard to
estimate [60], as many possible values would give roughly the same low value of F;
thus, numerous individuals with similarly high fitness exist and can be favoured by
the (SRES) selection step, which therefore becomes of little use in focusing the progres-
sion to x∗; the routine can thus come to resemble a purely random search in the flat
regions.
The output feature of interest for the LSA is F¯ itself; the sensitivity with respect to
the jth parameter is then given by:
C¯j =
F¯(x∗ + 0δj)− F¯(x∗)
δj/x
∗
j
, (6.14)
where 0δj is an n-dimensional vector of zeros, but with its jth element equal to δj, which
is taken to be±0.1x∗j (note that F¯(x∗) = 0, hence it is not used to divide the numerator).
The average of |C¯j| due to both ±0.1x∗j is calculated and used to rank the parameters,
the results of which are given in Table 6.4.2.
The W ∈ {1, 2, ..., 10} most sensitive parameters in Table 6.4.2 are then referred to
as the LSA TopW. Although many of the GSA Top 10 are also among the locally most
sensitive, they tend to be ranked differently (compare with Table 6.4.1); this is because
the GSA ranks the model parameters using an average of sensitivities calculated at se-
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Figure 6.5: A comparison of the globally and locally most sensitive parameters. There
are seven parameters which are identified by both sensitivity analyses.
lected points in parameter space, and so the GSA ranking, though representative of the
whole space, may be different at individual points. Probably for that reason, there are
parameters in the LSA Top 10 not represented in the GSA Top 10 (and vice versa), as
illustrated in Figure 6.5, their average significance across parameter space being dis-
similar to their local significance. Hence, some of the steepest directions around x∗,
kCa2+act+, kGTP+ and kIP3deg are not represented in the GSA Top 10. When the GSA Top
10 (or any subset within) are being estimated, kCa2+act+ and kGTP+ will be fixed at their
nominal values, and since they are ranked high (2 and 3 respectively) in terms of local
sensitivity, it might be possible to get good fits without getting close estimates for other
(locally less sensitive) parameters in the GSA Top 10.
It should be noted that due to model nonlinearity (which was clearly seen in Chap-
ter 4) the LSA results might not apply to more global regions; also, as sensitivity coeffi-
cients are calculated one parameter at a time, the LSA results do not account for effects
due to parameter correlation, even within the local region.
6.4.5 Estimating two parameters
In this section the search is first carried out in the hyperplane S2G ⊂ R2, to find the nom-
inal values of the GSA Top 2, kCa2+act− and kPIP2b+; for comparison, S2L is then searched
for the nominal values of the LSA Top 2. Since there are only 2 parameters to estimate,
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a population of λ = 20, and number of generations, G = 40 are initially chosen; selec-
tion pressure is set as PS = 7, so that µ = 3 parents survive for reproduction in every
generation. The accuracy of the estimates will be quantified by calculating a percentage
error as follows:
Ep =
100(xej − x∗j )
x∗j
, (6.15)
where xej is the estimated value of the jth parameter, and x
∗
j is its nominal value.
The results of the search are shown in Figure 6.6. Figure 6.6(a) shows that the best
solution is found after 4 generations with an error of F¯ ≈ 0.046; the pseudo-data and
the time course predictions of the best estimates are very close (Figure 6.6(c)), because F¯
is low, giving an average squared error of 0.000169117647 per data point, each of which
is ≥ 1. However, Figure 6.6(b) shows that the estimates are ≈ −40% less than their
nominal values, which again raises the question of how sensitive the Ca2+ response is
to particular parameters. It can be seen in Table 6.4.2 that kCa2+act− and kPIP2b+ are only
the 8th and 6th ranked parameters in terms of local sensitivity; it follows that since the
higher ranked parameters are fixed at their nominal values, good fits can be obtained
even though kCa2+act− and kPIP2b+ are imperfectly estimated.
After the fourth generation, the search seems to be drawn to subregions of S which
map on to similar values of F¯ ≈ 0.5 (Figure 6.6(a)). The average population’s fitness is
also converging towards that value; hence the members of the population are becom-
ing more similar, and little new information would be gained by increasing the number
of generations, since the selection operation becomes redundant in an increasingly ho-
mogeneous population. (A large mutation step size could re-introduce diversity in the
population, however, since the lognormal distribution is biased towards small muta-
tions, such a step size has a very low probability, and would generally require many
more generations to appear.) Two strategies are thus attempted to encourage further
exploration of the search space; first, a lower selection pressure, PS =
λ
µ =
20
7 ≈ 3, is
used, to allow more parents (7) to survive to reproduce; second, a higher population
λ = 50 is tried, to allow a more diverse population to be considered for selection.
In Figures 6.7(a)–(b) the results from choosing PS ≈ 3 are shown. As intended, the
rather low selection pressure keeps the average fitness of the population from converg-
ing (Figure 6.7(a)). The error is improved (from ≈ 0.046 to ≈ 0.035), but as the im-
provement is not a drastic one, it is hard to conclude that the lower selection pressure
improves the search, because the random elements involved in the algorithm make
small variations inevitable across independent searches. It can however be concluded
that the lower selection pressure does not solve the problem of finding global mini-
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Figure 6.6: Searching in S2G ⊂ R2 for the nominal values of the GSA Top 2, using the
search parameters λ = 20, G = 40, and PS = 7. (a) The best and the average F¯i in
each generation. (b) The errors associated with the estimates, calculated using equation
(6.15). (c) The fits obtained with the best individual. The pseudo-data and solution are
almost indistinguishable, even though the estimates are considerably different (≈ 25 ) of
the nominal values.
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Subspace λ PS G F¯
S2G 20 7 40 0.045592
S2G 20 3 40 0.035251
S2G 20 3 100 0.031787
S2G 50 7 40 0.012738
S2G 50 5 40 6.813200× 10−3
S2L 50 7 40 9.444200× 10−5
S4G 50 7 100 0.016938
S4G 50 5 100 0.026576
S4L 50 7 100 1.490000× 10−3
S10G 50 7 100 0.125090
S10G 50 7 300 0.070371
S10G 50 5 100 0.155420
S10G * 50 5 100 0.446665
S10L 50 7 100 0.307190
S10L 50 7 200 0.198360
Table 6.4.3: A summary of the optimisation results for the trial runs with the pseudo-
data. *This solution was found fitting to the noisy pseudodata.
mum’s vicinity, as the errors of the estimates in this run are even larger, at 97.4% and
103% (Figure 6.7(b)). (Another run that allowed 100 generations was also carried out,
but did not significantly improve the solution, giving a value of F¯ ≈ 0.032.)
Figures 6.7(c)–(d) show the results of increasing the population size to λ = 50 (PS =
7). The best solution is found in the first generation and is never improved thereafter
(Figure 6.7(c)). In this case, SRES does not improve the best initial trial solution, whose
fitness is high due to chance, helped by the large sample. The larger population size
does not guide the search beyond subregions where F¯ ≈ 0.4 (Figure 6.7(c)). However,
the fact that an average population F¯ value of greater than 100 is possible (Figure 6.7(c)),
means that there are regions of space with high F¯ values; the SRES algorithm does well
to steer away from those regions, but in low F¯ subregions it seems indiscriminate.
A combination of both diversity-promoting strategies is also tried by choosing λ =
50 and PS = 5, the results of which are shown in Figures 6.7(e) – (f). This run produces
the best solution, finding an individual which gives F¯ ≈ 0.0068, but the estimates are
still not very close (41.4% error for parameter 1 and 42.7% for parameter 2). It should
be noted that these strategies are elaborate schemes for the estimation of only two pa-
rameters, an indication of how difficult the optimisation problem might be. However,
an indication of why it is difficult can be gained; since the search space here is in R2,
the objective function surface can be visualised (this is done at the end of this section,
after all the optimisation runs have been implemented).
So far the searches have found several solutions with low F¯ values (see Table 6.4.3
for a summary of the results from all previous (and subsequent) searches), suggesting
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Figure 6.7: Searching in S2G ⊂ R2 for the nominal values of the GSA Top 2; search param-
eters (specified at the top of each row) are varied to promote population diversity. (a),
(c), (e) The best and the average F¯i in each generation; (b), (d), (f) the errors associated
with the estimates, calculated using equation (6.15). Decreasing the selection pressure
seems to improve the solutions.
143
CHAPTER 6: PARAMETER OPTIMISATION
that there are flat regions on the objective function surface not too far from the mini-
mum (as two of the runs found estimates with 41− 48% error (see Figures 6.7(d) and
(f)). To gain perspective on how the topology of F¯ influences the performance of the
search, the LSA Top 2, p2 and kCa2+act+, are now estimated, while all the other param-
eters are fixed at their nominal values. The search is thus carried out in a subspace in
which the LSA Top 2 serve as the independent axes, namely, S2L ⊂ R2 (the L subscript
indicates that the LSA Top 2 serve as the independent axes). Because the LSA Top 2 are
the locally most sensitive parameters, around x∗ the objective function surface is steep-
est along the axes of this hyperplane. Hence, it can be observed whether the selection
step performs better on a less flat region. This might also give an indication of whether
the locally sensitive parameters have to be correctly estimated to achieve a good fit.
Searching in S2L
This search is carried out with the higher population size λ = 50 and higher selection
pressure PS = 7, while G = 40. Figure 6.8(c) shows that for this estimation prob-
lem, SRES does perform considerably better, finding estimates for the LSA Top 2 with
very small percentage error: −0.35% and ≈ 0.73%. The best solution gives a value of
F¯ = 9.4442× 10−5 (Figure 6.8(a)), orders of magnitude lower than was found with the
best estimates of the GSA Top two; consequently, the simulations fit the pseudo data
extremely well (Figure 6.8(d)). The average population fitness does not converge (it
actually significantly fluctuates) towards the end of the search (see Figure 6.8(b)); this
means that the selection step continues to provide information that directs the search
(in fact, the majority of progress is made towards the latter half of the search, after G=23
(see Figure 6.8(b)).
Visualising F¯
The surfaces of F¯ in S2G and S
2
L are compared in Figure 6.9. In both subspaces there are
regions of high and low F¯ values (compare Figures 6.9(a) and 6.9(b)). Viewing the axes
on log scales allows the low F¯-value regions to be seen in more detail: the nominal
values of the GSA Top 2, (16.5s−1, 1012M−1s−1), form the only minimum in S2G (Figure
6.9(c)), while in S2L there are other (high fitness) minima besides that formed by the
nominal values (Figure 6.9(d)). This shows that even the LSA Top 2 do not need to be
correctly estimated to achieve an acceptable fit.
The colour maps of Figures 6.9(c) and (d) are defined using a log scale, so that the
low valued regions can be better observed. Both surfaces have valleys containing low
value solutions (coloured dark and light blue, for F¯ ≤ 100). All previous solutions
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Figure 6.8: Searching in S2L ⊂ R2 for the nominal values of the LSA Top 2, using the
search parameters λ = 50, G = 40, and PS = 7. (Note that the parameter labels are
as in Table 6.4.2.) (a) The value of F¯i for the best individual found in a generation. (b)
The average F¯i of the whole population. (d) The errors associated with the estimates,
calculated using equation (6.15). (d) The fits obtained with the best individual. The
pseudo-data and solution are indistinguishable, and, unlike when searches were carried
out S2G, the parameter estimates are very close to the nominal values.
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Figure 6.9: F¯ is shown in (a) S2G, and (b) S
2
L. In (c) and (d), the same plots are shown using
log axes; it might be inferred that optimal step sizes are hard (or require more time) to
find in S2G because of its flat valley; on the other hand the multiple minima in S
2
L allow
more step size information to be gained because of the more significant changes when
travelling along its valley.
found in S2G lie in its flat diagonal valley, where the global minimum, x
∗, also lies.
S2L also contains a curved valley which is littered with local minima. It can thus be
understood that, because of its gradual descent, a variety of step sizes along S2G’s valley
might survive the selection step, while in S2L’s valley, many would be rejected because
they more significantly change the F¯ value (by jumping in and out of minima). This
seems to be the reason that SRES performs better in S2L.
The comparison of searches in these low-dimensional subspaces gives an indication
of the performance of SRES. It is able to escape higher valued regions of F¯, even when
they occupy the majority of the search space (see Figures 6.9(c) and (d), where all so-
lutions found were in the low-valued regions). Also, flatness of the objective function
surface seems to be a harder problem for SRES than multi-modality. This also illus-
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trates the importance of including more than a handful of parameters from the GSA
Top ranks, when reducing the dimensions of the search space; as the GSA results pin-
point parameters that are most sensitive on average across space, the rankings are not
necessarily representative of each individual point in space, including the global mini-
mum, x∗. Hence, the most locally sensitive parameters may not be represented if only
a few are chosen for estimation, causing flatness in F¯ around x∗.
6.4.6 Estimating four parameters
In this section, the search is carried out in the hyperplane S4G ⊂ R4 for the nominal
values of the GSA Top 4, namely, kCa2+act−, kPIP2b+, kIP3Rb− and p1 (with all other pa-
rameter values fixed); for comparison, S4L is later searched for the nominal values of the
LSA Top 4. The larger population size, λ = 50 is used and the initial selection pressure
is given by PS = 7, while the search is carried out for longer (G = 100) because more
time might be needed to better explore a higher-dimensional space.
The parameter estimates found in this run have percentage errors of −70%, 25%,
75% and 250%, as shown in Figure 6.10(b), and yield a value of F¯ = 0.016938 (Figure
6.10(a)). As in the previous section, a very close fit to the pseudo-data is obtained with
these estimates, even though three of them are not very close to the nominal values.
It seems that the surface of F¯ in this subspace is similar to a 4-dimensional version
of that in Figure 6.9(c), with substantial flat regions, possibly in a long hypervalley.
The average population fitness progressively decreases to a value of F¯ ≈ 0.4 (Figure
6.10(a)), indicating that individuals are becoming more alike, since the lowest F¯ per
generation also converges to around the same value. The selection step is practically
redundant in a homogeneous population, and so it does not seem that increasing the
number of generations (except drastically) would improve the search.
Without increasing the number of function evaluations, population diversity (a
more thorough exploration of space) is encouraged by using a lower selection pres-
sure, PS = 5, which allows 10 parents, instead of 7, to survive for reproduction. Figure
6.11 shows that this scheme does not provide a better solution, with F¯ = 0.026576 (Fig-
ure 6.11(a)), and the errors in the estimates still significant (see Figure 6.11(b)). This is
perhaps unsurprising, since a similar scheme in the lower dimensional S2G did not make
any improvements.
Searching in S4L
The search is now carried out in S4L, for the nominal values of the LSA Top 4, namely,
p2, kCa2+act+, kGTP+, kIP3Rb+ (with all other parameters fixed at their true values). The
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Figure 6.10: Searching in S4G ⊂ R4 for the nominal values of the GSA Top 4, using the
search parameters λ = 50, G = 100, and PS = 7. (a) The best and the average F¯i in
each generation. (b) The errors associated with the estimates, calculated using equation
(6.15). (c) The fits obtained with the best individual. As when the search was carried
out in S2G, the pseudo-data and solution are almost indistinguishable, even though the
estimates are considerably different to the nominal values.
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Figure 6.11: Searching in S4G ⊂ R4 for the nominal values of the GSA Top 4, using the
search parameters λ = 50, G = 100, but with a lower selection pressure PS = 5 than
in Figure 6.10. (a) The best and the average F¯i in each generation. The lower selection
pressure does not improve on the solution in Figure 6.10. (b) The errors associated with
the estimates, calculated using equation (6.15).
search parameters are set to λ = 50, G = 100 and PS = 7. The results of the search
are shown in Figures 6.12(a)–(c). The best solution gives fits that are virtually indis-
tinguishable from the pseudo-data (Figure 6.12(c)), with an error F¯ = 1.49× 10−3 (see
Figure 6.12(a)); this F¯ value is only about one order of magnitude greater than the so-
lution in S2L, which was extremely close to the global minimum (F¯ = 9.4442 × 10−5).
However, in this case, the errors associated with parameters 2 and 3 are rather high
(−68.1%, 369% respectively, see Figure 6.12(b)), indicating that the solution is some dis-
tance from the global minimum. This illustrates that in S4L (as in S
2
L, where the function
surface was actually visualised, low error estimates are not required to achieve a good
fit. In other words, despite the fact that all other parameters are fixed at their nominal
values, there are combinations of the LSA Top 4, apart from that of the nominal values,
which give low F¯ values. (An independent run was carried out which found a different
solution that also had a low F¯ value, given by 3.4459× 10−3.)
6.4.7 Estimating ten parameters
The search is now carried out in S10G ⊂ R10 for the nominal values of the GSA Top
10; recall that this is the main optimisation problem. For comparison, S10L will then
be searched for the nominal values of the LSA Top 10. With search parameters that
seemed thorough, the true solutions were not found in the lower dimension hyper-
planes, S2G, S
4
G and S
4
L, therefore, the true solutions are not expected to be found in (the
higher dimensional) S10G and S
10
L . However, it is still informative to analyse the nature of
solutions that will be found. Initially, the search parameters are set as λ = 50, G = 100
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Figure 6.12: Searching in S4L ⊂ R4 for the nominal values of the LSA Top 4, using the
search parameters specified at the top of the rows. (a) The best and the average F¯i in
each generation. (b) The errors associated with the estimates, calculated using equation
(6.15). (c) The fits obtained with the best individual. As when the search was carried
out in S2G, the pseudo-data and solution are almost indistinguishable, even though the
estimates are considerably different from the nominal values.
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and PS = 7.
The best solution found gives F¯ = 0.12509 (see Figure 6.13(a)); searches in the 2-
dimensional subspace, S2G, found solutions with values as low as F¯ = 0.0068132, but
F¯ = 0.12509 still yields close fits (Figure 6.13(d)), since it gives an average squared error
per data point of ≈ 0.00046. In this run, six of the ten parameters are estimated with
> 500% error (Figure 6.13(c)), so the solution is quite far from the global minimum. For
the most part, the population’s average F¯ value hovers around 30, and does not show
convergence. Hence, the selection step has not necessarily become redundant, and the
search might be improved by allowing more generations. This might also be necessary
because this is a higher dimensional subspace that needs more time to be thoroughly
explored.
Figure 6.14 shows the results of carrying out the search with G = 300 (PS = 7).
Although the solution is better, with F¯ = 0.070371, this is not due to the increase in
G, as the solution was found in the 14th generation, so nothing has been gained by
increasing the number of generations from G = 100. At G = 300, the selection step has
not necessarily become redundant, since the average F¯ (≈ 22) is still much higher than
the lowest F¯ (≈ 2) (compare Figures 6.14(a) and 6.14(b)); the search might thus improve
with more generations, but would get computationally expensive, since this run took
181.51 hours (7.56 days), while the G = 100 search only took 13.72 hours (0.57 days).
Like the previous solution, these estimates also have generally high percentage errors
(6 estimates have > 500% error), meaning that the solution is again far from the global
minimum.
To promote further exploration of space, a higher population size, λ = 100, as well
as a lower selection pressure, PS = 5, are tried, allowing 20 parents to survive for
reproduction in each generation. The results are displayed in Figures 6.15(a)–(c), from
which it can be seen that the solution is not improved, because the best individual now
gives F¯ = 0.15542. Also, as when the population size was 50, the errors associated with
many of the parameters are large.
Searching in S10L
The search is now carried out in S10L for the nominal values of the LSA Top 10, using the
search parameters λ = 50, G = 100 and PS = 7. The best solution has F¯ = 0.30719, as
shown in Figure 6.16(a); compared to the initial search in S10G (see Figure 6.13(a), where
F¯ = 0.12509), the fits are visibly worse (Figure 6.16(d)). The large percentage errors
associated with some of the estimates (Figure 6.16(c)), indicate that the solution is far
from the global minimum. The fact that the solution found in S10G is considerably better
than that found in S10L might be due to the fact that there is more global sensitivity
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Figure 6.13: Searching in S10G ⊂ R10 for the nominal values of the GSA Top 10, using the
search parameters λ = 50, G = 100. (a) The value of F¯i for the best individual found
in a generation. (b) The average F¯i of the whole population. (c) The errors associated
with the estimates, calculated using equation (6.15). (d) The fits obtained with the best
individual. As previously seen, the fits are very close to the pseudo-data, even though
the estimates are considerably different from the nominal parameter values.
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Figure 6.14: Searching in S10G ⊂ R10 for the nominal values of the GSA Top 10, using
the search parameters specified at the top of the rows. (a) The value of F¯i for the best
individual found in a generation. (b) The average F¯i of the whole population. (c) The
errors associated with the estimates, calculated using equation (6.15).
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Figure 6.15: Searching in S10G ⊂ R10 for the nominal values of the LSA Top 10, using the
search parameters specified at the top of the rows. (a), (a) The value of F¯i for the best
individual found in a generation. (b), (b) The average F¯i of the whole population. (c), (c)
The errors associated with the estimates, calculated using equation (6.15).
information in S10G to guide the search (recall that the LSA Top 10 includes only seven
parameters from the GSA Top 10 (see Figure 6.5)).
The fact that the lowest and average F¯ values do not converge (compare Figures
6.16(a) and (b)) might mean that the selection step has not necessarily become redun-
dant, and that a better solution might be found with more generations; however, it has
previously been seen in S10G that 300 generations were not sufficient to allow this, and
that beyond this the search starts to be computationally unaffordable. Hence, a smaller
value of G = 200 was tried in S10L , which resulted in a better F¯ value of 0.19836, but this
was found just outside G = 100, at G = 108; in addition, a close value of F¯ = 0.2017
had already been found at G = 41 (results not shown). The computational time for this
scheme was 54.94 hrs (2.29 days).
Testing the effects of noise
A search is now carried out in S10G , but using Y˜
n
k,l (equation (6.13)) in equation (6.12) to
measure the sum of the squared deviations from the noisy version of the pseudo-data.
The concern is what quality of fit will be obtained when the data are noisy, not how
well the global minimum will be estimated, since the previous runs with the noiseless
pseudo-data generally did not result in good estimates (though they produced good
fits).
Figure 6.17 shows that the overall results are similar to those obtained with the
noise-less pseudo-data. Figure 6.17(d) shows that a good fit is obtained; and as would
be expected, based on the previous runs, the errors in the estimates are large (Figure
6.17(c)). The best solution’s F¯ value, at 0.44665, is higher than those found with the
noiseless pseudo-data, which is unsurprising, as the squared deviations generally in-
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Figure 6.16: Searching in S10L ⊂ R10 for the nominal values of the LSA Top 10, using the
search parameters λ = 50, G = 100, PS = 7. (a) The value of F¯i for the best individual
found in a generation. (b) The average F¯i of the whole population. (c) The errors as-
sociated with the estimates, calculated using equation (6.15). (d) The fits obtained with
the best individual. As previously seen, the fits are very close to the pseudo-data, even
though the estimates are considerably different from the nominal parameter values. This
occurs despite the fact that these are the locally most sensitive parameters.
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crease because of the noise.
The addition of noise therefore, does not noticeably worsen the fits. This means that
when fitting to the experimental data, a quality of fit can be expected, which is similar
to one that would be obtained using clean data.
6.4.8 Parameter uncertainty
The errors that accompany many of the estimates have generally been large. These are
examples of a phenomenon that has been referred to as ’sloppiness of parameter sen-
sitivities’. A study on seventeen systems biology models revealed that in each, there
were a few parameter combinations towhich themodel behaviour was sensitive (called
’stiff directions’), but that there were many more parameter combinations (’sloppy di-
rections’) over which huge changes could occur without significantly altering the re-
sponse. Thus, even with a comprehensive set of data, most parameter estimates had
large errors (uncertainties ranged from a factor of 50 up to around 1,000,000) [29]. This
section has shown that the Ca2+ model is similar, as the qualities of fit have been good,
even while the parameter estimates, have been poorly constrained.
A more recent study showed that, by carefully choosing the combination of ex-
periments so that they provide complementary information, parameters can be well
estimated [3]. The problem was posed as finding the subset of all possible experi-
ments, which though individually characterised by sloppy directions/sensitivities, col-
lectively combine to form stiff directions. Hence, comprehensive data are not necessar-
ily key to correct estimation, and a data set that might be much smaller, but provide
complementary information may be more important. The authors were able to use data
from only five experiments (knockdown, overexpression and single and two drug stim-
ulation) to estimate 48 parameters of a signalling model to 10% accuracy. Hence, a
similar process of computational (and actual) experimental design may be needed to
accurately estimate the parameters of the Ca2+-mobilisation model.
Another approach might be to use, togetherwith a comprehensive pseudo-data set,
very large SRES search parameters, similar to λ = 350 and G = 8000, as successfully
used in [60]. Even though parameter sloppiness causes flatness on the objective func-
tion surface, such large parameters might allow more time for the algorithm to adapt
to flat regions on the objective function surface, and to approach the global minimum.
Only pseudo-data for Ca2+ were generated here however, to reflect the available ex-
perimental Ca2+ data.
In summary, the trial runs for SRES indicate that the global minimum is not easily
found with a set of data for one model variable ([Ca2+]), but that comparably good
parameter sets (in terms of goodness of fit) will generally be found.
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Figure 6.17: Searching in S10G ⊂ R10 for the nominal values of the GSA Top 10, using the
search parameters λ = 50, G = 100, PS = 7. This case is different from those in Figures
6.13 and 6.14, because the noisy pseudo-data are used here. (a) The value of F¯i for the
best individual found in a generation. (b) The average F¯i of the whole population. (c)
The errors associated with the estimates, calculated using equation (6.15). (d) The fits
obtained with the best individual. The fits are close to the pseudo-data, even though the
estimates are considerably different from the nominal parameter values.
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6.5 Parameter estimation for experimental data
The parameters are now estimated by fitting to equation (6.2), the objective function (F)
which pertains to the experimental Ca2+ data. Recall that the data has been normalised
(see Figure 6.1), so that F is dimensionless. Note that the global minimum for this prob-
lem is not known, hence, there will be no way of knowing how good the estimates are;
however, the results of the previous section strongly suggest that the global minimum
will not be found.
6.5.1 Searching in S10G
In this section, the search is carried out in S10G , seeking optimal values for the GSA Top
10, while the other parameters are fixed at their nominal values. Based on the previous
section’s results, the search parameters G = 100, λ = 50 and PS = 7 are used.
Figure 6.18 shows the results of the search. The best solution gives F = 20.794
(Figure 6.18(a)), and the resulting fits are shown in Figure 6.18(b). The fits obtained at
the four highest agonist concentrations, [L] = 10−7 − 10−4M, are good, while the fits
obtained for [L] = 10−11M and [L] = 10−10M are good but trivial, because, to these
concentrations, there is no essentially no response. At [L] = 10−9M and [L] = 10−8M
the fits are poor; the times-to-peak are considerably slower in the simulations, and the
peaks considerably lower. Towards the end of the search, the average F seems to be
converging towards around the same value as the lowest F (Figure 6.18(a)). This indi-
cates that in the last stages, the population is becoming increasingly homogeneous, so
that the selection step is getting redundant. Thus, increasing the number of generations
might not yield a better solution; the population size is increased instead, to promote
diversity.
A population size, λ = 100, is tried, together with a selection pressure, PS = 7.
Figure 6.19(a) shows that the best solution found in this run has F = 21.381, which is
slightly higher than was found in the previous run, hence no improvement has been
made by increasing the population size from λ = 50; the fits from both runs are of a
similar quality: good for the higher agonist concentrations, but not when [L] = 10−9M
and [L] = 10−8M (compare Figures 6.19(b) and Figure 6.18(b)).
If the model is a very close reflection of the actual Ca2+ system, good fits to the ex-
perimental data should have been obtained for all agonist concentrations, as in the trial
runs with the pseudo-data. SRES was good at converging to low-valued regions in F¯,
so there are probably no values much lower than the F = 20.794 and F = 21.381 values
found here. It is therefore possible that the Ca2+ model, though detailed, requires some
extension. There is also the possibility that more appropriate parameter ranges should
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Figure 6.18: Searching in S10G ⊂ R10 for values of the GSA Top 10 that give good fits to
the experimental data, using the search parameters λ = 50, G = 100, PS = 7. This case is
different from those in Figures 6.13, 6.14 and 6.17, because actual experimental data are
used here. (a) The best and the average Fi for each generation. (b) The fits obtained with
the best individual.
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Figure 6.19: Searching in S10G ⊂ R10 optimal values of the GSA Top 10 that give good fits
to the experimental data, using the search parameters G = 100, PS = 7, and an increased
population size λ = 100 (compare with Figure 6.18, where λ = 50). (a) The best and the
average Fi for each generation. (b) The fits obtained with the best individual, which are
similar to those found with λ = 50 (compare Figure 6.18(b)), good at the higher agonist
concentrations, but not at [L] = 10−9M and [L] = 10−8M.
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be used in the search (which could contain significantly lower values of F). However,
there are no clear indicators of what those would be. Before making such conclusions
however, section 6.5.2 will check that the reduction of parameter space does not have
an adverse effect on the fit.
Local sensitivity of F
A local sensitivity analysis is now carried out at the two solution points found in S10G
(henceforth referred to as x10λ50 and x
10
λ100
, where the superscript a indicates the dimension
of the subspace in which the solution was found, and the subscript λb indicates that a
population size of b was used). Since some of the fits could do with improvement,
the LSA can identify sensitive points in the pathway which might pertain to processes
whose modelling should be revisited, should the model require extension.
Sensitivity coefficients are calculated using the following:
Cj =
(F(xbλa + 0δj)− F(xbλa))/F(x)
δj/x
b
λa,j
, (6.16)
where 0δj is an n-dimensional vector of zeros, but with its jth element equal to δj, and
xbλa,j is the jth estimated parameter. δj will be calculated as ±0.1xbλa,j and ±0.5xbλa,j. The
larger the value of |Cj|, the greater the sensitivity of F to that parameter; in particular,
|Cj| > 1 indicates a bigger relative change in F than in the parameter.
Figures 6.20(a) and 6.20(b) show the results of the sensitivity analysis. Each 4-
bar group represents the sensitivity coefficients for parameter perturbations of −50%,
−10%, +10%, +50% consecutively. Most of the parameters have at least one relatively
significant sensitivity coefficient (defined as |Cj| ≥ 1), except 5:kIP3Rb+, 8:kdeact, and
10:RTOT, when perturbed from x
10
λ100
(see Figure 6.20(b)). Among the significant param-
eters, the ones that do not just pertain to simple binding or unbinding, but to processes
that could be more extensively modelled are: 2:kPIP2b+, 7:[PIP2], 6:kdes+ and 9:p2. The
simplifying assumptions underlying the modelling of these processes, and ways in
which it can be revisited, will be discussed later in section 6.6. Before that, it is impor-
tant to check that there are no better solutions in the full search space that would be
missed by searching in the reduced space.
6.5.2 Searching in the full search space
The search is now carried out in the full search space, S ⊂ R40, for optimal values of all
40 parameters originally included in Chapter 4’s global sensitivity analysis (see Table
C.4.1); as previously stated, this is done to understand how well the search space S10G
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Figure 6.20: Sensitivity coefficients calculated (using equation 6.16) at the best three pa-
rameters sets found by SRES when fitting to the experimental data. (a) x10λ50 , (b) x
10
λ100
, (c)
x40λ100 . Several of the same parameters are sensitive at all three points, including 2:kPIP2b+,
7:[PIP2], and 9:p2.
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substitutes the full search space. The results are then compared with those obtained in
the previous section.
Figure 6.21 shows the results of the search. The best solution (referred to as x40λ100)
gives an F value of 21.824 (Figure 6.21(a)), slightly higher than those found by search-
ing in S10G . Hence, the fit is still not good at the lower ligand concentrations. Unlike
the previous search, however, the average population is not converging towards the
lowest F value (compare Figures 6.21(a) and (b)), implying that the selection step is not
necessarily redundant, and that improvements could possibly be made by increasing
the number of generations. However, the computational cost of searching in S can be
prohibitive; the search took 231.9 hours, an average of 10.4355s per model evaluation,
compared to 18.09 hours in S10G , which is an average of only 1.6282s per model evalua-
tion. It should also be noted that in the trial runs, increasing the number of generations
never improved the results (see sections 6.4.5 and 6.4.7).
The three solutions sets, x10λ50 , x
10
λ100
, and x40λ100 produce similar fits, but it is not neces-
sarily because the parameters are all similar to each other. Figure 6.22 plots each xaλb,j,
normalised to the maximum from {x10λ50 ,j, x10λ100,j, x40λ100,j}; therefore at least one xaλb,j will
have a value of 1. If the other two values are close to 1, then the estimates are similar;
if either or both of the two other values are << 1, then there is notable dissimilarity
across the estimates. Parameters 2, 4, 7 and 10 each take values as low as ≈ 0.1, with
parameter 10 getting as low as ≈ 0.001, so their values in each solution can take values
that differ up to 3 orders of magnitude. (The absolute values are given in Table C.4.1.)
’Parameter sloppiness’ is thus exhibited across the solution sets, as would have been
expected, based on the trial runs, which showed that parameter sets that were rather
different from the true solution could give very similar predictions.
It is clear that it is reasonable to search in S10G , in place of S, since the quality of the
fits found in both spaces are very similar; in other words, it is very reasonable to focus
on the GSA Top 10, and this constitutes a significant simplification of the analysis. It
should be noted however, that the success of a GSA-informed reduction of parameter
space likely depends on howwell the output features defined for the GSA represent the
overall output. It seems that this chapter’s parameter space reduction was successful
because the Ca2+ Peak-over-Basal, Ca2+ Time-to-Peak, Ca2+ Transient-Peak and Left-
Shift, as defined for the GSA in Chapter 4, constitute a suitable representation of the
overall Ca2+ response (as was intended when they were selected).
Local sensitivity of F
Using equation (6.16), sensitivity coefficients are also calculated for the parameter set
obtained in the full search space and the results are shown in Figure 6.20(c). Chapter
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Figure 6.21: Searching in the full search space, S ⊂ R40, for values that give good fits
to the experimental data, using the search parameters λ = 100, G = 100, PS = 7. (a)
The value of F¯i for the best individual found in a generation. (b) The average F¯i value of
the whole population. (c) The fits obtained with the best individual, are very similar to
those found searching in S10G (compare Figures 6.18(b) and 6.19(b)). The fits are good at
the higher agonist concentrations, but not at [L] = 10−9M and [L] = 10−8M.
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Figure 6.22: Each parameter from each solution set, xaλb,j
, normalised to the maximum
from {x10λ50,j, x10λ100,j, x40λ100,j} is shown. Some parameters range between one and < 0.1,
illustrating that they can take on a wide range of values.
4 showed that there are many parameters to which the Ca2+ response is insensitive, so
such parameters will have very small coefficients; the bottom 15 parameters in Table
C.4.1 (where the GSA rankings are shown) thus have insignificant coefficients, and are
not shown in Figure 6.20(c). The parameters are arranged according to their sensitivity
ranking (see Table C.4.1), so the first 10 parameters correspond to the GSA Top 10.
In this case, a relatively significant coefficient is defined as |Cj| ≥ 10. Other param-
eters outside the GSA Top 10 show relatively significant sensitivity, including 11:kdes−,
13:kGTP+, 14:kCa2+act+, and 25:GTOT. Of the parameters that have significant sensitivity
coefficients, the ones that pertain to processes that can be more extensively modelled
are 2:kPIP2b+, 7:[PIP2], 9:p2, and 11:kdes−. These are consistent with those identified by
the LSA carried out at x10λ50 and x
10
λ100
(see section 6.5.1). Potential ways to revisit the
modelling of those processes are discussed in the next section.
6.6 Potential model extensions
It was previously mentioned that some parameters identified as locally sensitive at the
three solution points (x10λ50 , x
10
λ100
, and x40λ100) pertain to processes that can be modelled
more extensively. Those parameters are 2:kPIP2b+, 6:kdes+, 7:[PIP2], 9:p2, and 11:kdes−.
7:[PIP2] and its rate constant of binding, 2:kPIP2b+, serve essentially the same func-
tion in reaction (3.6), since [PIP2] is assumed constant. The modelling of [PIP2] dynam-
ics has already been considered in Chapter 4; there, a simplified cycle of PIP2 depletion
and replenishment was incorporated, but did not significantly improve the predicted
Ca2+ response. It therefore does not seem that the cycle needs to be further described,
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especially since significant PIP2 depletion would typically occur only for strong ago-
nist stimulation, and the model already reflects those cases well (see Figures 6.18, 6.19,
6.21).
9:p2, which shows very high sensitivity in x
40
λ100
(see Figure 6.20(c)), pertains to the
Hill function that models the SERCA pump dynamics in the Ca2+ ODE, reproduced
below:
d[Ca2+]
dt
= (1+ νr)(γ0 + γ1[IP3 IP3RCa
2+])(Ca2+AV − [Ca2+])−
p1[Ca
2+]2
[Ca2+]2 + p22
. (6.17)
Equation 6.17 is a simple representation of processes that might be modelled in
more detail, since the SERCA pump actually undergoes a multi-step reaction cycle (in-
volving association and dissociation from Ca2+, and phosphorylation) [22]; indeed,
a realistic representation of the reaction scheme can include up to twelve states [28].
Other models have also described the pump with terms that account for modulation
of the pumping rate by the concentration of Ca2+ in the ER [95]. As the pump plays a
central role in the removal of cytosolic Ca2+, it can influence the steepness of the Ca2+
descent from peak. Hence, modelling its dynamics in more detail might enable better
reflection of the data at the lower agonist concentrations, where the descent needs to
be steeper to fit the data (see Figures 6.18(b), 6.19(b) and 6.20(c)).
6:kdes+ and 11:kdes− pertain to receptor desensitisation, which is an intricate set of
PKC-mediated processes which, in the Ca2+ mobilisation model, has been minimally
represented, for the sake of simplicity, as follows:
R∗G
kdes+−−⇀
↽−−
kdes−
R∗desG (6.18)
LR∗G
ρ+kdes+−−⇀
↽−−
ρ−kdes−
LR∗desG. (6.19)
There is definitelymore scope for re-modelling here, since the desensitisationmech-
anisms are not definitely understood. M3 receptors can also be desensitised as a result
of being phosphorylated by G-protein receptor kinases (GRKs), after which the binding
of Arrestin to the phosphorylated receptors inhibits further G-protein-receptor interac-
tion. Alternatively, some GRKs can directly inhibit signalling without phosphorylating
the receptor, possibly via binding to αGTP (or βγ) to inhibit phospholipase C activity,
and consequently, Ca2+ mobilisation [105]. These are all mechanisms that can be incor-
porated into the Ca2+ model and investigated. As desensitisation affects the lifetime
of the active GPCR’s, and consequently, the stimulus for Ca2+ release, these mecha-
166
CHAPTER 6: PARAMETER OPTIMISATION
nisms are promising extensions to the Ca2+ model that could improve the time course
predictions at the lower agonist concentrations.
6.7 Discussion
This chapter first tested the performance of the evolutionary algorithm, SRES, in find-
ing known global minima of a minimisation problem for the Ca2+ mobilisation model.
It was seen that, with computationally moderate optimisation parameters (λ, G), high
quality fits were obtained, but not good parameter estimates. This corresponds with
findings that systems biology models can have many ’sloppy parameter sensitivities’
such that several parameters values can vary widely without significantly altering the
response [29]. The presence of many high quality solutions can thus make the SRES al-
gorithm indiscriminate in choosing which individuals survive the selection step. Even
in a two-dimensional search space, the global minimum could not be found when the
combination of parameters formed a sloppy direction (GSA Top 2); when the search
was carried out along a less sloppy direction (LSA Top 2), a solution very close to the
global minimum was found. Promoting diversity in the population by increasing the
population size (λ) or decreasing the selection pressure (PS) did not generally cause
significant improvements.
It is possible that even higher SRES parameter values, such as λ = 350 and G =
8000 (used in a previous study [60]), can furnish the algorithm with more time and
information to adapt to the topology of the objective function surface, and allow con-
vergence to the vicinity of the global minimum (with respect to the pseudodata). The
computational expense of such a scheme would be considerable, and might need to
be carried out using programming languages, such as Fortran and C, which can be at
least an order of magnitude faster than MATLAB [60], which was used for this chap-
ter. Also, parallel computing, which exploits the availability of multiple processors in a
computing unit [7], would allow individual members of the population to be assessed
concurrently (instead of sequentially) per generation, and thus significantly reduce the
computation time, allowing more elaborate search parameters (high population sizes
and number of generations) to be used.
Sensitivity analysis and parameter estimation
The results of a global parameter sensitivity analysis (GSA) were used to reduce the
dimensions of the search space from 40 to 10. This significantly simplified the op-
timisation problem by reducing the computational expense, as a smaller population
size can be used in the smaller subspace (S10G ); in addition, the average time per model
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evaluation was much lower, presumably because the probability of extreme parameter
combinations is lower with only 10 parameters. When the model was fit to the experi-
mental data, a very similar quality of fit was obtained by searching in S10G , as in the full
space. The power of a global sensitivity analysis to simplify the analysis of complex
models such as the Ca2+ mobilisation model has thus been demonstrated. However,
it should be stressed, again, that this likely depends on how well the output features
defined for the GSA represent the overall output.
Possible model extensions
The trial runs in which SRES was used to fit the pseudo-data showed that SRES easily
finds, not the global minimum, but solution parameter sets which cause similar Ca2+
time course predictions. It thus seems reasonable that predictions of the global mini-
mum of F would not be very different from those of the three solutions that produced
the best fit to the experimental data. For all three solutions, good quality fits to the ex-
perimental Ca2+ data were only obtained for the higher agonist concentrations. If those
data were the only ones available, it would have been easy to conclude that the model
was sufficient, however the inability to fit the data at the lower agonist concentrations
suggests otherwise. (This highlights the importance of having significant amounts of
experimental data.) Thus, as comprehensive as the Ca2+ mobilisation model is, and
successful at predicting key features like the rapid time-to-peak, the transient peak and
signal amplification, it still lacks some mechanistic detail.
The local sensitivity analysis results in Figure 6.20 point to possible aspects of the
model which may be adapted. The dynamics of [PIP2], SERCA and GPCR desensi-
tisation were all highlighted as processes that can be modelled in more detail. Since
[PIP2] dynamics were already minimally modelled in Chapter 5, without significantly
altering the predictions of the model, the most promising model extensions should be
those applied to SERCA and GPCR desensitisation mechanisms.
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Conclusion
The main aim of this thesis was to assemble a detailed kinetic model of GPCR medi-
ated Ca2+ mobilisation in the M3 muscarinic receptor system, and, guided by available
data, to gain further insight into the pathway dynamics. Such insight could be used to
improve existing therapies for disease conditions associated with abnormal Ca2+ sig-
nalling, and new therapies could be developed based on the improved understanding
of the pathway.
As a first step in the construction of the comprehensive model, a base G-protein
activation model (the cTCAM) [86] was first analysed in Chapter 2. The total G-protein
(GTOT) and receptor concentrations (RTOT) were varied, based on results from a sensi-
tivity analysis [41] that identified them as key controlling parameters with respect to
the G-protein response. It was seen that increasing RTOT and GTOT can enhance ago-
nist stimulation, increasing G-protein activation but altering the qualitative nature of
the response; in particular, removing the transient peak. It was also shown that ago-
nist stimulated G-protein activation was more enhanced by G-protein overexpression
than by receptor overexpression, due to the receptor’s ability to bind sequentially to
multiple G-proteins. Subsequent sensitivity analysis results on the full Ca2+ model
ranked the desensitisation rate constant (which is not included in the cTCAM) higher
than RTOT and GTOT (see Tables 4.5.1 and 6.4.1), which highlights a need for an exten-
sion to the cTCAM (and related G-protein activation models) that at least takes GPCR
desensitisation into account.
A novel use of the cTCAM was in the simulation of specific agonists used in stan-
dard pharmacological agonist stimulation experiments on the M3 muscarinic receptor
system [52, 54, 93]. This involved using recent experimental results [92] to adapt the
affinity and efficacy parameters for each drug. Simulated dose-response curves then
revealed partial agonism by the drugs for the G-protein response. Also in Chapter 2,
a variant of the cTCAM was used to explore the hypothesis that the G-protein’s sub-
units do not dissociate, and it was shown that the cTCAM (in which the subunits do
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dissociate) is equivalent to the variant, if re-association happens quickly; otherwise, ag-
onist efficacy was diminished. This led to the testable hypothesis that agonist efficacy
depends on fast subunit reassociation. The cTCAM with fast re-association was then
used throughout the thesis.
In Chapter 3, the cTCAM was extended into the Ca2+ mobilisation model, using
downstream details from an existing model [37]. Data-guided numerical simulation
and parameter variation were carried out on the model in an initial attempt to reflect
the key features of the data, namely, signal amplification, the rapid time-to-peak, and
the transient peak. The publication of new results from αGTPγS (a non-hydrolysable
analogue of αGTP) stimulation experiments allowed some cTCAM parameters to be
fine-tuned, and these were then used in the full Ca2+ model. To better reflect the data,
a parameter change that enabled agonists to bind preferably to the GPCR’s pre-coupled
state (over its uncoupled one) had to be made; this might suggest that agonist efficacy
depends on receptor pre-coupling.
In the same chapter, receptor desensitisation had to be incorporated into the Ca2+
model to predict the transient peak when signal amplification occurred. This further
suggests that G-protein activation models need to take receptor desensitisation into
account. However, signal amplification and the rapid Ca2+ time-to-peak could not be
predicted simultaneously, hinting that the underlying mechanisms were highly fine-
tuned. This seemed to be confirmed through a global sensitivity analysis carried out on
the model parameters in Chapter 4, which identified a change in kIP3 , the rate constant
for PIP2 hydrolysis, as the only measure which could single-handedly account for the
amplified, yet rapid Ca2+ response. A value of kIP3 = 50, 000s
−1 produced the desired
change, suggesting that PIP2 hydrolysis could be as quick as some of the fastest known
catalytic reactions.
The sensitivity analysis also revealed that agonist potency, as quantified by the ex-
tent to which the Ca2+ peak was raised over its basal value (see equation 4.20), was
mainly sensitive to six parameters, namely, the rate constant of PLC activation, the rate
constant for GPCR deactivation, the rate constant of IP3 degradation, the rate constant
of (PKC-mediated) GPCR desensitisation, the maximal rate of the SERCA pumps and
the PIP2 concentration. The last four parameters could exert a biphasic effect. Agonist
potency experiments were thus recommendedwhich involve experimentally intruding
on those processes, with the hypothesis that such experimental manoeuvres can cause
known agonists to act as antagonists. The results might also shed light on why known
agonists can sometimes fail in therapy.
Another use of the sensitivity analysis was the identification of relatively insignif-
icant parameters. The total concentration of Phospholipase C (PLC), the enzyme that
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hydrolyses PIP2 (via αGTPPLC
∗PIP2
kIP3−→ αGTPPLC∗ + IP3 + DAG ) was shown to
be one such parameter. Hence —even though the rate of PIP2 hydrolysis drives the
rapid, amplified response— underexpression or overexpression of the mediating en-
zyme does not significantly influence the response, implying that PLC may not be a
worthwhile drug target. This hypothesis could possibly be tested experimentally, since
there are commercially available PLC inhibitors [73, 90]. On the other hand, the concen-
tration of PLC’s substrate, PIP2, was one of the most sensitive parameters, suggesting
that PIP2 is a more promising drug target.
After the results of the sensitivity analysis were used to make parameter changes
throughwhich the model qualitatively resembled the data, attempts weremade to pro-
duce a tighter quantitative fit. In particular, the steepness of the Ca2+ descent from peak
(which represents the rate of Ca2+ removal) needed to reflect the data more closely. In
Chapter 5, the influence that the membrane Ca2+ ATP-ase might have on the rate of
Ca2+ removal was considered, by extending the Ca2+ mobilisation model. In another
extension, the assumption of constant [PIP2] was reconsidered —due its high sensitiv-
ity ranking from Chapter 4—by incorporating a simple cycle of [PIP2] depletion and
replenishment. Neither variant model significantly improved the predictions of the
Ca2+ response. Hence, it was concluded that neither the membrane Ca2+ ATPases nor
PIP2 dynamics in fact needed to be included in the model, and the job of improving
the quantitative fit was left to a global parameter optimisation, using the original Ca2+
mobilisation model, in Chapter 6.
An evolutionary algorithm, the Evolution Strategy using Stochastic ranking (SRES),
was used to tackle the parameter optimisation problem, by minimising a least squares
function representing the deviation of the model from the Ca2+ data. Global sensitiv-
ity analysis results were used to reduce the dimensionality of the parameter space by
focusing only on the ten most influential parameters and fixing the values of all oth-
ers. It was shown that solutions found in the reduced subspace produced a similar
fit to that found in the full search space, highlighting the role of a global sensitivity
analysis in simplifying the analysis of complex, multi-parameter models like the Ca2+
mobilisation model.
The best parameter sets found by SRES produced good quality fits to the Ca2+ data
at the four highest agonist concentrations; however, at [L] = 10−9M and [L] = 10−8M,
the fits were poor. In initial trial runs fitting ’pseudo-data’ generated from model sim-
ulation, SRES had been shown to find, not the known global minimum, but solutions
which fit the pseudo-data well; thus (apart from the possibility that more appropriate
ranges need to be defined) it seemedmost likely to conclude that no significantly better
fit to themodel can be found. A key result of that chapter, therefore, was that additional
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mechanistic detail needs to be incorporated into the model. Local sensitivity analy-
ses of the least squares function, at the three points in parameter space corresponding
to the best solution parameter sets, identified parameters related to the dynamics of
[PIP2], SERCA pumps and PKC-mediated GPCR desensitisation as influential; hence,
revisiting the modelling of these aspects might improve the response. The ubiquity
of these parameters in the top ranks of all sensitivity analyses carried out in this the-
sis (see sections 4.5.2, 6.4.2 and 6.6) pinpoints the processes they mediate as central in
Ca2+ signalling; hence, in addition to [PIP2] (see above), the SERCA pump and PKC
may also be counted as potentially good drug targets.
The importance of the SERCA pump function is supported by experimental find-
ings that reduction (or loss) of its expression are associated with colon and prostrate
cancer [61]. Such experimental findings provide extra motivation to model the pump
in more detail (see below). The availability of pharmacological inhibitors of the pump
[61] could also make predictions from an extended model testable.
7.1 Future work
The role of a global sensitivity analysis (GSA) in reducing the number of parameters
for analysis has already been mentioned. A computationally efficient GSA method
(the method of elementary effects (EE)) was used because of the large number of pa-
rameters; however, this method could only identify the significant parameters, without
quantifying the contribution of each parameter to the variance of the output, something
which other more computationally expensive (variance-based methods) methods are
able to do [81]. As the EE method already provided a ranking for the parameters, and
as it was confirmed that it was reasonable to focus on just the ten highest ranked pa-
rameters, a variance based method could be applied to quantify the percentage which
each of these parameters contribute to the variance output, potentially reducing the
subspace of interest further.
Following the GSA and parameter optimisation results, an important next step
would be to extend the Ca2+- mobilisation model by including a more mechanistic
representation of Ca2+’s interaction with the SERCA pump. Also, variant extensions
of the model can be derived by incorporating different GPCR desensitisation hypothe-
ses from experimental evidence [105]. The fact that these extensions would increase
model complexity should not be taken lightly. Section 4.8 showed that the method
of elementary effects (especially when combined with an optimised sampling strat-
egy) still identified significant model parameters even when the number of trajectories
was significantly reduced. Less expensive, but useful, global sensitivity analyses could
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therefore be designed for an extension of the model.
The full potential of the Evolution Strategywith Stochastic Ranking (SRES) strategy
may not have been realised with the search parameters used in Chapter 6. The largest
population size ever used was λ = 100, while the biggest number of generations was
G = 300, whereas λ = 350 and G = 8000 have been successfully used for a simpler
optimisation problem [59]. Therefore, even larger parameters might be required for
a more efficient search, which would considerably increase computational expense.
However, the algorithm could be implemented using parallel computing, which can
significantly reduce the computational time, scaling the number of runs by the number
of available processors. It is possible then, that due to a more thorough exploration of
space, a better fit to the Ca2+ data at the intermediate agonist concentrations might be
obtained.
It has been shown that fitting to data from a few different experiments, which pro-
vide complementary information, can allow parameters to be well estimated [3]. The
data that was being fit here was from agonist stimulation experiments by a single drug.
Experiments in which two drugs are used to stimulate (e.g., agonist and antagonist) in
Ca2+-activating pathways are already routinely carried out at the University of Not-
tingham’s Institute of Cell Signalling, so such data can be easily obtained; receptor or
G-protein overexpression experiments are also possible. The latter experiments can be
simulated merely by varying the total receptor or G-protein concentrations, while the
former require extension of the Ca2+ model to include interaction with another drug.
Before attempting to fit such data, tests could be carried out with similar pseudo-data,
to see if the accuracy of parameter estimates from Chapter 6 is improved.
This thesis has demonstrated that, guided by experimental data, computational
methods can be used to glean insight from complex signal transduction models. The
collaborators from the experimental aspect of this work have confirmed that many of
the model predictions are experimentally testable; the results from such experiments
might lead to actual improvements of present therapy strategies.
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Glossary of pharmacological terms
Ligand: The ligand is a molecule that binds to another one to form a complex. The
ligand starts the signalling cascade and is also referred to as the first messenger.
Receptor: The receptor acts as a sensor for the cell. It binds selectively to ligands and
transduces the signal intracellularly.
GPCR: G-protein coupled receptor.
Affinity: This refers to the willingness of one molecule to bind to another [106].
Efficacy: This refers to the ability of a ligand to cause a response by binding.
SecondMessenger: This is the term used to refer to an intracellular molecule activated
as a result of binding, which relays the signal into the interior of the cell. It triggeres a
chain of events that eventually lead to a change in cell behaviour.
Agonist: An agonist is a ligand which has a higher affinity for active receptors. It
will shift the equilibrium in favour of the active receptors. Different agonists can have
different efficacies.
Antagonist: This is a ligand which binds indiscriminately to both states of the receptor.
It does not affect conformational equilibrium, but competes for binding sites with other
ligand types. In essence an antagonist has affinity but no efficacy.
Inverse agonist: This is a ligand which has a higher affinity for inactive receptors.It
will shift the equilibrium in favour of the inactive receptors.
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Dissociation constant (KD: This is the ratio of the dissociation rate constant of a ligand–
protein reaction to its association rate constant.
EC50 : This is the concentration of agonist it takes to produce half the maximal re-
sponse.
Desensitisation: This refers to a process by which the receptor is made unable to re-
spond to ligand application.
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B.1 Description
Here, the parameters for the various models in Chapters 2–6 are described.
Parameter Description Chapter
kact Receptor activation rate constant 2,3,4,5,6
kdeact Receptor deactivation rate constant 2,3,4,5,6
klb+ Drug/ligand binding rate constant 2,3,4,5,6
klb− Drug/ligand unbinding rate constant 2,3,4,5,6
kg+ G-protein binding rate constant 2,3,4,5,6
kg− G-protein unbinding rate constant 2,3,4,5,6
kGTP+ G protein activation rate constant 2,3,4,5,6
kgd+ GTP hydrolysis rate constant 2,3,4,5,6
kRA+ G-protein reassociation rate 2,3,4,5,6
kPLCb+ αGTP and PLC association rate constant 3,4,5,6
kPLCb− αGTP and PLC dissociation rate constant 3,4,5,6
kPLCact αGTPPLC and Ca
2+ association rate constant 3,4,5,6
kPLCdeact αGTPPLC and Ca
2+ dissociation rate constant 3,4,5,6
kPIP2b+ αGTPPLC
∗ and PIP2 association rate constant 3,4,5,6
kPIP2b− αGTPPLC∗ and PIP2 dissociation rate constant 3,4,5,6
kIP3 Rate constant for PIP2 hydrolysis 3,4,5,6
kPLCdis αGDP and PLC dissociation rate constant 3,4,5,6
kIP3deg Rate constant for IP3 degradation 3,4,5,6
kIP3Rb+ IP3 and IP3R association rate constant 3,4,5,6
kIP3Rb− IP3 and IP3 IP3R association rate constant 3,4,5,6
kCa2+act+ Ca
2+ and IP3 IP3R association rate constant (activating) 3,4,5,6
kCa2+act− Ca2+ and IP3IP3R dissociation rate constant 3,4,5,6
Continued on the next page...
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Parameter Description Chapter
kCa2+ inh+ Ca
2+ and Ca2+ IP3 IP3R association rate constant 3,4,5,6
kCa2+ inh− Ca2+ and Ca2+ IP3IP3R dissociation rate constant 3,4,5,6
kdes+ Forward desensitisation rate constant 3,4,5,6
kdes− Reverse desensitisation rate constant 3,4,5,6
kPIP2rep [PIP2] replenishment rate constant 5
ζ,ν,µ,θνµ ,θζµ, θζν Thermodynamic constants (explained in section 1.3.2) 2,3,4,5,6
νr ER to cytosol volume ratio 3,4,5,6
γ0 Basal permeability of the ER 3,4,5,6
γ1 Sensitivity of IP3R to IP3 3,4,5,6
p1 Maximal rate of SERCA 3,4,5,6
p2 [Ca2+] for half-maximal SERCA pumping 3,4,5,6
VP Maximal rate of PMCA 5
KP [Ca
2+] for half-maximal PMCA pumping 5
[L] Ligand (Drug) concentration 2,3,4,5,6
RTOT Total receptor concentration 2,3,4,5,6
GTOT Total G-protein concentration 2,3,4,5,6
PLCTOT Total PLC concentration 3,4,5,6
[PIP2] Total PIP2 concentration 3,4,5,6
[Ca2+AV ] Volume average Ca
2+ concentration,
Ca2++vr[Ca
2+
ER]
1+vr
3,4,6
[IP3RTOT] Total concentration of IP3R 3,4,5,6
Table B.1.1: Descriptions for all parameters.
B.2 Values
Here, the parameter values used in Chapters 2–6 are given.
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Parameter Value
kact 1s
−1
kdeact 10
3s−1
klb+ 8.4× 107M−1s−1
klb− 0.37s−1
kg+ 3.6× 107M−1s−1
kg− 3× 10−3s−1
kGTP+ 1s
−1
kgd+ 0.1s
−1
kRA+ 1.2× 1010M−1s−1
ζ+ 1
ζ− 10−3
µ+ 1
µ− 0.5
ν+ 1
ν− 1
θνµ 1
θζµ 1
θζν 1
Table B.2.1: Parameter values specific to the G-protein activation models, as used in
Chapter 2.
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Parameter Preliminary Base GSA-guided
kact 1s
−1 10s−1
kdeact 10
3s−1 104s−1
kg+ 3.6× 107M−1s−1 3.6× 108M−1s−1
kg− 3× 10−3s−1 3× 10−2s−1
kGTP+ 1s
−1 0.001s−1 0.01s−1
kgd+ 0.1s
−1 1s−1
kRA+ 1.2× 1010M−1s−1 1.2× 1011M−1s−1
ζ+ 1
ζ− 10−3
µ+ 1
µ− 0.5
ν+ 1 100
ν− 1
θνµ 1
θζµ 1
θζν 1
kPLCb+ 2.25× 106M−1s−1 2.25× 107M−1s−1
kPLCb− 1s−1 10s−1
kPLCact 30× 106M−1s−1 30× 107M−1s−1
kPLCdeact 1s
−1 10s−1
kPIP2b+ 10
9M−1s−1 1011M−1s−1 1012M−1s−1
kPIP2b− 5× 103s−1 5× 104s−1
kIP3 100s
−1 50000, 500000s−1
kPLCdis 1.667s
−1 16.67s−1
kIP3deg 2.5s
−1 25s−1
kIP3Rb+ 1.2× 107M−1s−1 1.2× 109M−1s−1 1.2× 1010M−1s−1
kIP3Rb− 8s
−1 80s−1
kCa2+act+ 15× 106M−1s−1 15× 107M−1s−1
kCa2+act− 1.65s−1 16.5s−1
kCa2+inh+ 1.8× 106M−1s−1 1.8× 105M−1s−1 1.8× 106M−1s−1
kCa2+inh− 0.21s−1 2.1s−1
kdes+ 0 2.75× 10−2s−1 2.75× 10−1s−1
kPKCdes− 0 2.75× 10−6s−1 2.75× 10−5s−1
vr 0.185
γ0 0.2s
−1
γ1 40× 106M−1s−1 40× 107M−1s−1
p1 6× 10−6Ms−1 6× 10−5Ms−1
p2 0.45× 10−6M
[GTOT] 4.15× 10−10M 4.15× 10−6M
[RTOT] 4.15× 10−10M 10−8M
[PLCTOT] 0.8× 10−6M
[PIP2] 25× 10−6M
[Ca2+AV ] 0.78× 10−6M
[IP3RTOT] 0.8× 10−6M
KP 0.425× 10−6M
VP 28× 10−6Ms−1 28× 10−13Ms−1
kPIP2rep 0.015, 0.1s
−1
Table B.2.2: Parameter values for the Ca2+ models in Chapters 3, 4, 5 and 6.
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B.3 The Ca2+ mobilisation model
The Ca2+ mobilisation model assembled in Chapter 3 is given here. Note that in the
first half of that chapter, GPCR desensitisation was not included (kdes+ = kdes− = 0).
d[R]
dt
= −kact[R] + kdeact[R∗]− klb+[L][R] + klb−[LR]
−kg+[R][G] + kg−[RG] (B.1)
d[R∗]
dt
= kact[R]− kdeact[R∗]− ζ+klb+[L][R∗] + ζ−klb−[LR∗]
−µ+kg+[R∗][G] + µ−kg−[R∗G]
+kGTP+[R
∗G] (B.2)
d[LR]
dt
= klb+[L][R]− klb−[LR]− ζ+kact[LR] + ζ−kdeact[LR∗]
−ν+kg+[LR][G] + ν−kg−[LRG] (B.3)
d[LR∗]
dt
= ζ+klb+[L][R
∗]− ζ−klb−[LR∗] + ζ+kact[LR]− ζ−kdeact[LR∗]
−θνµµ+ν+kg+[LR∗][G] + θνµµ−ν−kg−[LR∗G]
+ν−kGTP+[LR∗G] (B.4)
d[RG]
dt
= kg+[R][G]− kg−[RG]− µ+kact[RG] + µ−kdeact[R∗G]
−ν+klb+[L][RG] + ν−klb−[LRG] (B.5)
d[R∗G]
dt
= µ+kg+[R
∗][G]− µ−kg−[R∗G] + µ+kact[RG]− µ−kdeact[R∗G]
−θζνζ+ν+klb+[L][R∗G] + θζνζ−ν−klb−[LR∗G]
−kGTP+[R∗G]− kdes+[R∗G] + kdes−[R∗desG] (B.6)
d[LRG]
dt
= ν+kg+[LR][G]− ν−kg−[LRG]− θζµζ+µ+kact[LRG]
+θζµζ−µ−kdeact[LR∗G] + ν+klb+[L][RG]− ν−klb−[LRG] (B.7)
d[LR∗G]
dt
= θνµµ+ν+kg+[LR
∗][G]− θνµµ−ν−kg−[LR∗G]
+θζµζ+µ+kact[LRG]− θζµζ−µ−kdeact[LR∗G]
+θζνζ+ν+klb+[L][R
∗G]− θζνζ−ν−klb−[LR∗G]
−ν−kGTP+[LR∗G]− kdes+[LR∗G] + kdes−[LR∗desG] (B.8)
d[G]
dt
= −ν+kg+[LR][G] + ν−kg−[LRG]
−θνµµ+ν+kg+[LR∗][G] + θνµµ−ν−kg−[LR∗G]
−µ+kg+[R∗][G] + µ−kg−[R∗G]
−kg+[R][G] + kg−[RG] + kRA+[αGDP][βγ]− kRA−[G] (B.9)
d[αGTP]
dt
= kGTP+[R
∗G]− kGTP−[R∗][αGTP][βγ]− kgd+[αGTP] + kgd−[αGDP]
−ν+kGTP−[LR∗][αGTP][βγ] + ν−kGTP+[LR∗G]
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−kPLCb+[αGTP][PLC] + kPLCb−[αGTPPLC] (B.10)
d[βγ]
dt
= = kGTP+[R
∗G] + ν−kGTP+[LR∗G]− kRA+[αGDP][βγ] (B.11)
d[αGDP]
dt
= kgd+[αGTP]− kRA+[αGDP][βγ] + kPLCdis[αGTPPLC∗] (B.12)
d[PLC]
dt
= −kPLCb+[αGTP][PLC] + kPLCb−[αGTPPLC]
+kPLCdis[αGTPPLC
∗] (B.13)
d[αGTPPLC]
dt
= kPLCb+[αGTP][PLC]− kPLCb−[αGTPPLC]
−kPLCact[αGTPPLC][Ca2+] + kPLCdeact[αGTPPLC∗] (B.14)
d[αGTPPLC
∗]
dt
= kPLCact[αGTPPLC][Ca
2+]− kPLCdeact[αGTPPLC∗]
−kPIP2b+[αGTPPLC∗][PIP2] + kPIP2b−[αGTPPLC∗PIP2]
+kIP3 [αGTPPLC
∗PIP2]− kPLCdis[αGTPPLC∗] (B.15)
d[αGTPPLC
∗PIP2]
dt
= kPIP2b+[αGTPPLC
∗][PIP2]− kPIP2b−[αGTPPLC∗PIP2]
−kIP3 [αGTPPLC∗PIP2] (B.16)
d[IP3]
dt
= kIP3 [αGTPPLC
∗PIP2]− kIP3deg[IP3]
−kIP3Rb+[IP3][IP3R] + kIP3Rb−[IP3 IP3R] (B.17)
d[IP3R]
dt
= −kIP3Rb+[IP3][IP3R] + kIP3Rb−[IP3 IP3R] (B.18)
d[IP3 IP3R]
dt
= kIP3Rb+[IP3][IP3R]− kIP3Rb−[IP3 IP3R]
−kIP3Ract+[IP3 IP3R][Ca2+] + kIP3Ract−[IP3 IP3RCa2+] (B.19)
d[Ca2+ ]
dt
= (1+ vr)(γ0 + γ1[IP3 IP3RCa
2+])([CAV ]− [Ca2+])
− p1[Ca
2+]2
[Ca2+]2 + p22
(B.20)
d[IP3 IP3RCa2+]
dt
= kIP3Ract+[IP3 IP3R][Ca
2+]− kIP3Ract−[IP3 IP3RCa2+]
−kIP3Rinh+[IP3 IP3RCa2+][Ca2+]
+kIP3Rinh−[IP3 IP3RCa
2+Ca2+] (B.21)
d[IP3 IP3RCa2+Ca2+]
dt
= kIP3Rinh+[IP3 IP3RCa
2+][Ca2+]
−kIP3Rinh−[IP3 IP3RCa2+Ca2+] (B.22)
d[R∗desG]
dt
= kdes+[R
∗G]− kdes−[R∗desG] (B.23)
d[LR∗desG]
dt
= kdes+[LR
∗G]− kdes−[LR∗desG] (B.24)
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C.1 Parameter bounds and labels
Parameter Label Range Unit
RTOT 1 10
−10 − 10−6 M
GTOT 2 10
−10 − 10−6 M
PLCTOT 3 8× 10−9 − 8× 10−5 M
IP3RTOT 4 8× 10−9 − 8× 10−5 M
[PIP2] 5 2.5× 10−7 − 2.5× 10−3 M
ζ− 6 10−3 − 10−2 Unitless
ζ+ 7 10
−1 − 1 Unitless
µ− 8 10−3 − 10−2 Unitless
µ+ 9 10
−1 − 1 Unitless
ν− 10 3.162× 10−1 − 3.162 Unitless
ν+ 11 31.62− 316.2 Unitless
kdeact 12 100− 10000 s−1
kact 13 10
−1 − 1 s−1
kg− 14 3× 10−4 − 3× 10−2 s−1
kg+ 15 3.6× 108 − 3.6× 1010 M−1s−1
kGTP+ 16 10
−4 − 10−2 s−1
kRA+ 17 1.2× 109 − 3.6× 1011 M−1s−1
kgd+ 18 10
−2 − 1 s−1
klb+ 19 288.56− 28856 M−1s−1
klb− 20 0.14× 101 − 0.14× 103 s−1
kPLCb+ 21 2.25× 105 − 2.25× 107 M−1s−1
Continued on the next page...
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Parameter Label Range Unit
kPLCb− 22 10−1 − 10 s−1
kPLCact 23 30× 105 − 30× 107 M−1s−1
kPLCdeact 24 10
−1 − 10 s−1
kPLCdis 25 1.667× 10−1 − 16.67 s−1
kIP3deg 26 2.5× 10−1 − 25 s−1
kIP3 27 10− 1000 s−1
kPIP2b+ 28 10
10 − 1012 M−1s−1
kPIP2b− 29 5× 102 − 5× 104 s−1
kIP3Rb+ 30 1.2× 108 − 1.2× 1010 M−1s−1
kIP3Rb− 31 8× 10−1 − 8× 101 s−1
kCa2+act+ 32 15× 105 − 15× 107 M−1s−1
kCa2+act− 33 1.65× 10−1 − 16.5 s−1
kCa2+ inh+ 34 1.8× 104 − 1.8× 106 M−1s−1
kCa2+ inh− 35 0.21× 10−1 − 2.1 s−1
kdes+ 36 2.75× 10−3 − 2.75× 10−1 s−1
kPKCdes− 37 2.75× 10−7 − 2.75× 10−5 s−1
γ1 38 20× 104 − 20× 108 M−1s−1
p1 39 6× 10−8 − 6× 10−4 Ms−1
p2 40 0.45× 10−8 − 0.45× 10−4 M
Table C.1.1: Model parameters and their corresponding labels, as used in the sensitivity
analysis in Chapter 4.
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C.2 Sensitivity results for Chapter 4
Ranking Parameter Overall sensitivity (S
′
AR)
1 p2 0.76
2 p1 0.75
3 kdes+ 0.72
4 IP3RTOT 0.72
5 kIP3deg 0.63
6 [PIP2 ] 0.62
7 kCa2+act− 0.57
8 γ1 0.57
9 kPIP2b+ 0.53
10 kIP3 0.52
11 kCa2+act+ 0.51
12 kPLCdis 0.50
13 kIP3Rb+ 0.49
14 kIP3Rb− 0.49
15 kPIP2b− 0.46
16 kGTP+ 0.46
17 kdeact 0.45
18 kPKCdes− 0.41
19 kact 0.41
20 GTOT 0.41
21 RTOT 0.38
22 µ− 0.25
23 µ+ 0.23
24 PLCTOT 0.23
25 kgd+ 0.21
26 kPLCb+ 0.21
27 kPLCact 0.17
28 kPLCb− 0.13
29 ζ+ 0.11
30 ν+ 0.09
31 kCa2+inh− 0.08
32 kCa2+inh+ 0.08
33 ν− 0.07
34 ζ− 0.07
35 kPLCdeact 0.07
36 klb+ 0.06
37 klb− 0.06
38 kg− 0.05
39 kg+ 0.04
40 kRA+ 0.01
Table C.2.1:Model parameters ranked according to their overall influence on the five ob-
jective functions, as quantified by (4.36), produced with r = 1000 trajectories. Averaged
over parameter subspaces 1 and 2.
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C.3 Extra simulations for Chapter 4
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Figure C.1: The rates of the reversible reactions involving the least significant rate
constants, 15:kg+ and 14:kg−, 19:klb+ and 20:klb−, 34:kCa2+inh+ and 35:kCa2+inh−, and
24:kPLCdeact, do not reach steady state quickly.
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C.4 GSA (and optimisation) results for Chapter 6
Ranking Parameter Overall score x10λ50 x
10
λ100
x40λ100 Unit
1 kCa2+act− 0.74 149.95 108.30 159.18 s−1
2 kPIP2b+ 0.63 0.395× 1012 3.84× 1012 3.8997× 1012 M−1s−1
3 kIP3Rb− 0.62 536.5 447.01 670.49 s
−1
4 p1 0.61 3.02× 10−4 5.96× 10−4 5.8526× 10−3 M−1s−1
5 kIP3Rb+ 0.59 0.82× 1010 1.04× 1010 0.83067× 1010 M−1s−1
6 kdes+ 0.54 1.43 2.16 2.1102 s
−1
7 [PIP2 ] 0.51 3.997× 10−4 0.366× 10−4 0.97612× 10−4 M
8 kdeact 0.48 15850 37358 58759 s
−1
9 p2 0.47 0.9247× 10−6 2.8684× 10−6 1.1462× 10−6 M
10 RTOT 0.46 1.682× 10−7 0.44141× 10−7 459.37× 10−7 M
11 kPKCdes− 0.44
12 γ1 0.43
13 kGTP+ 0.42
14 kCa2+act+ 0.42
15 kIP3deg 0.41
16 kact 0.38
17 kPLCact 0.35
18 kPLCdis 0.34
19 kCa2+inh+ 0.33
20 IP3RTOT 0.33
21 µ+ 0.33
22 ν+ 0.30
23 kCa2+inh− 0.30
24 µ− 0.28
25 GTOT 0.28
26 kPLCb− 0.28
27 kg− 0.27
28 PLCTOT 0.18
29 ζ+ 0.16
30 kPLCb+ 0.15
31 klb− 0.15
32 kgd+ 0.12
33 ζ− 0.12
34 kIP3 0.11
35 ν− 0.11
36 klb+ 0.10
37 kPIP2b− 0.08
38 kg+ 0.06
39 kPLCdeact 0.06
40 kRA+ 0.01
Table C.4.1: The ranking of parameters, according to a GSA carried out in a parameter
space constrained around the GSA-guided parameter set (see Table B.2.2). This is the
ranking that was used to reduce the search space in Chapter 6. The best parameter
estimates found from fitting to the experimental data in Chapter 6 are also shown.
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